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CO2 Carbon Dioxide
CoW Circle of Willis
CP Caudate Putamen
CSF Cerebrospinal Fluid
CVR Cerebrovascular Reactivity
DG Dentate Gyrus
Dias Diastole
ECG Electrocardiogram
FAIR Flow-sensitive Alternating Inversion Recovery
FAS Functional Assessment Score
FDR False Discovery Rate
fMRI Functional MRI
FOV Field of View
GFAP Glial Fibrillary Acidic Protein
GM Grey Matter
HADS Hospital Anxiety Depression Scale
HD Huntington’s Disease
HET Heterozygous
HOM Homozygous
i.p. Intraperitoneal
IB Inclusion Body
IPAQ International Physical Activity Questionnaire
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KI Knock -in
M1 Primary Motor Cortex
MAP Mean Arterial Pressure
MCA(v) Middle Cerebral Artery (Velocity)
mHTT Mutant Huntingtin
MRI Magnetic Resonance Imaging
n.s Not significant
NHS Natural Horse Serum
NO Nitrous Oxide
OEF Oxygen Extraction Fraction
PAL Paired Associates Learning
PASL Pulsed Arterial Spin Labelling
pCASL Pseudo-continuous ASL
PET Partial Pressure of End Tidal
PFA Paraformaldehyde
PICORE Proximal Inversion with a Control for Off-Resonance Effects
PVC Partial Volume Correction
QUIPPS Quantitative Imaging of Perfusion using a Single Subtraction
RCT Randomised Clinical Trial
RER Respiratory Exchange Ratio
ROI Region of Interest
ROI Region of Interest
RPE Rating of perceived exhaustion
SCOLP Speed and Capacity of Language Processing
SDMT Symbol Digit Modalities Test
SMC Smooth Muscle Cells
SNR Signal to Noise Ratio
SVD Small Vessel Disease
SVZ Sub-ventricular zone
Sys Systole
TAT Tissue Arrival Time
TBS Tris buffered saline
TCD Transcranial Doppler
TFC Total Functional Capacity
TI Inversion Time
TMS Total Motor Score
TTC Time to Climb
TTT Time to Turn
UHDRS Unified Huntington’s Disease Rating Scale
VEGF Vascular Endothelial Growth Factor
VO2max Maximal Oxygen Volume
WHO-QL World Health Organisation Quality of Life Questionnaire
WM White Matter
WT Wild Type
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Thesis Summary
This thesis explores the benefits of physical activity on cerebrovascular health in 
healthy subjects and in Huntington’s Disease (HD), where cerebrovascular health 
is thought to be jeopardised. A cross-species approach was employed, to inform 
the relevance of MRI findings in humans, using histology and pre-clinical imaging.
In Chapter 2, measurement of cerebrovascular markers using arterial spin labelling 
(ASL) MRI showed that arterial compliance and resting cerebral blood flow was 
lower in subjects with higher cardiorespiratory fitness, whilst differences in 
cerebrovascular reactivity (CVR) to a breath-hold task were not statistically 
significant.
Measurements of vessel density in Chapter 3 showed that running mice had 
greater vessel density than non-running mice following a 6-week voluntary wheel 
running intervention, which may be attributed to a process of angiogenesis.  
Methods developed in healthy subjects were subsequently applied to investigate 
the cerebrovascular benefits of exercise in HD.  In Chapter 4, pre-/early-
symptomatic patients with HD were assessed for subtle differences in 
cerebrovascular health and whether this varied with cardiorespiratory fitness. 
Disease-related differences were observed in cognition, and ASL measures 
including resting CBF and CVR, but no clear relationship with fitness was observed.
Preclinical imaging was used in Chapter 5 to measure longitudinal changes in 
resting CBF and CVR in a transgenic Q175 mouse model of HD, prior to 
behavioural deficits (preHD).  Neither CBF or vessel density differed between 
preHD animals and controls, and did not appear altered by voluntary running.
xiii
It is concluded that physical activity may convey cerebrovascular benefits to 
healthy individuals early in life, including increased arterial compliance, blood flow 
efficiency and angiogenesis, however the pre-/early-stages of HD may be too early 
to detect the cerebrovascular benefits conveyed by physical activity.
xiv
Aims of thesis
A growing body of evidence now demonstrates the link between maintaining a healthy, 
active lifestyle and cognitive health, and that this may be mediated by alterations in 
cerebrovasculature.  Neuroimaging methods are being developed by which to non-
invasively assess these changes in the human brain, however the challenge lies in the 
sensitivity of these methods for detecting these alterations before overt cognitive function 
is affected. The majority of exercise MRI research has been applied to the aged or 
diseased brain. However, it is important that we explore these changes in the young adult 
brain if we are to recommend exercise as a prophylactic for cognitive decline.
Complex interactions between neurons, glia and cerebral blood vessels play critical roles 
in maintaining cerebrovascular health which cannot be addressed using MRI.  
Consequently, the brain’s ability to provide sufficient flow to active regions may lead to 
brain dysfunction. Alterations in these cellular interactions are known to occur in 
Huntington’s Disease and also to be improved by exercise.  Whether exercise can mediate 
these cellular interactions in the context of Huntington’s Disease is not yet known, and will 
be the focus of this thesis. 
This thesis will tackle this question using a translational approach by which use of non-
human subjects, enables interpretation of macrostructural function in terms of 
microstructural changes, using ex vivo histology to complement in vivo MRI. 
The studies described in this thesis, including planning, data collection and analysis were 
carried out by myself except where otherwise indicated,
xv
Human Subjects
Chapter 2:
❖ To identify neuroimaging biomarkers of cerebrovascular health in a cohort of young 
healthy males with a broad range of O2MAX. using PASL in humans
Chapter 4:
❖ To characterise cerebrovascular and cognitive function in pre/early symptomatic 
HD patients compared to matched controls using PASL measures developed in 
Chapter 2.
❖ To address whether CBF changes vary with fitness ( O2peak) and can explain 
differences in cerebrovascular and cognitive function.
Non-human Subjects
Chapter 3:
❖ To investigate changes in blood vessel density following a 6-week voluntary wheel-
running intervention in young healthy male C57/BL6 mice.
Chapter 5:
❖ To measure cerebrovascular function in an asymptomatic male Q175 HD mouse 
model compared to WT controls using PASL MRI (resting CBF and CVR) and 
vascular histology (vessel density).
❖ To assess cerebrovascular changes following a 6-week voluntary wheel-running 
intervention in Q175 mice compared to WT controls. 
1
2Chapter 1
General Introduction
1.1 The cerebrovascular architecture
No organ in the body depends on a continuous supply of blood as much as the brain. 
Interruption of cerebral blood flow (CBF) causes brain function to cease within 
seconds, and leads to irreversible cellular damage within minutes (Hossmann, 1994).  
The brain’s dependence on blood flow is attributable to both its lack of fuel reserves 
and high energy demands. The importance of the cerebrovasculature is frequently 
overlooked, and often thought of as a silent bystander to the healthy function of the 
neuron.  The cerebrovasculature is in fact vastly complex and is constantly working 
to maintain blood flow through 1) prioritisation of systemic circulation to the brain 
when cerebral perfusion is threatened, 2) cerebral autoregulation to protect the brain 
where normal fluctuations in arterial pressure are observed and 3) through regulation 
of CBF distribution according to the functional activity of different brain regions.   
1.1.1. The Cerebrovascular tree
The cerebrovascular system is complex and is made up of different vessel subtypes 
which serve different functions. Large cerebral arteries branch into smaller arteries 
and arterioles that run along the surface of the brain known as the pial arteries. Pial 
arteries consist of an endothelial cell layer, a smooth muscle cell layer and an outer 
layer of leptomeningeal cells, called the adventitia which is separated from the brain 
by the Virchow-Robin space (Peters et al, 1991). As the arterioles penetrate deeper 
into the brain (penetrating arteries), this space disappears and the vascular 
basement membrane comes into direct contact with the astrocytic end feet at the 
level of the intracerebral arterioles and capillaries (Figure 1.1). 
31.1.2. Major cerebral arteries
The major arteries are vital for supplying blood to the brain. Major cerebral arteries 
include the internal carotid (ICA) and vertebral arteries (VA). The ICA’s originate from 
the common carotid arteries, located in the neck, whereas VAs branch from the 
subclavian arteries within the thorax and continue throughout the cervical region of 
the spinal cord. Vertebral arteries anastomose at the level of the brainstem to form 
the basilar artery (BA), which bifurcate to form the left and right posterior cerebral 
arteries (PCAs) whilst the ICAs, bifurcate to form the middle and anterior cerebral 
arteries (MCA and ACA respectively). The Circle of Willis is formed by the 
communicating arteries between the posterior and middle cerebral arteries, and 
between the middle and anterior cerebral arteries (Figure 1.1). 
1.1.3. The neurovascular unit
The neurovascular unit comprises neurons and non-neuronal cells including vascular 
cells (endothelial cells, vascular smooth muscle cells and pericytes) and glia 
(astrocytes, microglia and oligodendroglia). These non-neuronal cells form the 
anatomical, biochemical and immune blood-brain barriers (BBBs) of the central 
nervous system, maintaining the chemical cellular composition of the neuronal 
‘milieu’, required for proper functioning of neuronal synapses and circuitry. 
Perivascular neurons, astrocytes and vascular cells constitute a functional unit, of 
which the main role is to protect the brain by maintaining the homeostasis of the 
cerebral microenvironment. The neurovascular unit also provides a first line of 
defence against the detrimental effects of brain injury such as cerebral ischemia 
(Iadecola, 2004).
4.  
1.2 Healthy cerebrovascular function
1.2.1. Cerebral pressure autoregulation
Cerebral pressure autoregulation is the process by which cerebral arteries and 
arterioles, maintain a constant blood flow (CBF) during changes in cerebral perfusion 
pressure, in order to protect the brain from oxygen and nutrient depletion (Peterson 
et al., 2011).  Quantification of cerebral autoregulation is calculated by measuring 
the variation of CBF in response to changes in blood pressure.  Arterial blood 
pressure can be most accurately measured using an invasive arterial line. However, 
non-invasive finger arterial pressure can also be measured using a volume clamp 
Figure 1.1 Cerebrovascular Architecture. Left) Schematic of the major cerebral arteries. 
The main supply of arterial blood comes from the internal carotid (ICA) and vertebral arteries 
(VA). The VA joins up at the level of the caudal pons to form the basilar artery (BA), which 
together with the ICA supplies the Circle of Willis. The major arteries branching from the Circle 
of Willis are the anterior (ACA), middle (MCA) and posterior (PCS) cerebral arteries.  Right) 
Pial arteries have a dense structure of perivascular nerves (blue) originating from the 
peripheral nervous system in the outer layer (tunica adventitia) of the arteries. Arteries and 
arterioles have a thick middle layer (tunica media) which consists of smooth muscle cells 
(purple) as well as elastin and collagen fibres. The tunica adventitia and media, become 
thinner along the vascular tree such that intracerebral arterioles and capillaries are innervated 
by neurons and interneurons.  Intracerebral arterioles but not capillaries have a single layer 
of smooth muscle cells, and both are surrounded by astrocyte end-feet and pericytes which 
aid blood flow regulation. Figure taken from (Iadecola, 2004. Nature Reviews, Neuroscience, 
207, 2, 141-152). 
5technique, which is an inflatable finger cuff in combination with an 
infrared plethysmograph, or an infrared plethysmograph on its own.
Ever since a study in 1959 which measured total brain blood flow from 7 studies 
involving 11 different patient groups with a wide range of drug- and/or pathology-
induced BP levels (Lassen, 1959; Figure 1.2.), it has been generally well accepted 
that CBF appears to be completely stable across blood pressures, ranging between 
50-150mmHg. Although regularly cited, the view that CBF remains constant within 
this mean arterial pressure (MAP) has come into contention.  For example, one study 
showed that blood flow velocity in the MCA tracked a drop in MAP following release 
of an inflated thigh occlusion cuff used to produce transient hypotension, following 
which CBF recovered quickly (Aaslid et al., 1989).  This and other studies since have 
challenged the classical view that CBF is constant in this range, and that cerebral 
arteries may in fact play an active role in mechanically buffering relative flow in the 
brain (Willie et al., 2014)
Maintaining a continuous CBF profile in the face of changing BP, requires increased 
cerebrovascular resistance within the vessels, that is, a change in vascular tone of 
the smooth muscle cells, to withstand the high-pressure blood flow arising from the 
heart. Whether increased resistance occurs within the smaller pial arterioles alone, 
or whether the major cerebral arteries are also able to be compliant to BP fluctuations 
is under scrutiny (Peterson et al., 2011; Warnert et al., 2015a; Willie et al., 2014).
The majority of research into human cerebral autoregulation uses CBF velocity 
measurements by Transcranial Doppler (TCD) ultrasound assessments of the MCA 
or PCA.  A study by Ainslie et al. (2005) observed increased cerebrovascular 
resistance but no change in peak MCA velocity following a hand grip task.  The 
limitations of TCD will be discussed in more detail below, but it is important to mention 
that TCD measures assumes that cerebral arteries do not change in diameter, and 
may therefore overlook changes in the compliance of the cerebral arteries that 
contribute to altered cerebrovascular resistance (Willie et al., 2011). 
6A recent study using ASL MRI, observed increased cerebrovascular resistance with 
increased BP during post-exercise ischemia, caused by decreased compliance of 
the major cerebral arteries, such as the MCA, with no change in CBF (Warnert et al., 
2015a).  This promising evidence suggests that compliance of the major cerebral 
arteries may actually contribute to autoregulation by buffering BP fluctuations at the 
major vessels and thereby protecting downstream tissue from damage 
(Santisakultarm et al., 2012).
1.2.2. Arterial compliance
Low arterial compliance is associated with increased arterial stiffness.  Arterial 
stiffening occurs with normal ageing and disease, whereby arteries are less able to 
regulate CBF fluctuations with changes in BP such that CBF becomes increasingly 
pulsatile (Figure 1.3). Increased pulsatile stress can lead to damage of small vessel 
walls and has been associated with cerebrovascular pathologies such as cerebral 
Figure 1.2 Cerebral Blood Pressure Autoregulation. Idealised curve demonstrating 
cerebral blood pressure autoregulation. (Lassen, 1959).  Cerebral blood flow is 
thought to remain relatively stable within a wide arterial pressure range (50-
150mmHg) via the process of cerebral autoregulation.  More recent evidence 
suggests that this may not be the case and that cerebral arteries may play a role in 
buffering BP fluctuations (Willie et al., 2014) ; figure taken from (Peterson et al., 
2011).
7small vessel disease (O’Rourke and Hashimoto, 2007), neurodegenerative diseases 
such as Alzheimer’s Disease (Hughes et al., 2015) and cerebral aneurysms (Dusak 
et al., 2013).
Where arterial compliance is inversely related to cerebrovascular resistance (Thiele 
et al., 2011), arteries constrict in response to increases in BP, to resist pressure 
fluctuations.  A decrease in compliance is thought to be caused by an increase in the 
tone of the active smooth muscle cells (SMC) in the arterial walls, since the elastin 
and collagen components are thought to be passive (Bank et al., 1996).  Whilst SMC 
tone does not affect the mechanical properties of the arterial wall at low transmural 
pressures, relative contributions from all three components alters the stiffness of the 
arterial wall.  At high transmural pressures, >100mmHg, an increase in SMC tone 
also causes increases in arterial stiffness (Bank et al., 1995).
1.2.3. Cerebral flood flow regulation
Among the factors that influence CBF are the perivascular nerves which constrict or 
dilate arteries and arterioles (Drake and Iadecola, 2007), the astrocytes which 
envelope arterioles and influence arteriolar diameter (Carmignoto and Gómez-
Gonzalo, 2010), the endothelial cells which release vasodilators (e.g. nitric oxide; 
Figure 1.3 Arterial Compliance. Arterial 
compliance is inversely related to the 
stiffness of the artery wall and is thought to 
be mediated by the tone of the smooth 
muscle cells (SMCs).  In the healthy brain, 
compliant arteries are able to buffer the 
pulsatile blood flow arriving to the brain from 
the heart, such that flow profile into the 
microvessels is smooth.  In the case of 
ageing and disease, arteries become stiffer 
which may be detrimental to downstream 
microvessels where capillaries are prone to 
rupture with pulsatile flow (O’Rourke and 
Safar, 2005).  This could consequently lead 
to small vessel disease and cognitive decline 
(Prins et al., 2005).
8NO) and vasoconstrictors such as endothelin (Faraci and Heistad, 1998), and finally 
the pericytes which can cause capillary contraction and relaxation (Hall et al., 2014).  
Together these factors work together to ensure that the brain is properly perfused, 
and that brain tissue has the oxygen and nutrients it needs to function. If the function 
of one or more of these mechanisms is impaired, the brain is vulnerable to 
hypoperfusion and increasing risk of cerebrovascular disease.  
Endothelial cells produce vasodilators such as nitric oxide (NO), prostacyclin, carbon 
monoxide and the endothelium-derived hyperpolarizing factor, and vasoconstrictors 
such as endothelin and the endothelium-derived constrictor factor (Busse and 
Fleming, 2003; Faraci and Heistad, 1998).  Endothelial reactive oxygen species 
(ROS) also influence vascular tone, whereby they act as vasodilators at low 
concentrations, but can cause vascular dysregulation such as hypertension and 
hyperhomocysteinaemia at high concentrations (Iadecola and Gorelick, 2004). 
Endothelial vasoactive substances are released by receptor-dependent agonists or 
by changes in the viscous drag that is generated at the luminal surface of endothelial 
cells by the flowing blood, known as ‘shear stress’ and the strain upon the vessel 
wall that results from pulsatile changes in blood pressure (Busse and Fleming, 2003).  
Electrical signals between endothelial and/or smooth muscle cells through gap 
junctions mean that vasodilation or constriction can travel rapidly along the vessel 
wall (Segal, 2000). 
Smooth muscle cells and pericytes finally convert the chemical signals that originate 
from endothelial cells, neurons and astrocytes into changes in vascular diameter by 
inducing changes in intracellular Ca2+ concentration and altering the phosphorylation 
state of light chain myosin (Carmignoto and Gómez-Gonzalo, 2010) (Figure 1.4).   
Astrocytic end-feet almost completely surround intra-parenchymal blood vessels and 
also contribute to vasomotor activity through multiple pathways (Stobart and 
Anderson, 2013).  Astrocytes are enriched in potassium (K+) channels.  Potassium 
is released from astrocyte end-feet and the amount of K+ released is directly 
proportional to astrocyte Ca2+ level. Potassium is subsequently taken up into smooth 
muscle through which causes dilation at low concentrations and constriction at high 
concentrations. Intracellular Ca2+ also activates NO to produce CO2, which also 
triggers dilation via the smooth muscle. 
91.3 Cerebrovascular pathology and disease
Poor cerebrovascular function, including reduced blood flow, capillary loss, arterial 
stiffening and breakdown of the BBB, or both, are just some of the factors thought to 
precede many neurodegenerative diseases and or age related cognitive decline (Bell 
et al., 2011; Ruitenberg et al., 2005).  Despite an emerging amount of evidence, there 
is still no consensus regarding the role of the vascular component in 
neurodegeneration (Zlokovic, 2011).  This section will highlight some of these 
cerebrovascular deficits in more detail.
Figure 1.4 Propagation of vasodilation within vessels. Vasodilation from vessels 
in the activated site (arterioles and capillaries) propagates to resistance arteries 
upstream (pial arteries).  Local release of vasoactive agents from neurons and glia 
(astrocytes, pericytes) causes relaxation of the smooth muscle which propagates 
upstream through gap junctions that link neighbouring endothelial and smooth 
muscle cells. An increase in blood flow upstream causes an increase in shear 
stress on endothelial cells which causes further vasodilation through the release of 
endothelium-dependent vasodilators (flow-mediated vasodilation).  (Figure taken 
from Iadecola, 2004, Nature Reviews, Neuroscience, 102, 2, 141-152).
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1.3.1. Arterial Stiffening
Aortic stiffness is known to increase with age and other vascular risk factors, and is 
associated with an increased risk for structural and functional brain abnormalities. In 
cases where cerebral autoregulation is jeopardised or MAP is outside normal limits, 
cerebral microcirculation is exposed to the harmful effects of excessive pressure and 
flow pulsatility. High flow organs such as the brain and kidneys are especially 
sensitive to excessive pressure and flow pulsatility (Mitchell et al., 2008).  High CBF 
is associated with low microvascular impedance, which facilitates penetration of 
excessive pulsatile energy into the microvascular bed.  Pulsatility in the distal arterial 
bed is thought to cause deterioration of vessel walls, which in the brain can manifest 
as cerebral small vessel disease (SVD)(Poels et al., 2012). Incidence of cerebral 
SVD increases with ageing and has been associated with cognitive decline, such as 
slowed processing speed and deficits in executive function (Prins et al., 2005) in 
healthy older people at risk for dementia and Alzheimer’s Disease (AD). 
1.3.2. Hypoxia and angiogenesis  
Whilst interpretation of cerebral angiogenesis is as a beneficial mechanism by the 
brain to increase blood flow by forming new blood vessels from pre-existing vessels, 
increased vascularity is also known to occur in brain pathologies such as tumour 
(Yancopoulos et al., 2000), stroke (Beck and Plate, 2009), AD (Biron et al., 2011) 
and HD (Lin et al., 2013) as a compensatory response to combat deficits in blood 
flow circulation.  In the healthy brain, angiogenesis is initiated by vascular endothelial 
growth factor (VEGF) (LaManna et al., 2004), and this can be triggered in response 
to hypoxia via the hypoxia-inducible factor-1 (HIF-1) transcription factor (Saint-
Geniez and D’Amore, 2004).  
It appears that with age, there is a decline in the capacity for cerebral angiogenesis 
where the responsiveness of HIF-1 to hypoxia decreases (Rivard et al., 1999), 
thereby reducing VEGF expression in ageing (Banderro and LaManna, 2011).  
Failure of the vasculature to recover from hypoxia-induced capillary loss with age 
and disease, is therefore thought to reflect a loss of cerebrovasculature which may 
underpin some of the functional deficits observed.  
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Angiopoietins such as Angiopoietin-1, are a group of proteins that contribute to blood 
vessel maturation and capillary stability.  Pericytes signal the release of angiopoietin-
1 which activates the Tie-2 receptors on endothelial cells. Activation of the Tie-2 
receptors is thought to maintain vascular integrity and stability whereas under 
hypoxic conditions, activation of other angiopoietins such as angiopoietin-2, occupies 
these binding sites such that pericytes move away from the capillaries, consequently 
destabilizing them. 
1.3.3. Blood-brain Barrier Leakage (BBB).  
The BBB refers to the extensive network of capillary blood vessels, comprised of 
highly specialized endothelial cells, which compartmentalize the brain from the 
peripheral blood. The BBB controls the passage of metabolites and other substances 
from the blood to the neurons, via gap junctions between endothelial cells.  Disruption 
of the blood-brain barrier has been strongly implicated in neurodegenerative 
diseases such as AD (Zlokovic, 2011), Parkinson’s Disease (Guan et al., 2013) and 
Huntington’s Disease (Drouin-Ouellet et al., 2015) (Figure 1.5.).  
In AD, recent evidence has observed a deposition of -amyloid within arteries which 
results in cerebral amyloid angiopathy, in more than 80% of AD cases (Jellinger, 
2010). Disruption to the BBB leads to reduced vascular integrity and leakage such 
that peripheral cells are able to enter the CNS compartment, and in doing so, result 
in inflammatory cascades and release of neurotoxins (Zlokovic, 2010).  BBB leakage, 
also leads to a loss of blood flow such that neurodegenerative substances, such as 
mHTT in the case of HD (Drouin-Ouellet et al., 2015) and -amyloid in the case of 
AD, are not properly cleared (Sagare et al., 2012) thereby potentiating blood flow 
dysfunction and vascular-mediated neurodegeneration.  
12
1.3.4. Hypoperfusion
Sufficient cerebral blood flow (CBF) is vital to neuronal function, thus, cerebral 
perfusion (millilitres of blood passing through a volume of tissue over a given duration 
(ml/100g/min)), has been used as a useful indicator of cerebral health. CBF is 
normally coupled to cerebral oxygen metabolism (CMRO2) and glucose consumption 
in steady state (Hoge et al., 1999), such that disruption of this system hints towards 
compromised vascular function and/or metabolism. 
It is not surprising that decreased resting cerebral blood flow (CBF) and 
cerebrovascular reactivity to neuronal activation are associated with an elevated risk 
of cerebrovascular diseases such as AD, stroke and hypertension (Jennings et al., 
2013), and occur with healthy aging (Fisher et al., 2013).  With healthy human aging, 
a progressive decline in CBF has been repeatedly observed in the order of 28–50% 
from the age of 30 to 70 years (Ogoh and Ainslie, 2009).  In AD, perturbations in 
microvascular flow in association with an over-expression of amyloid precursor 
protein, appear to precede detectable neuronal dysfunction (Farkas and Luiten, 
2001). This has led to the belief that CBF may play important roles in the progression 
and clinical expression of neurodegenerative disease.  In AD, loss of cholinergic 
innervation of brain blood vessels (Roman and Kalaria, 2006) is thought to reduce 
cerebral perfusion.  Hypoperfusion is also correlated with increased expression of 
the hypoxia-inducible factor HIF1α and number of white matter lesions (Fernando et 
al., 2006).  Regional effects of age on CBF are thought to be independent of  those 
seen in cortical atrophy, so that reduction in CBF cannot be explained by a decline 
in gross volume differences (J. J. Chen et al., 2011).
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1.4 How can cerebrovascular health be measured in humans?
Evidence of decreased (CBF) over the lifespan and in cerebrovascular disease 
(Stoquart-ElSankari et al., 2007) has been described and is the most widely reported 
non-invasive marker of cerebrovascular health.  CBF can be measured by a number 
of techniques whereby quantification and definition of blood ‘flow’ is variable, but 
used interchangeably. For example, studies utilising trans-cranial Doppler ultrasound 
frequently refer to changes in CBF but do not directly quantify cerebral blood flow, 
rather cerebral blood velocity of major cerebral arteries (e.g. Middle cerebral artery).  
Interpretation of different studies, therefore require an understanding of how CBF is 
quantified.
Figure 1.5  The vascular hypothesis of neurodegeneration. Vascular damage can 
result in reduced CBF and hypoxia from one end and BBB dysfunction from the 
other. The BBB breakdown might lead to accumulation of potentially toxic serum 
proteins inside the brain. Reduced CBF and BBB disruption might contribute to 
secondary neuronal injury and the development of neurodegenerative changes 
(figure taken from Zlokovic, 2010, Nature Medicine, 16, 12, 1370-71).
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1.4.1. Non MRI methods for measuring CBF
1.4.1.1. Single-photon emission computed tomography (SPECT)
SPECT is a 3D nuclear medicine tomographic imaging technique using gamma rays. 
The technique requires delivery of a gamma-emitting radioisotope into the patient via 
intravenous injection. A marker radioisotope is attached to a specific ligand to create 
a radioligand which bind to specific tissue types which can then be viewed using a 
gamma camera.  The most common gamma-emitting tracer used in functional brain 
imaging is 99mTc-HMPAO (hexamethylpropylene amine oxime). Combining 
HMPAO to 99mTc allows it to be taken up by brain tissue in a manner proportional 
to brain blood flow, such that CBF can be assessed. Tight coupling between CBF 
and local brain metabolism means that 99mTc-HMPAO tracer is used to assess 
regional brain metabolism regionally, in an attempt to diagnose and differentiate the 
different causal pathologies of neurodegenerative diseases such as dementia.  
1.4.1.2. Positron Emission Tomography (PET)
Positron emission tomography (PET) is also capable of providing in vivo quantitative 
measures of CBF and H215O PET has evolved to be considered the gold standard 
for studying cerebral hemodynamics (Chen et al., 2008). Caveats of PET imaging 
involves the injection of radioactive tracers, which limit repeatability and application 
in healthy subjects. It also has low temporal and spatial resolution, low signal-to-
noise ratio (SNR), and requires a cyclotron, often rendering it an inconvenient option. 
ASL MRI in contrast is widely available and has a relatively high spatial and temporal 
resolution.
1.4.1.3. Transcranial Doppler (TCD) 
TCD is a type of Doppler ultrasonography that measures the velocity of blood 
flow through the cerebral arteries, by measuring the echoes of ultrasound waves 
moving transcranially.  TCD can be used as an efficient tool to access blood 
velocities within the cerebral vessels, cerebral autoregulation, cerebrovascular 
reactivity to CO2, and neurovascular coupling, in both physiological states and in 
pathological conditions such as stroke (Willie et al., 2011). Compared to MRI, these 
parameters are global measures and not regionally specific.  Developments in TCD 
equipment mean that it is portable and therefore practical for clinical purposes and 
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benefit from being far cheaper than MRI for assessing cerebrovascular function.  A 
drawback of TCD is that it cannot measure arterial geometry, such as volume or 
diameter such that changes in blood flow velocity can only be interpreted by if there 
is no change in arterial diameter. Accurate TCD sonography assessment also relies 
upon the examiner’s technical skill and anatomical knowledge.
1.4.2. MRI methods for measuring CBF
1.4.2.1. DSC-MRI
Dynamic contrast enhanced (DCE)-MRI is performed by acquiring a dynamic image 
in which an intravenous bolus of standard small molecular weight gadolinium-based 
contrast agent is injected in to the subject. Signal intensity changes can be analysed 
to derive parametric maps of microvascular biomarkers. MR images can be acquired 
using either T2 * or T2 weighting (also known as dynamic susceptibility contrast MRI 
(DSC-MRI)) or T1 weighting (T1 weighted DCE-MRI).  
DSC-MRI is currently the clinical method of choice for measurement of cerebral blood 
flow (CBF) and Cerebral Blood Volume (CBV) with MRI.  DSC-MRI images result 
from changes in local field strength within the tissue induced by the paramagnetic 
contrast molecules. Water molecules at some distance from the contrast can be 
affected, so that the apparent contrast agent concentration measurement will be 
dependent upon the local vascular structure. For example, the same amount of 
contrast in a diffuse capillary bed will have a larger signal than it would if contrast 
were concentrated in a single large vessel, due to dispersion of the local changes in 
field strength (O’Connor et al., 2011). Imaging of signal changes resulting from T2* 
and matched T2 weighted sequences, where susceptibility effects are smaller, can 
be used to gain information regarding the size and distribution of blood vessels within 
the voxel, known as "vessel size imaging" (Batchelor et al., 2010).
A caveat of DSC-MRI is that increased blood-brain barrier permeability can cause 
extravasation of the contrast agent where susceptibility contrast is reduced, such that 
signal appears to be greater (Sourbron et al., 2009).  This can be an issue in diseases 
where BBB is thought to be disrupted. Another major source of error in DSC-MRI is 
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the difference between blood and tissue relaxivity which needs to be accurately 
estimated as this enters into the quantification of CBV and CBF (Kiselev, 2005).
1.4.2.2. Arterial Spin Labelling (ASL)
ASL utilises blood as an endogenous tracer whereby arterial blood water is
magnetically labelled and then imaged.  Arterial blood water is first magnetically 
labelled below the region (slice) of interest by applying a 180 radiofrequency (RF) 
inversion pulse.  This inversion pulse leads to a net magnetisation of blood water that
flows into the tissue of interest after a period (inflow time) where it exchanges with 
tissue water.   Inflowing inverted spins within the blood water subsequently reduce 
the tissue magnetization and attenuate the MR signal.  During this time, an image is
taken (known as the tag image).  Acquisition of an image in which arterial blood has 
not been labelled, is known as the control image.  A perfusion image is calculated by 
subtraction of the control image from the tag image to produce a perfusion image, 
also referred to as cerebral blood flow.  This image will reflect the amount of arterial 
blood delivered to each voxel of tissue within the inflow time (Figure 1.6).
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1.4.2.2.1. ASL labelling schemes. 
There are two main ASL labelling schemes, these are pulsed arterial spin labelling 
(PASL) and pseudo-continuous ASL (pCASL). Pseudo-continuous ASL evolved from 
the continuous ASL (CASL) labelling scheme whereby hydrogen molecules are 
continuously inverted as blood flows through the tagging plane, using a relatively 
long radiofrequency (RF) pulse (~ 1-2 seconds). The need for a long and continuous 
RF pulse meant that this method was not feasible for use in humans due to high 
specific absorption rates (SAR) and specialist system hardware, such that the 
development of pCASL came about.  In pCASL a single, long, RF pulse is substituted 
for a train of short RF pulses.  In comparison, pulsed ASL (PASL) magnetically labels 
the blood with a single short RF pulse covering a large slab of tissue (~10-20 cm).  
pCASL has benefits over PASL, since the longer labelling duration, yields potential 
for increasing the signal-to-noise ratio (SNR).
Figure 1.6. Basic PASL principles. Blood is magnetically labelled in the neck, and 
an image is acquired in the brain after an inflow time.  A control image in which 
blood has not been magnetically labelled produces a change in signal intensity 
proportional to the exchange of water into the tissue (i.e. perfusion).  Models can be 
used to quantify the amount of blood delivered per 100 g brain tissue per minute 
(ml/100 gr/min)(Buxton et al., 1998).
18
1.4.2.2.1.1. Pulsed ASL (PASL)
PASL sequences differ according to the zone of labelling with respect to the slices, 
known as symmetrical and asymmetrical (Ferré et al., 2013). 
Symmetric Methods.  The basic symmetrical method is flow alternating inversion 
recovery (FAIR), in which the control image is acquired using a non-selective global 
inversion pulse, and the tag image is acquired with a slice-selective gradient for 
labelling (Kim, 1995; Figure 1.7). During the slice-selective inversion time, intra-
vascular spins are fully relaxed. During the non-selective global inversion time, 
inflowing spins were relaxing back to M0 according to T1. Static tissue should have 
relaxed to the same extent in both images, such that residual signal within the image 
is flow weighted. By measuring the T1 of grey matter, the effect of the inflowing spins 
on the apparent T1 relaxation constant (T1app) following the slice selective inversion 
can be used to quantify CBF. The symmetric nature of this sequence automatically 
thereby compensates for MT effects.
Figure 1.7 FAIR Imaging Principles. The flow-sensitive alternating inversion-
recovery (FAIR) pulse sequence generates tagged and control images. The tagged 
images (a) are produced after applying a slice-selective 180 inversion pulse to the 
imaging slice; Since the spins outside the imaging plane are not inverted, their entry 
into the imaging slice as the result of blood flow will modulate the T1 relaxation of 
the imaging slice. The control images (b) are produced at the same plane as 
marked in (a) but after applying a non-slice-selective inversion pulse to the entire 
sensitive volume of the RF coil as shown by the gray area in (b). 
19
Asymmetrical methods.  Asymmetrical methods such as echo-planar MR imaging 
and signal targeting with alternative radio frequency (EPISTAR) have a thick labelling 
zone of ~10–15 mm, located upstream from the volume of interest.  An inversion 
pulse labels the blood after saturation of the magnetization. During the control 
acquisition, the inversion volume is located downstream from the volume of interest 
to control for MT effects (Edelman et al., 2004).  Several modifications of this 
sequence have been made since such that multiple slices could be properly acquired 
(Edelman and Chen, 1998), including limiting the MT effects (TILT sequence) (Golay 
et al., 1999), improving the profile of the labelling slice (PICORE) (Wong et al., 1998) 
and to reduce the sensitivity of the arterial transit time (QUIPPS, QUIPPS II, Q2TIPS 
sequences) (Luh et al., 1999; Wong et al., 1998) and these are the most common 
PASL sequences used in human imaging.
1.5 What is Cardiorespiratory Fitness and how can it be 
measured?
Cardiorespiratory fitness refers to the ability of the circulatory and respiratory 
systems to supply oxygen to the body during sustained physical activity.  Fitness can 
be improved by regular exercise, where oxygen delivery becomes more efficient, 
through a number of mechanisms, including enlargement of the heart muscle to 
provide more blood to the body, and by increasing the number of small arteries that 
supply oxygen to the metabolising tissue.
Research methods for investigating the link between cardiorespiratory fitness and 
cerebral health are broad, and can be split into cross-sectional or interventional 
designs.  Interventional studies attempt to address within-subject differences, by 
making measurements before and after a well-defined exercise programme.  Whilst 
interventions are more beneficial for assessing causation, they have more 
methodological challenges since they are often time-consuming, expensive and 
require more participant investment.  Cross-sectional studies tend to take a single 
measure of cardiorespiratory fitness as the independent variable, and correlate these 
scores with aspects of brain function and for identifying individual differences.  These 
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will be the basis of the human methods used in this thesis.  There are several means 
of measuring fitness, and these will be discussed in this section.
1.5.1. Self-report
Subjective physical activity is most commonly measured via self-report, making this 
an easy, low-cost measure and more efficient when large sample sizes are required.   
A big caveat, is that self-reported physical activity, especially where clear desirability 
biases are present, due to lack of understanding, differing perceptions of item content 
and cross-cultural reliability (Sallis and Saelens, 2000).  It is recommended that 
internationally validated tests such as the International Physical Activity 
Questionnaire (IPAQ) should be used where possible (Craig et al., 2003).
1.5.2. Accelerometry
Accelerometry is often used as an objective measure of physical activity, as the 
device is light to carry and non-invasive.  Data from accelerometers are not, however, 
entirely accurate since more common accelerometers are unable to detect increased 
energy cost from upper body movements, load carriage, or changes in terrain 
(Hendelman et al., 2000). More advanced measures such as acceleration signals 
recorded at different locations such as lower back, heels and wrists may improve 
accuracy and information about gait, especially in clinical populations (Micó-Amigo 
et al., 2016).
1.5.3. The O2MAX test
The O2MAX test is considered the gold standard test of maximal oxygen uptake and 
is a fundamental measure of cardiorespiratory fitness, where O2MAX refers to the 
maximal capacity for oxygen consumption at a maximal rate of exertion (Hill, Long 
and Lupton, 1924). O2MAX values can be reported as an absolute rate of litres of 
oxygen per minute (L/min), but are more commonly reported as a relative rate, 
standardized by body mass (mL/ min/Kg) such that values can be compared across 
individuals.  Typical exercise tests take place on a treadmill or cycle ergometer, 
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whereby intensity is progressively increased while measuring the end-tidal gases for 
measures of ventilation O2 and CO2.
O2 is defined as the amount of oxygen taken up, transported, and used at the 
cellular level by the body, and is the difference between the amount of O2 inspired 
and O2 expired (Plowman and Smith, 2003, p. 124).  Working muscles increase 
oxygen uptake as a result of increased cardiac output (heart rate × stroke volume), 
which may increase to up to 6 times resting heart rate. Cardiac output is also 
redistributed away from non-active tissues to the skeletal muscles, to prioritise 
O2 delivery where it is most needed. Blood flow increases due to an increase in both 
the cardiac output and by vasodilation of the blood vessels.  As O2 is extracted from 
the blood into the perfusing tissue, a widening of the arteriovenous oxygen (a− O2) 
difference is seen.  
Accurate O2MAX tests require intense physical effort for a sufficient period, such that 
the aerobic energy system is fully exerted, and such that O2 plateaus.  It is not 
uncommon for subjects to complete a graded exercise test without reaching this 
classical plateau.  As such several secondary criteria have been established in 
guidelines by the American College of Sports Medicine (2010) to characterize 
whether a O2MAX has been reached. These include 1) high levels of blood lactate 
(8mmol-1) post exercise (Howley et al., 1995) 2) elevated respiratory exchange ratio 
(RER) >1.0 (Aspenes et al., 2011), >1.10 (Nelson et al., 2010), or > 1.15 (Howley et 
al., 1995) 3) Percentage of subject’s age adjusted maximal heart rate. 85% of 220-
age (Jackson et al., 2009) or 95% of 220-age (Edvardsen et al., 2014) 4) subject’s 
rating of perceived exertion (RPE) using the Borg Scale rating or Visual Analog Scale 
(Church et al., 2008). Consensus of the best criteria to use are varied, with a great 
deal of subject exclusion in older cohorts where rigid criteria are used (Edvardsen et 
al., 2014).
Cardiac output, pulmonary diffusion capacity, oxygen carrying capacity, and 
peripheral limitations like muscle diffusion capacity, mitochondrial enzymes, and 
capillary density are all determinants of O2MAX. If one of these factors is not 
functioning properly, as might be expected in ageing and disease, then this will affect 
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O2MAX. Since this test is the most widely used and most accurate measure of 
aerobic fitness, this test has been adopted as the method of choice in this thesis.
1.5.4. Predictive O2MAX tests
In many cases, it is not feasible to carry out a full O2MAX.  test and thus predictive 
tests are used to estimate O2MAX.  where ventilation information is not available.  
Validated tests include the Storer Maximal Bicycle Test (Storer et al., 1990) and the 
submaximal Rockport Walking Test (George et al., 1998), The 1-Mile Jog Test 
(George et al., 1998), Single Stage Submaximal Treadmill Test  (Waddoups et al., 
2008) and The YMCA Submaximal Bicycle Test (YMCA, 1989), which have been 
shown to correlate with O2MAX.  at an R > 0.85.  The most well validated however, 
is the Storer Maximal Bicycle Test which has R>0.93, by accounting for variance 
associated with age, gender, weight and maximal load (Storer et al., 1990).  End-
tidal measurements make O2MAX. a favourable measure of fitness, however 
calculation of predicted O2MAX is an interesting measure to complement O2MAX
since it can account for gender differences in O.
1.6 Aerobic exercise for improving cerebrovascular health
The British Heart Foundation (Townsend et al., 2015) recommends that adults 
engage in physical activity for >10mins per day, totalling 150mins of moderate 
exercise or 75mins vigorous exercise per week, in order to maintain health and 
wellbeing.  Whilst exercise-related benefits have been well documented in chronic 
systemic illnesses such as cardiovascular disease, cancer, diabetes, obesity, 
hypertension and osteoporosis (Warburton et al., 2006), the benefits to the brain 
have only been addressed in the past couple of decades.  A great deal of research 
is now focussing on the long-term side effects of inactivity upon mental health and 
cognition, and whether exercise should be recommended as a preventative measure 
for cognitive decline and general cerebral health.  In review of the neurological 
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changes that are taking place in the brain therefore, we need to look to research from 
both humans and animals.
1.6.1. Cognitive Function associated with Exercise
Maintaining a physically active lifestyle has been associated with benefits to cognitive 
function and differences in cognitive functioning can provide a useful metric by which 
to assess the beneficial outcomes of exercise (Dupuy et al., 2015; Wendell et al., 
2013). Meta-analyses have demonstrated that the greatest benefits occur on 
measures of executive control such as task coordination, planning, goal 
maintenance, working memory, and task switching (Colcombe and Kramer, 2003; 
Dupuy et al., 2015). These declines, particularly when they escalate to dementia, can 
have a dramatic impact on the independence, safety, activities of daily living, and 
overall quality of life of older adults.  A cross-sectional study in older highly fit and 
aerobically trained individuals, showed task relevant increases in prefrontal and 
parietal cortices, which are regions involved in spatial selection and inhibitory 
functioning (Colcombe et al., 2004).  Interventional studies have also reported 
alterations in WM (Colcombe et al., 2006; Voss et al., 2013) and GM (Erickson et al., 
2011) structure within task functionally relevant regions, as well as functional 
alterations in fMRI BOLD during a motor task in regions including the hippocampus 
and frontal lobe (Voelcker-Rehage et al., 2010). 
Few studies have observed any cognitive benefits of physical activity in young 
people, due to ceiling effects in the tests used, or compensatory strategies that may 
mask impaired functioning in implicated brain regions (Hillman et al., 2006). Studies
that have detected fitness related differences in young adults have measured 
performance on tasks sensitive to executive function, such as the stop signal reaction 
time task (SSRT) (Mujika and Padilla, 2001), Stroop (Dupuy et al., 2015) and task 
switching (Kamijo and Takeda, 2010), although the evidence is not unequivocal and 
it has been recommended that only strongly theoretically driven tasks be used (Etnier 
et al., 2009). 
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1.6.2. Cerebrovascular benefits of exercise: Ageing and Disease
The view that cerebrovascular health may mediate the positive association between 
physical exercise and a better cognitive reserve, is becoming increasingly 
widespread (Davenport et al., 2012). In a study of women aged 50-90 years old, it 
was found that physically fit women had a lower resting arterial pressure (MAP) and 
greater cerebrovascular tone (cerebrovascular conductance (CVC)) than sedentary 
women, and that these cerebrovascular measures were predicted by O2MAX.  
Fitness in addition to measures of macrovascular health are also able to predict 
global cognitive function, particularly in domains of cognitive speed, verbal ability, 
perception, and executive function (Brown et al., 2010).  
MRI studies have provided further evidence for the mediating link between fitness 
and cognitive function. Using ASL, Zimmerman et al., (2014) reported that age-
related declines in CBF could be explained by declines in aerobic fitness and that 
CBF was related to alterations in MAP. In a short term interventional study, subjects 
aged 57-75 years carried out a 12-week aerobic exercise intervention, 3 times/week 
and PASL MRI was carried out at 3 time points at baseline, mid and post training.  
Higher resting CBF was observed within the anterior cingulate and hippocampus, 
following exercise and hippocampal CBF was correlated with improved memory 
performance after just 12 weeks of training (Chapman et al., 2013), indicating that 
CBF may be the mediating factor between ageing and cognitive function, and that 
this can be moderated by exercise, at least in later life.  
1.6.3. Cerebrovascular benefits of exercise: Young adulthood
There is some evidence that has reported a positive association between chronic 
physical activity and cerebrovascular functioning in young healthy adults. In a cross-
sectional TCD study involving sedentary and aerobically trained healthy young and 
older adults, Bailey et al.  (2013) reported a positive relationship between fitness 
( O2MAX) and 1) resting blood flow velocity of the middle cerebral artery (MCAv) as 
well as 2) MCAv response to hypercapnia (cerebrovascular reactivity). In another 
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study of young and elderly adults, a 12-week aerobic intervention did not find a 
fitness related elevation in resting MCAv although an MCAv CVR did increase by 10-
15% (Murrell et al., 2013).  Barnes et al. (2013) however, observed a positive 
relationship between MCAv and  O2MAX, both at rest and in response to 
hypercapnia, but only in elderly adults and not in the younger cohort.  
The scarcity of research reporting exercise related differences in cerebrovascular 
function suggests that we need to identify more sensitive markers of vascular health.  
It is fundamentally important to understand whether exercise is beneficial earlier in 
life, despite the absence of any apparent cognitive decline since exploring this 
question in late adulthood may mean missing a critical window for preventative 
interventions, whereby health, mobility and task processing become more difficult 
with age.  It is also worth noting that naturally occurring variation in fitness levels 
within the general ‘non-athletic’ population is narrow, and it may be that the absence 
in the observed association between fitness ( O2MAX) and outcome measures of 
cerebrovascular health cannot be teased apart where the sample is tightly clustered 
around the norm.  Studying a broader range of fitness levels within an experimental 
sample may help resolve this issue.
1.6.4. Cerebrovascular benefits of exercise: Preclinical Studies
Despite its common usage as a marker of cerebrovascular health, what drives 
alterations in CBF between individuals is less clear since it can be due to a number 
of mechanical, neuronal and chemical factors which are difficult to quantify non-
invasively in the human brain.  The benefit of using animal models, is the ability to 
measure neuroprotective physiological and cognitive enhancing effects of physical 
activity since potential to manipulate exercise intensity (aerobic vs anaerobic), 
duration (chronic vs acute) and methods (voluntary wheel running vs forced treadmill 
running) is far more versatile than in humans.  The use of non-human animals, is 
also better suited for determining the physiological and neurochemical mechanisms 
that underpin some of the macroscopic effects described above.  Observing changes 
in the human brain non-invasively enables us to guide the questions we ask in non-
human studies. Interpreting similar MRI differences in combination with the molecular 
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context, then allows us to translate our findings from rodents back into interpretation 
of human MRI research. 
Evidence from preclinical research studies suggest that exercise may exert its 
mediatory effects by a range of mechanisms. Production and release of 
neurotrophins such as vascular endothelial growth factor (VEGF; Udo et al., 2008), 
brain derived neurotrophic factor (BDNF; van Praag et al., 1999) and nerve growth 
factor (NGF; Hall et al., 2013) are shown to be upregulated in the rodent brain 
following either voluntary wheel or forced treadmill running.   Release of these 
neurotrophins can explain the growth of vessels (angiogenesis) (Bloor, 2005; Isaacs 
et al., 1992; Muramatsu et al., 2013; Rosenstein et al., 1998; Swain et al., 2003; Udo 
et al., 2008; Wälchli et al., 2014) and neurons (neurogenesis) (Brown et al., 2003; 
Creer et al., 2010a; Gould et al., 1999; Sahay et al., 2011) and neuronal plasticity 
(Allen and Messier, 2013; Ferris et al., 2007) that have also been associated with 
running activity.  Elevation of glutamate transporters on epithelial cells of capillaries 
of running animals has been observed (Allen and Messier, 2013) which may relate 
to increases hippocampal metabolites such as glutamate and glutamine 
(Biedermann et al., 2012).  Cytogenetic alterations have also been reported as result 
of exercise where cerebral mitochondrial respiratory capacity is increased within the 
striatum (Herbst and Holloway, 2015) whilst spine density (Stranahan et al., 2007) 
and progenitor cell survival in  the hippocampus is increased (Herbst and Holloway, 
2015).  
Several these mechanisms are known to be altered in neurodegenerative diseases.  
In this thesis, we were interested in whether exercise and/or fitness might mediate 
some of these mechanisms, and their outcomes, in a clinical disease such as 
Huntington’s Disease for which 1) there is a need for therapeutic targets, 2) diagnosis 
can be made prior to symptom onset such that physical exercise is a feasible 
recommendation, 3) both mouse models and patient cohorts are readily available for 
assessment and 4) there is a cognitive and motor symptom profile by which to assess 
the possible benefits of exercise and/or fitness.
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1.7 What is Huntington’s Disease?
Huntington’s disease is an autosomal-dominant neurodegenerative disorder in which 
those affected present with a range of motor, cognitive, psychiatric, and metabolic 
abnormalities.  Disease prevalence is 3-12 cases per 100, 000 (Evans et al., 2013).  
Patients with HD develop involuntary movements, known as chorea, although deficits 
in other domains are often present prior to this the onset of motor symptoms.   
Possibly the largest burden to both patient and carers are the cognitive impairments, 
behavioural abnormalities and psychiatric changes that worsen with disease 
progression (Paulsen, 2011). Results from a multinational prospective observational 
study of Huntington's disease (HD) (TRACK-HD) reports clinical and biological 
phenotypes of disease progression over three years as well as baseline predictors 
in people with pre-manifest HD (preHD) and early-stage HD (Tabrizi et al., 2013, 
2009). The following sections will detail these genetic, cognitive, neuropsychiatric, 
motor and neurological impairments further.
1.7.1. Genetic profile
Clinical and pathological signs of HD result from an abnormal CAG repeat expansion 
in exon 1 of the huntingtin gene (HTT) leading to expression of the mutant huntingtin 
(mHTT) protein. It is this mutant protein which encodes and gives rise to oligomers 
and fibrillary structures that ultimately lead to the formation of insoluble protein 
aggregates within the cytoplasm and nucleus of neurons, which are thought to lead 
to either a gain of toxic function or a loss of function of the altered protein (Cisbani 
and Cicchetti, 2012). HD patients typically carry alleles containing more than 35 
glutamine-encoding CAG repeat lengths.  The mean age of clinical onset is 
understood to be strongly related to length of the CAG trinucleotide such that 
the greater the repeat length, the earlier the disease onset, and the worse the 
severity.  A parametric survival model that predicts the age-specific probability of 
onset has been determined for CAG repeat-lengths between 36-56, with much 
narrower confidence intervals than described previously.  For example, a 40-year-
old individual with a repeat length of 42 has a 90-93% chance of symptom onset by 
age 65 (95% confidence interval) (Langbehn et al., 2011, 2004). Individuals with a 
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CAG repeat length greater than 55 typically have symptom onset before the age of 
20 (juvenile HD) and this makes up an estimated ~5% of all HD cases (Quarrell et al, 
2012).
1.7.2. Cognitive profile
Cognitive and behavioural symptoms (and signs) of HD are thought to be evident at 
least 15 years prior to motor diagnosis (Paulsen et al., 2008), where subtle emotion 
recognition deficits and poorer cognitive performance are observed compared to 
gene-negative controls (Stout et al., 2011).  
Pre-symptomatic Stage. Pre-symptomatic gene-carriers show subtle impairments in 
recognising facial expressions, such as recognising disgust, which is thought to be 
an early symptom of decreased insula function (Hennenlotter et al., 2004).  More 
proximal to disease onset are impairments that manifest in a similar pattern to mild 
cognitive impairment (MCI) , including impairments in visuo-motor performance, 
working memory and executive function (Kirkwood et al., 2000; Papp et al., 2013).  
Nearly 40% of participants were found to meet criteria for mild cognitive impairment 
at this pre-symptomatic stage (Duff et al., 2010).  Slowed cognitive processing 
becomes progressively worse closer to disease onset, which can be detected in 
tasks of processing speed.  These symptoms implicate the early dysfunction of the 
caudate nucleus and prefrontal cortex (Ho et al., 2003).  Impoverished performance 
on cognitive tests including emotion recognition as well as the STROOP test and 
Symbol Digit Modalities Test, thought to tap into executive functioning, can be seen 
in patients with pre-manifest HD <10 years from disease onset, which continues to 
get worse with disease progression (Tabrizi et al., 2013).  Decline in executive 
function with disease progression implicates striato-cortical dysfunction which is 
known to be downregulated in HD
Early- Stage. Memory deficits are observed at the more advanced stages of the 
disease, where deficits are greatest in memory retrieval rather than memory 
encoding (Rohrer et al., 1999).  Compared to Alzheimer’s Disease, where the profile 
of deficits is thought to be more cortical in nature, cognitive deficits in manifest HD 
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are thought to be more subcortical in origin whereas semantic memory and delayed 
recall memory are less affected (Ho et al., 2003; Kirkwood et al., 2000).  
Late-stage. Towards the more advanced stages HD patients show deficits in tests 
of verbal fluency, i.e. the ability to retrieve vocabulary whilst suppressing 
inappropriate or repeated word retrieval. Decline in verbal fluency over time is less 
marked compared to other executive function tasks, such as the Stroop (Ho et al., 
2003), and it has been supposed that fluency deficits are secondary to slowed 
processing speed and verbal ability (Henry et al., 2005).  Slowed processing is a 
general feature of HD, which manifests also in the motor (bradykinesia) and 
psychiatric domains (apathy), suggestive of an overlapping neuronal basis (Zamboni 
et al., 2008).  By the late stages of the disease cognitive symptoms are debilitating, 
although patients can usually still understand speech and recognize familiar faces.
1.7.3. Neuropsychiatric profile
According to the Europe-wide REGISTRY study, 20% of patients at all disease 
stages displayed severe psychiatric problems (Orth et al., 2011).  Characteristic 
features include depression, apathy, anxiety, irritability perseveration and suicidal 
ideation (Duff et al., 2007; Epping et al., 2014; Tabrizi et al., 2013). 
Depression symptoms in the pre-symptomatic stage do not increase with proximity 
to formal HD diagnosis (Epping et al., 2014) unlike the majority of cognitive 
symptoms.  Prevalence is estimated at 33-69% depending on disease stage (van 
Duijn et al., 2007).  Depression has been shown to decrease with disease 
progression as quantified using the Unified Huntington’s Disease Rating Score 
(UHDRS) motor scale (Van Duijn et al., 2013) which may occur due to adaptation to 
illness and acceptance of their diagnosis.  It has also been suggested that 
neurodegeneration of the CNS and communication of negative emotional states is 
impaired.
Apathy encompasses a loss of initiation, spontaneity, motivation, interest and 
concern about self-care. Compared to depression more generally, prevalence and 
severity of apathy is known to increase with disease progression (Tabrizi et al., 2013). 
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Prevalence rates vary between 34-76% for apathy depending on disease stage and 
measurement criteria (van Duijn et al., 2007).  Apathy is negatively associated with 
worse global and executive functioning and use of medicines such as neuroleptics 
and benzodiazepines (Duijn et al., 2010) 
Anxiety is also a prominent symptom, with prevalence estimated between 13% and 
71% depending on the sample and rating scale used (Dale 2015)
Irritability is a prominent symptom of both pre- and symptomatic HD with an
estimated prevalence of between 38-73% (Paulsen et al., 2008) and has been shown 
to be associated with impulsivity and aggression, presumed to be driven by an 
underlying disruption to emotional processing circuitry. Irritability has been found to 
increase with motor impairment (Van Duijn et al., 2013).
Psychosis and other symptoms. Less commonly experienced psychiatric symptoms 
include psychosis, delusions, hallucinations (van Duijn et al., 2007). Obsessive and 
compulsive symptoms, such as repetitive behaviours, inflexibility, perseveration, and 
preoccupation with idiosyncratic topics are common features of HD whereby 
obsessive symptoms are twice as prevalent as compulsive symptoms (Anderson et 
al., 2011). 
Suicidal Ideation.  Suicidal ideation co-occurs with depression, anxiety and irritability 
as well as by substance abuse. HD patients have a suicide rate which is 4-6 times 
higher than the normal population with 19% pre-symptomatic patients reporting 
current suicidal ideation (Wetzel, et al., 2011).
1.7.4. Motor profile
Subtle motor symptoms such as oculomotor deficits, slowed movement speed, weak 
tongue protrusion, slowed reaction time, and abnormalities in muscle stretch are 
observable even prior to clinical diagnosis (Kirkwood et al., 2000; Smith et al., 2000).  
Slow motor tapping speed can be detected more than 10 years prior to symptom 
onset, whilst other motor symptoms such as tongue and grip force is not affected 
until <10 years prior to symptom onset (Tabrizi et al., 2013).  Accurate diagnosis of 
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clinical onset depends therefore, on the sensitivity of the measure used. Formal 
diagnosis of adult-onset HD is made after the onset of a motor symptom profile 
including chorea, coordination deficits, poor handwriting, oculomotor dysfunction and 
rigidity.   With disease progression, involuntary movements become more 
pronounced, patients often present with dystonia and parkinsonism as well as 
difficulties with balance, speech, gait, swallowing, manual dexterity, and slowed 
voluntary movements. Towards the end of life, language and mobility is jeopardised 
because of deficits such as rigidity and bradykinesia. Loss of muscular control often 
leads to difficulty swallowing as well as bladder and bowel control (Girotti et al., 1988; 
Tabrizi et al., 2009). 
1.7.5. Neurological Deficits
1.7.5.1. Microscopic changes
Toxic function of the mHTT manifests in a number of cellular changes that produce 
HD pathology.  Although HTT protein expression is ubiquitous at the cellular level, 
selective neuronal loss occurs in the medium spiny neurons (MSNs) of the striatum 
with sparing of the cortical interneurons. Ninety-five percent of the striatum is made 
up of these (GABA)-ergic projection medium spiny neurons (MSN’s), with just ~ 5% 
classified as interneurons.  Neuronal loss extends to other brain regions including 
the cortex, thalamus and sub-thalamic nucleus as the disease progresses. 
Microscopic changes begin in the head of the dorsal caudate and progress to the 
ventrolateral striatum.  Protein aggregates form specifically within the nucleus, 
cytoplasm and neuronal processes, known as neuronal inclusion bodies (IBs) 
(Vonsattel and DiFiglia, 1998).  These IBs appear to occur in higher concentrations 
within the cortex than the striatum, although the role of the aggregates is still not fully 
understood (Arrasate and Finkbeiner, 2012) and it has been suggested that 
aggregation of mHTT may be a coping mechanism to clear toxic mHTT from the cell. 
A number of paths by which mHTT may cause cell death have been proposed. 
Studies in a number of HD mouse models find that mHTT alters histone 
acetyltransferase activity, and indicate that aberrant activity of this enzyme might 
underlie transcriptional dysregulation in Huntington’s Disease.  
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Mitochondrial damage within striatal cells has also been linked to metabolic 
deficiency in HD patients. Mitochondrial dysfunction facilitates impaired Ca2+ 
homeostasis which has been linked to the glutamate receptor-mediated excitotoxicity.  
Interactions between mHTT and neuronal functioning is thought to lead to glutamate 
excitotoxity, thereby increasing cell vulnerability. Even in the absence of excessive 
levels of glutamine, the increased vulnerability of the cell means that even normal 
amounts glutamine can cause excitotoxins to be expressed (Damiano et al., 2010).
Furthermore, an abnormal increase in the number of astrocytes and microglia have 
been reported, possibly in response to immune activation as an early defence 
mechanism (Lobsiger and Cleveland, 2011).  
1.7.5.2. Macroscopic changes
Post-mortem and MRI studies have shown gross atrophy throughout the brain of HD 
patients, which increases throughout the disease.  The earliest effects occur in the 
striatum which is comprised of the caudate nucleus and the putamen (Domínguez et 
al., 2013) where volume decreases of ~56% have been reported (Lange et al., 1976). 
Further basal ganglia including the globus pallidus and cortical atrophy supports the 
vulnerability of striato-thalamo-cortical circuitry in HD (Rosas et al., 2003; Tabrizi et 
al., 2009). Of the cortex, premotor and sensorimotor cortices (Douaud et al., 2006) 
are particularly affected and longer disease duration has been associated with more 
widespread cortical changes, suggesting that cortico-striatal circuits are affected in 
HD.
Two projection pathways from the striatum are thought to define the symptoms 
observed in HD.  A direct pathway projects axons to the globus pallidus or substantia 
nigra, whilst the indirect pathway projects axons to the external segment of the 
globus pallidus, and it is the MSN’s of the latter pathway that are affected in the early 
stages of HD, leading to disinhibition of the subthalamic nucleus and thalamus. It is 
this disinhibition of the thalamus, that leads to overstimulation of the motor cortex 
and subsequently, the erratic and uncontrolled motor movements that are 
characteristic of HD (Deng et al., 2004).
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The basal ganglia are also known to be involved in many of the cognitive symptoms 
that manifest in HD through altered cortico-striatal circuitry such as obsessive-
compulsive behaviours (Anderson et al., 2011).  Functionally distinct cortico-striatal 
loops have been proposed, that may explain the heterogeneous cognitive symptoms 
experienced by patients.  Core circuits arise from different cortical areas and project 
to the globus pallidum and substantia nigra via the striatum, then projecting to the 
thalamic nuclei and back to the frontal cortex.  Degeneration in the cerebral cortex 
however is more likely to underlie the cognitive disturbances in executive function 
and psychiatric symptoms experienced. 
There is now an increasing body of research showing white matter abnormalities are 
another pathological feature of HD, independent of neuronal loss (Paulsen et al., 
2008; Tabrizi et al., 2009).  Changes in white matter are thought to occur due to a 
number of factors, including loss of axons, demyelination, and as a direct effect of 
grey matter atrophy known as Wallerian degeneration.
1.7.6. Cerebrovascular health in Huntington’s disease
Alterations in cerebral blood flow (CBF) have been described in several 
neurodegenerative disorders, including Alzheimer's disease (AD) (Iadecola, 2004), 
Parkinson's disease (PD) (Borghammer, 2012) and Huntington's disease (Ma and 
Eidelberg, 2015) suggesting important and likely early commonalities in fairly distinct 
pathophysiological diseases. In AD, perturbations in microvascular flow have been 
linked to overexpression of amyloid precursor protein and to precede neuronal 
dysfunction. It is likely therefore, that alterations in CBF might play an important role 
in the expression and progression of HD symptoms.   
Primarily HD mouse models have been used to probe differences in cerebrovascular 
health further at a molecular level, although post mortem patient tissue is also used.  
Visualisation of greater vascular density has been reported in both transgenic and 
post mortem patient studies (Cisbani et al., 2013; Drouin-Ouellet et al., 2015; 
Franciosi et al., 2012; Lin et al., 2013), in addition to other morphological changes in 
the vasculature including alterations in length, lumen size, branching and vessel type 
(Franciosi et al., 2012; Lin et al., 2013).   Blood-brain-barrier permeability has also 
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been shown to increase with HD, whereby a decrease in the proteins that form the 
tight junctions of the BBB such as occluding and claudin-5 in the caudate and 
putamen has been observed in post mortem tissue from HD patients (Drouin-Ouellet 
et al., 2015).
A few studies conducted in the 1990’s showed reduced CBF in the basal ganglia of 
HD patients secondary to cell loss.   Harris et al. (1999) observed perfusion deficits 
using SPECT in the caudate and putamen in addition to volumetric differences in 
these regions in patients <6 years from predicted onset. Another study, observed 
extended perfusion deficits in the frontal and parietal cortices, and a positive linear 
relationship between executive function and rCBF in the caudate using SPECT 
(Hasselbalch et al., 1992). However, both SPECT and CT provide relatively low 
spatial resolution and/or tissue contrast compared to MRI measures.  A more recent 
SPECT study observed a reduced elevation in blood flow during a maze learning 
compared to rest, than HD negative controls in the caudate and orbitofrontal cortex 
(Deckel et al., 2000).  Whilst interesting, SPECT provide relatively low spatial 
resolution and tissue contrast compared to MRI imaging, where more regional CBF 
changes can be examined.
A study by Chen et al. (2012) used PASL MRI where they observed perfusion deficits
in cortical regions in which atrophy was not observed, suggesting an important role 
of perfusion abnormalities in the pathophysiology and regional selectivity of HD.  A 
CASL MRI found decreases in rCBF particularly within the lateral prefrontal cortex, 
which declined with proximity to motor symptom onset (Wolf et al., 2011). Alterations 
in CBF are not homogenous however, since in the striatum increases in CBF have 
been observed in the putamen (Chen et al., 2012) and the pallidum (Wolf et al., 
2011).  A recent study at 7T used an LL-EPI ASL sequence, and observed a 
significant increase in arterial CBV in cortical gray matter in the HD cohort but not in 
the putamen or caudate (Drouin-Ouellet et al., 2015).
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1.8 Animal models of HD
Following the discovery of the HTT gene in 1993 (The Huntington’s Disease 
Collaborative Research Group, 1993), several mouse models have been genetically 
engineered, and have contributed to our understanding of the pathogenesis of HD 
as well as for evaluating new therapeutics.  These HD mouse models differ greatly 
in terms of the background strain, CAG repeat length, disease onset, presentation 
and severity.
Genetic mouse models can be grouped into 3 main categories according to how they 
are engineered, N-terminal transgenics, full-length transgenics and knock-in (KI) 
models.  N-terminal transgenic animals carry the 5’ proportion of the human HTT
gene, which contains CAG repeats whereas full-length transgenic models carry the 
full length HTT sequence and express the full length HTT protein containing the 
expanded CAG repeats.  In comparison, knock-in mouse models, have an HD 
mutation which is directly manipulated by varying the number of CAG repeats at the 
huntingtin (Htt) genomic locus.  As a result, phenotypes of the disease vary greatly 
because of the species of origin, repeat length, background strain and promoters that 
drive expression.  
1.8.1. Knock-In (KI) Mouse Models
In contrast to N-terminal and full-length HD transgenic models, KI HD models are 
generated by insertion of a CAG repeat mutation into the endogenous animal 
Huntingtin (Htt) gene via homologous recombination techniques or when the animal 
exon 1 is replaced with the pathologically expanded human exon 1 (Ishiguro et al., 
2001; Wheeler et al., 2000). Over-expression of the gene does not occur as there is 
no change in the number of copies of the gene.  The endogenous Hdh promoter 
means therefore that KI models should produce a similar expression profile to that 
seen in the human condition and therefore express the complete mutant gene.  This 
makes knock-in models advantageous in that the variability in expression levels and 
tissue distribution is eliminated compared to microinjection based HD models.  As a 
result, effective manipulation of the Htt gene dosage (i.e. one mutant and one normal 
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allele) has enabled the generation of an allelic series of knock-in mice that differ in 
CAG repeat length, and enable us to investigate the influence of CAG size on 
disease phenotypes.  As a result, KI models more closely reflect the genetic context 
of human patients with HD.  Knock-in models may contain either expanded CAG 
repeat length within an unmodified murine gene (e.g. Hdh (CAG (150)) or a chimeric 
human/mouse exon 1 carrying both the expanded CAG repeat region and the human 
polyproline region (e.g. CAG 71, CAG 94, CAG 140, and the zQ175 models.)  The 
severity of motor and cognitive symptoms as well as age of symptom onset tend to 
correlate with the CAG repeat length and are thought to resemble the pre-
symptomatic stages of HD.
1.8.2. Q175 Knock-in Mouse Line
Genetic Background.  The HdhQ175 (zQ175) mouse line is one of the more recently 
characterised knock in lines (Menalled et al., 2012).  This mouse-line was derived 
from a spontaneous expansion of the CAG repeat number identified in a litter from a 
CAG 140 KI colony (Menalled, 2005) derived by Scott Zeitlin. Founder mice from this 
litter were used to establish a novel colony carrying around 175 CAG repeats, leading 
to the name zQ175.  The inverse relationship between age of HD onset and CAG 
repeat length means that the zQ175 mouse line is expected to produce a more robust 
and earlier abnormal phenotype in both heterozygotes (HETs) and homozygotes 
(HOMs).  
Behavioural characterisation has shown more potent deficits in homozygous animals 
than in heterozygous animals when compared to wild-type littermates and have an 
overall decreased life span (Menalled et al., 2012).  Where the human condition is 
characterised by a single allelic mutation, heterozygous zQ175 animals were chosen 
for investigation in this thesis as they may be more realistic in terms of the severity 
of symptoms seen in humans than the homozygous animals.  Because these mice 
exhibit a more rapid disease progression compared to earlier mouse-lines carrying 
fewer repeats, progression of HD symptoms can be observed within a shorter period, 
making this a more robust model for long term assessment than transgenic HD 
models, or those carrying shorter repeat lengths.
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Motor Impairments. HOMs display a reduction in grip strength from 4 weeks of age, 
hypoactivity in open field testing as young as 16 weeks of age (36 weeks in HETs), 
increased rearing at 8 weeks of age decreased latency to fall from the rotarod at 30 
weeks (HOMS and HETS).  HETs show increased rearing frequency at 2-4 months 
of age (Heikkinen et al., 2012; Menalled et al., 2012) and altered gait from as early 
as 1 month of age (G. A. Smith et al., 2014).
Cognitive Impairments. Deficits in HET mice in a more complex visual discrimination 
reversal task with a touchscreen have been found previously (Murphy et al, 
unpublished).  Deficits in procedural response learning in zQ175 HOM mice was 
seen at 58 weeks but no impairment was detected in the HET mice.  HOMs showed 
impaired performance on the procedural two choice swim test, a discrimination 
learning test of stimulus – response association, at 12months compared to WT mice, 
but HETs showed no difference (Heikkinen et al., 2012). Decreased alternation on 
the Y-maze and a decreased capacity to nest build has been reported at 16 months 
(G. A. Smith et al., 2014).
Neurological Impairments. Behavioural validation and longitudinal characterisation 
with MRI has been carried out.  Whereas Heikkinen et al. (2012) reported whole brain, 
cortical and striatal volumetric decreases in HOM but not HET Q175 mice using MRI 
at 12months of age, a histological study by Smith et al. (2014) did observe significant 
cortical thinning and striatal volume decreases in HET Q175 at 12 months compared 
to WT controls. Metabolic deficits in glutamate transmission compared to WT controls 
in both HOM and HET has also been observed by 12 months using magnetic 
resonance spectroscopy MRI (MRS) (Heikkinen et al., 2012). Electrophysiological 
examination revealed early hyper excitability of MSNs of HET zQ175 animals at 4 
months of age and evidence for striatal IB’s within the striatum has been in HET 
Q175 mice from 6 months of age (G. A. Smith et al., 2014).  Further still, decreased 
levels of the synaptic protein, dynein, in the striatum at 6 months of age as well as 
changes in cytoskeletal and axonal transport at 12 months of age (Smith et al. 2014).
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1.9 Treatment options in HD
HD is a heterogeneous disease, whereby each patient displays a different symptom 
profile.  Current treatment options are limited to symptomatic therapies as there are 
currently no available treatments that are known to slow the neurodegeneration or 
loss of function known to occur with disease progression. Over the last ten years 
however, there have been many more clinical trials for symptomatic and small 
molecular therapies that are being trialled. 
1.9.1 Symptomatic treatments
Motor Symptoms. Drugs that act to reducing dopamine neurotransmission, via 
presynaptic depletion or via D2 receptor blockade, are thought to reduce excessive 
movement and is the basis of most pharmacological treatments for movement. 
Tetrabenazine (TBZ) is the only medication currently FDA-approved for treatment of 
chorea in Huntington’s Disease and works by reversibly inhibiting the vesicular 
monoamine transporter 2 (VMAT-2) in the CNS (Hayden et al., 2009). Since VMAT-
2 packages dopamine, serotonin and norepinephrine from the cytoplasm into 
presynaptic vesicles, inhibition leads to premature degradation of these monoamines.  
Although this drug is useful for reducing symptoms of chorea via dopamine depletion, 
a side-effect is depletion of serotonin and norepinephrine can worsen symptoms of 
depression and anxiety, symptoms which are already more likely in patients with HD 
(Huntington Study Group, 2006).  Furthermore, depletion of dopamine itself can also 
give rise to extrapyramidal symptoms including parkinsonism and dysphagia.  More 
recently, a randomized, double-blind, placebo-controlled trial found promising effects 
of deutetrabenazine (SD- 809) on chorea, in which deuterium-carbon bonds require 
more energy for cleavage such that that fewer and lower doses are needed to obtain 
the same benefit as TBZ (Huntington’s Study Group, 2017). A comparator study 
between TBZ and SD-809 is needed to compare the efficacy of these drugs better. 
Another common option are antipsychotics, as they may simultaneously act to 
improve psychiatric symptoms associated with HD.  Antipsychotics such as 
haloperidol, olanzapine, rispiridol and fluphenazine are commonly used, however 
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they have varying affinity for the D2 receptor, and as such, vary in their ability to 
control chorea.  They also lead to a range of extrapyramidal side effects and 
controlled research studies have shown only mixed effect on chorea.  Atypical 
antipsychotics are also poorly supported by research evidence to support their use 
in patients with HD. 
Amantadine, is an NMDA antagonist has anti-dyskinetic properties in Parkinson 
disease, and thus might be expected to treat chorea in HD.  High doses of 
amantadine are thought to be required to reduce chorea, but also leads to side 
effects including sleepiness, hallucinations, confusion, insomnia, agitation, and 
anxiety (O’Suilleabhain and Dewey, Jr, 2003).  Riluzole, is another anti-glutamatergic 
drug thought to alleviate excitotoxicity, but this drug failed to yield improvement in 
functional independence, chorea, behavioural symptoms or cognitive symptoms, 
compared to those of placebo in a large 3-year RCT (Landwehrmeyer et al., 2007). 
Cognitive Symptoms. There is currently a lack of good evidence for any drugs that 
can be used to enhance cognition in HD. There have been a few small open-label 
studies which suggest improvement in cognitive testing after treatment with short-
and long-term treatment with rivastigmine (Sešok et al., 2014), but these rely on 
sufficient cognitive tests to detect alterations following drug administration.
Memantine is a non-competitive glutamate receptor antagonist that stabilizes 
glutamatergic tone and it has been suggested that this might benefit patients with HD 
by reducing excitotoxicity caused by large amounts of glutamate coming into the 
striatum from the cortex and thalamus. One small, open-label study observed a 
potential neuroprotective effect following long-term treatment in HD (Ondo et al., 
2007) but this warrants replication.  In the absence of efficacious drug therapies, 
supportive measures should be recommended, including strategy formation, such as 
providing cues, minimizing multitasking, and time allocation for cognitive training. 
Psychiatric Symptoms. Depression is the most common psychiatric symptom of HD. 
Despite this, in a review of the European HD cohort (REGISTRY) of 1,993 patients, 
only half that reported moderate to severe depression were on medications for their 
symptoms (Duijn et al., 2014). A systematic review reported a lack of sufficient 
evidence to guide anti- depressant treatment in HD (Moulton and Mrcp, 2014), 
40
although anecdotally, patients appear to respond well to selective serotonin reuptake 
inhibitors (SSRIs) (Wyant et al., 2017).  For example, SSRIs, fluoxetine and 
citalopram appear to have the most notable effects on a self-reported measure of 
depression (Beglinger et al., 2015). VenlafaxineXR is an SNRI (selective 
noradrenergic reuptake inhibitors) that has been found to improve depressive 
symptoms after 4weeks of treatment (Wyant et al., 2017). Other behavioural 
disturbances include apathy, OCD, anger, irritability and psychotic episodes in a 
small number of individuals (van Duijn et al., 2007).  For adjunctive therapy, anti-
psychotics and mood-stabilizing antiepileptic drugs (AEDs) are favoured by clinicians, 
such as valproate, carbamazepine, lamotrigine, and topiramate (Wyant et al., 2017).  
However, with little research evidence to suggest the efficacy of these drugs, 
education of families and caregivers on trigger identification and behavioural 
strategies is favoured in combination with a supportive, structured environment with 
routines and cue identification. 
1.9.2. Disease Modifying Therapies
Since the discovery of the Huntington’s disease gene, there have been many 
attempts at disease modification based on likely functions of the huntingtin gene and 
on theories of neuronal injury.  Despite this, we do not fully understand the important 
functions that huntingtin protein (HTT) plays in the brain, or exactly how mHTT 
causes the disease.  Ideas have ranged from metabolic interventions to protect 
neurons, to cell transplantation and gene silencing therapies. There is also an 
ongoing work looking for genetic modifiers that determine symptom onset and non-
pharmaceutical interventions that may delay the progression of the disease.  
1.9.1.1. Cell-based therapies
Animal research has provided promising evidence for the use of foetal primary 
transplants. Transplantation of embryonic striatal tissue grafts following an 
excitotoxic lesion have been shown to not only survive and proliferate, but to also 
express a range of cellular markers characteristic of neuronal viability and 
behavioural phenotypes that are characteristic of normal striatal function (Mazzocchi-
Jones et al., 2009;  Dunnett, 2010). Clinical trials using foetal primary transplants 
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have produced mixed results, with evidence of a short-term but not long-term clinical 
improvement (Dunnett and Rosser, 2014).  A multi-site study of 5 transplanted 
patients across the UK (NEST-UK) yielded non-significant long-term benefits 10 
years post-surgery (Barker et al., 2013). A caveat of this line of research is the limited 
supply of donor tissue such that standardisation and quality control is a challenge.  
Alternative transplantation options using human cells lines include 1) embryonic stem 
cells (ESC’s) derived from blastocysts 2) foetal stem cells, neural progenitor cells 
taken from an embryo, foetus, or neonate, 3) adult neural stem cells, with neural 
progenitor cells isolated from the adult sub-ventricular zone (Vazey and Connor, 
2010) 4) embryonic germ cells that are isolated from the gonadal ridge of the embryo, 
5) non-neural stem cells, such as adult bone marrow stem cells or umbilical cord 
cells, and 6) induced pluripotent stem cells (iPS cells) which can be generated from 
adult human fibroblasts (Mattis et al., 2013).  Whilst promising, further work is needed 
to improve reliability of transplant survival, whilst simultaneously tackling the practical, 
ethical and regulatory difficulties in this field (Dunnett and Rosser, 2014).
1.9.1.2. Gene-based Therapies
Reducing Huntingtin Expression. Gene-based therapies offer a potential powerful 
treatment option for the future by targeting the expression of mHTT.  Such strategies 
are known as “gene silencing” because they act by down-regulating transcription or 
preventing translation of mHTT, although no approach is expected to completely stop 
mHTT expression altogether. These approaches are considered among the most 
promising emerging therapeutics for prevention of HD and include 1) RNA 
interference (RNAi) using short interfering RNA (siRNA); 2) translational repression 
using single-stranded DNA-based antisense oligonucleotides (ASOs); and 3) 
transcriptional repression using zinc finger proteins (ZFPs).  By reducing the levels 
of mHTT protein in this way, it is hoped that disease progression will be delayed or 
halted by mitigating it at the source. The IONIS-HTTRx is an antisense 
oligonucleotide drug (ASO) delivered via intrathecal injection that binds to huntingtin 
RNA and signals the cell to destroy it and is currently in phase 1 clinical trials. This 
technique has already been shown to reduce HTT expression in mice by 
approximately 75% following injection into the lateral ventricle (Kordasiewicz et al., 
2012). Ongoing clinical trials are taking place with the hope that the benefits of 
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lowering the toxic mHTT protein will significantly outweigh the potential side effects 
of lowering wild-type HTT, since it is unknown what the effect of lowering wild-type 
HTT is in humans. Allele selective silencing methods circumvent this by targeting the 
mutant allele selectively to achieve allele-selective knock-down, or by identifying 
single nucleotide polymorphisms (SNPs) on the mutant allele so that allele- selective 
mHTT silencing for a certain percentage of HD mutation carriers, can lead to an 
individualised genomic medicine (Lombardi et al., 2009).  However, targeting 
polymorphisms increasing the chance of off-target effects. Finally, Zinc-finger 
proteins (ZFPs) can repress protein production by reducing transcription (Papworth 
et al., 2006). Successful selective repression of mHTT and reduction of motor 
manifestations have been reported in the R6/2 HD mouse model (Zeitler et al., 2014) 
and therefore provides an exciting avenue for genome editing work in the future.
Protein Homeostasis. After expression has occurred, mHTT interacts with other 
proteins, undergoes post-translational modification, forms intra-nuclear and 
cytoplasmic aggregates, and may be cleared through autophagy. There are therefore, 
several potential therapeutic targets under investigation, but prioritization is limited 
by our understanding of the most toxic HTT species.  The most prominent targets 
have been reviewed in a paper by Wild and Tabrizi, et al (2014) and include small-
molecule kinase inhibitors which modulate N-terminal mHTT phosphorylation (Atwal 
et al., 2011), infusion of gangliosides (e.g. GM1) thought to improve membrane 
functioning and cell signalling (Pardo Di et al., 2012), upregulation of chaperone 
proteins to reduce harmful misfolding of mHTT (e.g. HSJ1a (Labbadia et al., 2012), 
TCP1-ring complex (Trice) (Kitamura et al., 2006) and ApiCCT1) and upregulating 
autophagy for mHTT clearance by therapies such as mammalian target of rapamycin 
(mTOR) inhibition (Ravikumar et al., 2004) and promoting acetylation with inhibitors 
such as Selisistat which inhibits deacetylase sirtuin 1 (M. R. Smith et al., 2014).
Histone Deacetylase Inhibition. Histone deacetylase (HDAC) inhibitors such as 
suberoylanilide hydroxamic acid have been under study for several years, with the 
aim of correcting transcriptional dysregulation.  Suberoylanilide hydroxamic acid has 
been shown to regulate transcription through chromatin modification and have been 
shown to ameliorate the motor phenotype in R6/2 mice (Hockly et al., 2002). 
Systematic work has shown HDAC4 to be the only HDAC among 11, to ameliorate 
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the HD phenotype in mouse following genetic knockdown. Potent, selective small-
molecule inhibitors of its enzymatic function have been developed and the 
noncatalytic functions of suberoylanilide hydroxamic acid are currently under study 
(Benn et al., 2009).
Phosphodiesterase (PDE) Inhibition. Detailed study of phosphodiesterases (e.g. 
PDE10A and its pharmacological inhibition) is underway to validate it as a therapeutic 
target in HD. PDE10A is almost exclusively expressed in the striatum (Coskran et al., 
2006) and its function is linked to the synaptic biology of MSNs whose death is a 
prominent feature of HD.  PDE10A regulates cyclic adenosine monophosphate 
(cAMP) and cyclic guanosine monophosphate signalling, synaptic plasticity and the 
response to cortical stimulation (Threlfell and West, 2014), which are known to be 
impaired in HD.  In the R6/2 mouse, PDE10A inhibition with TP-10 has been found 
to ablate motor deficits, reduce striatal atrophy and increased (BDNF) levels in HD 
(Apostol et al., 2008).
Mitogen-Activated Protein Kinase (MAPK) Cell Signalling. Abnormal MAPK 
signalling is a feature of HD.  Over-activation of the MAPKs JNK (c-Jun terminal 
kinases), ERK (extracellular signal-regulated kinases), and p38, and the upstream 
kinase mixed lineage kinase 2 (MLK2), is seen in HD (Gianfriddo et al., 2004).  Small-
molecule approaches to activate MKP-1 and ERK, or to inhibit MLK2, JNK, and p38 
(Taylor et al., 2013), are being explored, but the pathways, roles, targets and means 
of modulating these pathways are incompletely understood.
Neurotrophic Factors Depletion. Depletion of BDNF is characteristic in Huntington’s 
Disease. BDNF is produced by cortical interneurons and promotes neuronal growth, 
survival, and plasticity, especially within striatal neurons affected prominently in HD, 
and BDNF is thought to protect against excitotoxicity (Zuccato et al., 2010).  
Restoration of neurotrophins including BDNF and glial cell–derived neurotrophic 
factor (GDNF), is problematic since protein-based drug delivery to the CNS is difficult. 
Delivery using viral or stem-cell vehicles have shown some potential, for example 
intraparenchymal AAV-mediated delivery of the GDNF analogue neurturin to the 
putamen in PD has been shown to be safe and well-tolerated (Jr et al., 2010). Small-
molecule agonists such as TrkB agonists, have been developed to mimic the effects 
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of BDNF with some success (Simmons et al., 2013).  Another approach is to target 
the transcriptional dysregulation that partly underlies the BDNF deficiency in HD, for 
example a compound, C91, has been found to increase BDNF mRNA levels in Htt-
knockdown and mHTT-expressing zebrafish models (Conforti et al., 2013). 
1.9.2. Environmental enrichment
In the absence of successful pharmacological treatments, researchers have begun 
looking for more holistic approaches by which to either optimise general neuronal 
health or work in concert with other cellular or gene treatments to optimise outcomes. 
Physical, social and cognitive interventions, may bring us closer to a disease-
modifying treatment in HD.
1.9.2.1. Cognitive training
Cognitive training, with a particular focus on tasks of executive function, have been 
conducted in patients with Parkinson's (Milman et al., 2014; París et al., 2011) and 
Alzheimer's disease (AD) (Bahar-Fuchs et al., 2013) and have shown promising 
evidence for improvements in both cognitive and motor outcomes.  A recent study in 
the Q111 mouse model, observed that an operant attentional training task improved 
motor performance 8 months later, compared to those that had not received training 
(Yhnell et al., 2016).  Future investigations of cognitive training programmes in HD 
patients is warranted to explore these effects further. 
1.9.2.2. Environment 
Environment has been suggested to play a role in the variability of HD age-of-onset, 
according to the U.S. –Venezuela Collaborative Research Project (Wexler, 2004). 
This research estimated that 60% of the variance in age of onset, unexplained by 
CAG repeat length, lies in the shared environmental factors between siblings and 
40% is attributable to other genetic factors e.g. polymorphisms in genes that encode 
neurotransmitter receptors, energy metabolism, Htt-interacting proteins, stress 
response, synaptic processes and apoptosis (Arning and Epplen, 2013) . Shared and 
non-shared environmental factors have thus received an increasing amount of 
scientific attention and as such there has been an increasing number of preclinical 
and clinical support for physical and cognitive activity, stress and diet as potential 
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modulators of HD onset and progression.  These are nicely summarised in a review 
by Mo et al. (2015).  Typically, environmental enrichment is operationalised by 
providing objects, food and bedding in the home cage.  In a study by Hockly et al. 
(2002), even minimal enrichment, including the addition of a cardboard tube and 
bedding yielded slower decline in Rotarod performance in R6/2 transgenic mice 
compared to non-enriched controls.  Perhaps the most promising research has 
shown that environmental research may be more beneficial in altering the psychiatric 
symptoms associated with mood.  A study in R6/1 transgenic mice, showed that 
home cage enrichment, including larger cages, and novel objects led to a reduction 
in anxiety and reduced stress response but non depressive-like symptoms (Renoir 
et al., 2013).  
It is known that an enriched and healthy lifestyle is beneficial, and can improve brain 
health, such that it is not absurd to believe that such factors would benefit patients, 
however evidence in mice is not consistent (Skillings et al., 2014) and there remains 
an absence of well-controlled studies to address the effects of environmental 
enrichment in humans.
1.9.2.3. Exercise
To date, it is not known to what extent exercise is beneficial to patients with HD. 
There is growing belief that exercise delivered in home and community settings may 
be of functional benefit in other neurodegenerative disease such as MS (Rietberg et 
al., 2005) and PD (Goodwin et al., 2008), that cannot be explained by the impact of 
environmental enrichment. 
Studies in HD mouse models have been mixed.  Voluntary wheel running has been 
shown to delay onset of motor symptoms (Pang et al., 2006; van Dellen et al., 2008), 
preserve cognition (Harrison et al., 2013; Kim et al., 2015; Pang et al., 2006) and 
reduce neuropathology by improving mitochondrial function (Herbst and Holloway, 
2015) and altering striatal mHTT expression (Harrison et al., 2013).  Other findings 
have suggested that exercise may actually increase neuropathology including 
reduced BDNF production, sparser MSN spines (Döbrössy and Dunnett, 2006)  
impoverished motor and cognitive function and reduced striatal volume (Potter et al., 
2010).
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Only a few studies have employed exercise interventions in HD patients, ranging 
from balance training or a combination of muscle strengthening, stretching and 
cardiovascular exercise.  Findings have ranged from patients showing preserved 
(Zinzi et al., 2007) or improved (Quinn and Rao, 2002) balance, cognitive and motor 
performance, whilst reported case studies have suggested that exercise cannot 
delay onset (Altschuler, 2006) or may in fact be detrimental.  A recent randomised 
clinical trial (RCT) in Huntington’s disease patients, observed improved performance 
in measures of gait speed, balance, function and level of physical and no related 
adverse events (Khalil et al., 2013a). A 12-week intervention involving a weekly 
supervised gym session of stationary cycling and resistance exercises in addition to 
a twice weekly independent home-based walking program, yielded improvements in 
cognition and walking (Busse et al., 2013).  Results from the first multi-site 
longitudinal RCT, where a 12week intervention of progressive exercise three times 
per week including aerobic (stationary cycling) and strengthening exercise are the 
most promising so far for the feasibility, safety and motor improvements (UHDRS 
mMS) of exercise is HD patients.
Large scale RCT’s are needed to investigate the clinical potential of exercise, using 
neuroimaging outcome measures such as macrostructure, microstructure and 
cerebrovascular changes in response to exercise that can be performed 
longitudinally. To date, the benefits of physical exercise or cardiorespiratory fitness 
have not been assessed using MRI methods.  Piloting of feasible, reliable and 
informative MRI measures related to exercise in HD patients is warranted before 
these measures can be introduced into large scale RCTs and will be the goal of this 
thesis.
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Chapter 2
Investigating the relationship between aerobic 
fitness and cerebrovascular health in young 
adult males using PASL MRI.
Chapter Summary
The primary aim of this chapter is to examine whether MRI correlates of 
cerebrovascular health are associated with cardiorespiratory fitness in a cohort of 
healthy young adult subjects.  The second aim was to explore the feasibility of these 
MRI measures before applying them in Chapter 4, to a patient population.  As 
outlined in the General Introduction, there is a mounting array of research that has 
highlighted the importance of the cerebrovasculature for efficient brain metabolism.  
In this chapter, we address the challenge of identifying whether and, if so, how 
exercise may exert these beneficial effects on the brain by focusing on potential MRI 
biomarkers of cerebrovascular health.  The present study uses pulsed arterial spin 
labelling (PASL) techniques to explore the relationship between cardiorespiratory 
fitness and markers of cerebrovascular health, including resting cerebral blood flow 
(CBF), cerebrovascular reactivity to CO2 (CVR) during breath-holding. Arterial 
compliance of the middle cerebral arteries (MCAC) was also assessed using ASL 
methods, and is the first time this has been assessed in relation to cardiorespiratory 
fitness.  Healthy males aged 20-24 years with varying levels of cardiorespiratory 
fitness (maximal oxygen uptake ( O2MAX) range= 38-76 ml/min/kg) underwent MRI 
scanning at 3 Tesla followed by cognitive testing in domains previously shown to be 
influenced by cardiovascular health.  Contrary to previous findings, subjects with 
higher cardiorespiratory fitness demonstrated lower GM CBF and lower CBF CVR, 
although the latter was not significant.  In line with non-MRI evidence, arterial 
compliance of the MCA was associated with higher aerobic fitness.  O2MAX was not 
associated with cognitive performance on tests of pattern separation, paired 
associate learning or the n-back tasks of memory and executive function. The results 
of the current experiment suggested that exercise-induced differences in 
Chapter 2
49
cerebrovascular health can be detected in early adulthood despite the absence of 
any cognitive differences.
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2.1. Introduction
It is fundamentally important to understand whether exercise is beneficial earlier in 
life, despite the absence of any apparent cognitive decline.  It is possible that ceiling 
effects, insensitive cognitive tests or a bias away from reporting null results, has 
contributed to the absence of reported effects.  Exploring this question in late 
adulthood may be too late for the implementation of therapeutic exercise 
interventions where motor function may already be impaired, and as such the need 
for understanding these early physiological processes becomes more important.  
This warrants continued efforts into the search for sensitive non-invasive biomarkers
of cerebrovascular health that precede changes in cognition.
Studies using ultrasound methods have reported improvements in parameters of 
cerebrovascular health such as resting cerebral blood flow velocity (Ainslie et al., 
2008) and cerebrovascular reactivity (Bailey et al., 2013) associated with 
cardiorespiratory fitness, however these methods often lack spatial specificity, 
reliability and consistency across individuals (Willie et al., 2011). Evidence has 
demonstrated that MRI may be a better tool than TCD for assessing fitness-
associated changes in cerebrovascular function, as it is a more sensitive and 
quantifiable measure of regional changes in blood flow (Ainslie and Hoiland, 2014). 
Nonetheless, TCD studies provide a useful platform from which to direct further 
investigation.  Advances in arterial spin labelling (ASL) magnetic resonance imaging 
(MRI) have brought us closer to identifying non-invasive biomarkers of 
cerebrovascular health due to its enhanced spatial sensitivity for quantifying 
individual differences in whole brain cerebral dynamics (Wolk and Detre, 2013).  
Application of novel MRI methods, can bring us closer to understanding the 
relationship between cardiorespiratory fitness and cerebrovascular health.
One mechanism by which exercise may improve cerebrovascular health and prevent 
cognitive decline, is by preventing the typical vessel stiffening seen with ageing 
(O’Rourke and Safar, 2005).  Non-MRI studies that have used ultrasound imaging 
and simultaneous arterial applanation tonometry of the arterial waveform have 
demonstrated that central arterial stiffness is reduced in those who exercise regularly.  
In a cross-sectional study, Tanaka et al. (2000) found that central arterial compliance 
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was 20-35% higher in endurance-trained men than in less active controls.  
Complementary findings have been shown in the radial artery, following a 6-month
aerobic exercise intervention, whereby stiffness, as quantified using the radial 
augmentation index (AIx), declined by 3% as a result of exercise (Tabara et al., 2007).  
Whilst these findings are insightful, the beneficial effects of cardiorespiratory fitness 
on cerebral arteries are yet to be adequately addressed.  
Due to the inability to assess diameters of intracranial arteries, changes in arterial 
compliance using methods such as Doppler sonography are only able to inform us 
about compliance of the vascular bed of the extracranial arteries and not the local 
stiffness profile of the cerebral vessels themselves (Carrera et al., 2011). Promising 
advances in ASL methods allow for more precise quantification of the local arterial 
wall properties rather than those distal to the site of measurement (Warnert et al., 
2014; Warnert et al., 2015).  This method relies on ASL to measure changes in 
arterial blood volume (aBV) within the major cerebral arteries throughout the cardiac 
cycle.  Given the novelty of this method, the present experiment is the first to probe 
MCA differences in compliance in relation to cardiorespiratory fitness using PASL.
More established MRI measures of cerebrovascular health include resting cerebral 
blood flow (CBF) and cerebrovascular reactivity (CVR), although reported changes 
in these MRI parameters in relation to fitness or exercise is lacking.   Cerebral blood 
flow (CBF) is possibly the most commonly reported parameter of cerebrovascular 
health in studies that investigate the effects of exercise or fitness, however 
quantification and definition of blood ‘flow’ depends upon the method used.   Most of 
the studies to date that have reported fitness mediated alterations in cerebrovascular 
health (Ainslie et al., 2008; Bailey et al., 2013; Guiney et al., 2014) tend to rely upon 
TCD measures; reporting resting MCAv (middle cerebral artery velocity) and 
regulation of MCAv to hypercapnia, as CBF or CVR respectively. As described 
previously, these methods have their caveats (Ainslie and Hoiland, 2014) such that 
MRI studies in younger cohorts are still needed to validate these findings. 
Data reporting a relationship between cardiorespiratory fitness and resting CBF 
using ASL MRI in elderly cohorts suggest a positive association between 
cardiorespiratory fitness and grey matter/regional CBF (Thomas et al., 2013b; 
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Zimmerman et al., 2014) but contrary to TCD findings (Bailey et al., 2013; Chapman 
et al., 2013) MRI data observed a reduction in regional CVR with increased levels of 
fitness (Gauthier et al., 2014; Thomas et al., 2013).  Since CVR is generally 
considered to be a marker of cerebrovascular health, these results are counter-
intuitive, and may in part be attributable to the use of BOLD MRI to measure CVR 
which is a complex hemodynamic response and may not directly relate to alterations 
in blood flow or cerebrovascular health (Buxton et al., 1998).  Further investigation 
using ASL MRI methods to measure changes in CBF in younger cohorts is needed 
in order elucidate and extend our understanding of the association between 
cardiorespiratory fitness and cerebrovascular health.
The present study examined the potential association between cardiorespiratory 
fitness O2MAX), cognition and a number of cerebrovascular parameters in a cohort 
of healthy young males.  Computer based cognitive tasks known to tap into aspects 
of hippocampal and executive function were chosen since performance on these are 
thought to be influenced by exercise (Colcombe and Kramer, 2003).  Indirect 
evidence of the systemic vasculature suggests a relationship between O2MAX and 
vascular compliance (Vaitkevicius et al., 1993) leading us to hypothesise that the 
same would be true of the cerebrovasculature, as measured using ASL by assessing 
the compliance of the MCA.  In the absence of sufficient ASL research in highly fit 
young adults, it was also hypothesised that those with higher aerobic fitness 
O2MAX) would show elevated resting CBF such as that seen in highly-fit elderly 
cohorts (e.g. Zimmerman et al., 2014).  Furthermore, this study hypothesised that 
CBF CVR to CO2 during breath-holding, would show a similar relationship to that 
reported in previous fMRI studies (Gauthier et al., 2014; Thomas et al., 2013), 
whereby an inverse relationship has been demonstrated between O2MAX and BOLD 
CVR.  To maximise the variance within our sample, we recruited participants across 
a range of fitness levels.  Exploring fitness related differences in measures of 
cerebrovascular health in young adulthood will help to shed light on the possible 
mechanisms underlying the benefits of exercise on the brain.
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2.2. Methods
2.1.1. Participants
Eleven healthy males, aged 20-24 years old, provided informed consent under 
ethical approval from the University of South Wales (USW) and Cardiff University 
School of Psychology Ethics Committee, and all experiments were performed in 
accordance with the guidelines stated in the Cardiff University Research Framework 
(version 4.0, 2010).  
Initial recruitment took place at USW.  Recruitment was carried out to maximise the 
range of cardiorespiratory fitness within the sample.  Participants who regularly 
engaged in aerobic exercise were recruited from running and cycling clubs whereas 
other subjects were recruited through University-wide advertisement and word of 
mouth.   During session 1 at USW, subjects underwent a detailed clinical examination 
that included 12-lead functional diagnostic exercise electrocardiography and were 
excluded if they showed signs of any cardiovascular, cerebrovascular or respiratory 
disease. Participants were also screened by self-report for any neurological or 
psychiatric illnesses, regular smoking or prescribed medication.  Testing at Cardiff 
University (session 2) was carried out within 6 months of VO2MAX assessment and 
subjects who reported any change in their physical activity patterns between 
experimental sessions were excluded from the study.
2.1.2. Fitness testing ( O2MAX) (Session 1)
Online respiratory gas analysis (Medgraphics, MA, USA) was performed during an 
incremental cycling exercise test to volitional exhaustion on an electronically braked, 
semi-recumbent cycle ergometer (Lode Corival, Cranlea & Company, UK) for the 
specific determination of ventilation, O2 and CO2.  The test began with 2 minutes 
of rest, followed by 5 minutes of unloaded pedalling (0W) and increased by 5W every 
10s thereafter.  Participants were required to maintain a cadence of ~70 revolutions 
per minute (RPM).  Maximum exertion and corresponding O2MAX was confirmed 
when at least two of the following established criteria were met: 1) Failure to increase 
O2 with increasing exercise load 2) a respiratory exchange ratio (RER; the ratio 
Chapter 2
54
between PET CO2 and PET O2 during cycling) of >1.15, or 3) a heart rate within 10 
beats of an age-predicted maximum (i.e. 220 – age in years) (Barnes et al., 2013).
2.1.3. MRI data acquisition (Session 2)
All scanning was carried out using a 3T GE HDx scanner (GE Healthcare, Milwaukee, 
WI, USA) equipped with an 8-channel receive-only head coil. All participants 
underwent whole brain T1-weighted structural scans (3D FSPGR, 1x1x1 mm3 voxels, 
TI= 450ms, TR =7.8ms, TE = 3ms) for registration purposes.  
2.1.3.1. Arterial compliance and Resting CBF 
Tissue perfusion (or CBF) can be measured with ASL by magnetically labelling blood 
before it reaches the volume of interest.  This method is typically used to measure 
tissue perfusion which represents delivery of blood to the capillary bed, usually at an 
inversion time (TI) of >1sec after the label has been applied. Before reaching the 
capillary bed, blood must first flow through the macrovasculature of the brain, namely 
the arteries and arterioles, which have arrival times of <1sec.  Imaging at shorter TI’s 
therefore results in images of arterial blood flowing through major arteries such as 
the middle cerebral artery.  Using the multi-TI sequence described below, acquisition 
over a range of inversion times from short (250ms) to long (2000ms) enables 
examination of the signal arising in both arterial and tissue compartments for 
measuring arterial compliance or resting CBF respectively.
A multi-inversion time (MTI) PASL acquisition was performed (PICORE with a 
QUIPSS II cut-off at 700ms (Wong et al., 1998)). Ten inversion times (TI’s) were 
acquired, whereby short (TI’s = 250, 350, 450, 550, 650ms) medium (TI’s = 750, 850) 
and long TI’s (TI’s = 1,000, 1,500, 2000ms) were acquired as separate scans in which 
the label (width 200mm) was applied 10mm below the most proximal slice. Images 
were acquired with similar parameters to those described elsewhere (Warnert et al., 
2015b) using a spiral gradient echo sequence (TE=2.7ms) with the following 
acquisition parameters: a variable repetition time (1,000ms to 3,400ms), eight 
control–tag pairs per TI, 12 slices, slice gap=1mm, voxel size=3x3x7mm3. Total 
acquisition time was ~18 minutes. For quantification of perfusion, a (M0) calibration 
scan was acquired without labelling in which the same acquisition parameters were 
applied as above except for the TR=4s. Brachial artery blood pressure (BP) was 
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measured at 3 time-points across the scan session using an MRI-compatible BP cuff 
(OMRON, Tokyo, Japan).
2.1.3.2. Cerebrovascular Reactivity (CVR)
A breath-hold paradigm was carried out as described elsewhere (Bright and Murphy, 
2013).  Breath-holding as a form of gas-challenge was chosen for a number of 
reasons.  It is more time efficient and easier to administer than other gas modulation 
paradigms and importantly, we wanted to assess the feasibility of the paradigm for 
use in patient cohorts (Chapter 4).  Breath-holding removes the uncomfortable 
presence of a face mask within the head coil, and is self-directed such that it allows 
the patient to abort the task at any point, thereby improving safety and providing 
reassurance for the patient where recruitment is troublesome. 
Participants were instructed to complete 5 end-expiration breath-holds (15s each) 
interleaved with 30s periods of paced breathing at rate of 12 breaths per minute 
(Murphy et al., 2011b). After each breath-hold the subject was cued to exhale first to 
obtain a measure of peak end-tidal CO2 (fig. 2.1) Total scan duration was  ~4 minutes 
during which quantitative arterial spin labelling (PASL) and BOLD-weighted images 
were acquired with a single-shot PICORE QUIPSS II (Wong et al., 1998) pulse 
sequence (TR=2.2 s, TI1=700ms, TI2=1500ms, 20-cm tag width, and a 1-cm gap 
between the distal end of the tag and the most proximal imaging slice) with a dual-
echo gradient echo (GRE) readout (Liu et al., 2002) and spiral acquisition of k-space 
(TE1=2.7ms, TE2= 29ms, flip angle=90°, field of view (FOV)=22 cm, 64×64 matrix).  
Twelve slices of 7mm thickness were imaged, with an inter-slice gap of 1mm. 
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2.1.3.3. Physiological Monitoring
Throughout scanning, the cardiac pulse was recorded using a finger plethysmograph 
and a pneumatic belt just below the ribcage was used to measure the respiratory 
cycle. Expired gas content was monitored continuously via a nasal cannula whereby 
end-tidal O2 and CO2 data were recorded using a rapidly responding gas analyser 
(AEI Technologies, PA, USA) to provide representative measures of arterial partial 
pressures of both gases at the prevailing barometric pressure. 
2.1.4. MRI Data analysis
2.1.4.1. Physiological Noise Correction
Physiological noise correction was carried out on the raw data using a modified 
RETROICOR pipeline (Glover et al., 2000).  For the raw CBF data, the 1st and 2nd 
harmonics of the cardiac and respiratory cycles (and the interaction term) were 
calculated, as well as variance related to end-tidal CO2, end-tidal O2, heart rate, and 
respiration volume per time (RVT; Birn et al., 2009) using a general linear model 
framework and subsequently regressed from the raw CBF signal.  For the MCAC 
Figure 2.1  Breath-hold paradigm. Each breath-hold challenge (N=5, 
duration=15s) was preceded by paced breathing and ended on an exhalation.  
Participants were instructed to produce a small exhalation following the hold to 
provide accurate end-tidal measurements. An example trace from the respiratory 
bellows is provided (figure adapted from Bright & Murphy, 2013).
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data, only respiratory noise correction was performed since the cardiac trace was 
necessary for retrospective synchronisation of aBV maps across the cardiac phase.
2.1.4.2. ROI masking
MCAC masking. Masking was carried out as described previously (Warnert et al., 
2015b).  For each participant, an average ΔM image was obtained for the full-time 
series of TI=750ms.  Regions of interest were determined based on data from 
TI=750ms because on average this has been shown previously to be the TI with the 
maximum intensity in the raw difference images (Warnert et al., 2015b). An ΔM 
image mask was created such that each slice only contained the 5% of voxels with 
the highest intensities. Broad ROIs were manually drawn around the bilateral MCAC 
territories within each slice. Each of the broad masks was multiplied by the 
thresholded ΔM image to produce the ROI maps (~6 slices).
Resting CBF and CVR masking. Individual whole brain tissue segmentation was 
performed on the T1-weighted images using the FMRIB automated segmentation tool 
(FAST; Zhang et al., 2001). Individual temporal, occipital, frontal and parietal lobe 
masks were defined by registration of MNI lobular masks to subject's individual grey 
matter mask’s derived from FAST using FMRIB's Linear Image Registration Tool 
(FLIRT; Jenkinson and Smith, 2001). 
2.1.4.3. Arterial Compliance Quantification
Arterial compliance measurements were carried out using the methods described by 
(Warnert et al., 2015b).  Arterial blood volume (aBV) within the bilateral middle 
cerebral arteries (MCA) was assessed in systole and diastole (fig. 2.2). Brachial 
artery blood pressure cuff recordings were averaged over three time points to 
calculate average systolic and diastolic BP for each subject.  Only data from short 
TI’s (250-850ms) were necessary for deriving aBV to ensure that signal being 
measured was originating from the arteries rather than the tissue. 
To determine systole and diastole, the cardiac cycle was divided into 5 phases using 
the finger plethysmography trace. The short TI images were retrospectively 
organized into the 5 cardiac phases and an arterial input function was fitted voxel-
wise for each of the 5 phases. Fitting of the acquired images were retrospectively 
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synchronised to account for a 225ms delay between the cerebral and finger pulse 
(fig. 2.2a). This time period was deduced from delay times found in the literature 
between the R-peak in the electrocardiogram and the left finger (Myllylä et al., 2012) 
and the time delay between R-peak in the ECG and the onset of the carotid pulse 
wave (Holdsworth et al., 1999).  The cardiac phases with the maximum and minimum 
blood volumes, averaged over both MCA, were used as systole and diastole, 
respectively.  
Voxel-wise differences between aBVSys and aBVDia were calculated to reflect arterial 
distensibility, normalised for the aBV in diastole to produce arterial compliance values 
of percentage change in aBV/mmHg (%/mm Hg) (fig.2.2.c, d) within the bilateral 
MCAC mask.
2.1.4.4. Resting CBF Quantification
The full MTI time series was used for quantification of resting CBF.  Signal within the 
ventricles (M0 CSF) was used to estimate M0 blood (Lu et al., 2004) and subsequently 
modelled to calculate whole brain perfusion maps based on the entire MTI dataset 
using FSL BASIL toolbox (FMRIB Software Library, Oxford, UK).  Whole-brain and 
Figure 2.2  Measuring Arterial Compliance. (a) Images acquired during scanning 
are retrospectively synchronised to the cardiac cycle according to finger 
plethysmography. (b) Signal from images acquired within the systolic pressure phase 
have greater signal than images acquired within the diastolic pressure phase. (c) 
Arterial compliance (AC) is quantified by determining the voxel wise percentage 
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lobular grey matter masks were applied to CBF maps to produce average GM CBF 
estimates within each region. 
2.1.4.5. Cerebrovascular Reactivity Quantification
Simultaneously acquired CBF and BOLD time-series images were corrected for head 
motion with MCFLIRT (Jenkinson et al., 2002), brain-extracted (Smith, 2002) and 
spatially smoothed with a Gaussian kernel of 6 mm using SUSAN (Smith and Brady, 
1997). BOLD images were calculated from the second echo data using interpolated 
surround averaging of the tag and control images to yield a BOLD weighted time-
series, as described previously (Liu and Wong, 2005).  The first echo data were used 
to calculate a subtraction time-series (Murphy et al., 2011a) from which CBF was 
quantified to the standard single-compartment CBF model (Wong et al., 1998).   
BOLD and CBF time-series data were converted to percentage change in the signal 
relative to the baseline (mean) of the time-series to produce a %ΔBOLD and %ΔCBF 
time-series respectively.  Signal was averaged across whole-brain GM and lobular 
GM ROIs. A regression analysis was performed to measure %ΔBOLD/ %ΔCBF per 
mmHg change in absolute end-tidal CO2 with a 3rd order polynomial included to 
remove slow signal drift.  Temporal lag-fitting (time-shift steps of 0.1s) was also 
carried out, to account for the delay between end-tidal CO2 increase in response to 
breath-holding and the subsequent blood flow response (Bright and Murphy, 2013). 
CVR was thus defined as the beta-weight from the regression model, where BOLD 
and CBF were measured in units of %BOLD/mmHg or %CBF/mmHg respectively.  
Whole-brain and lobular grey matter masks were applied to the CVR time-series to 
produce average CBF and BOLD CVR estimates within each region.
2.1.5. Cognitive Testing
The cognitive testing session was conducted prior to the MRI scan session and 
lasted approximately 30 minutes. Testing was conducted in a quiet testing room at 
Cardiff University Brain Research Imaging Centre (CUBRIC). Participants carried out 
each test in isolation to prevent distraction and were informed to instruct the 
experimenter between tests.  
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2.1.5.1. N-back (2-back)
To test working memory, a version of the N-back task was used.  This task requires 
on-line monitoring, updating, and manipulation of remembered information and is 
thought to place great demands on a number of key processes within working 
memory (Owen et al., 2005).  The n-back task has been shown previously to vary 
with aerobic exercise training in subjects of different ages (Hansen et al., 2004; 
Voelcker-Rehage et al., 2010). 
The task was developed and validated at Cardiff University using MATLAB 2012b 
software (MathWorks, Natick, Mam USA)), using the Psychophysics Toolbox 
extensions (Brainard, 1997; Pelli, 1997; Kleiner et al, 2007).  During this task, the 
volunteer was required to monitor a series of numbers as they appeared on an LCD 
screen positioned in front of them, and to respond whenever a stimulus was 
presented that was the same as the one presented n trials previously, where n is a 
pre- specified integer, 0, 1, or 2, such that working memory load increased with n.  
Six blocks were presented for each n-back and each block consisted of ten trials, 
such that there were 60 trials for each load.  Scores were calculated as the total 
number of correct responses within each block, out of 60.
2.1.5.2. Paired Associates Learning (PAL)
To test spatial recognition memory, a paired associates learning task was adopted.  
Performance on this task has been shown previously to improve with exercise 
training (Fabre et al., 2002) and is thought to implicate the hippocampus (Yoon et al., 
2011), a target region known to be functionally and structurally effected by exercise 
(e.g. Creer et al., 2010).  It is commonly used to assess memory impairments in aging 
clinical populations (Gould et al., 2005).
The PAL was adopted from a battery of publicly available cognitive assessment tools 
that were designed and validated at the Medical Research Council Cognition and 
Brain Sciences Unit (Owen et al., 2010) and made freely available at 
http://www.cambridgebrainsciences.com. 
During this test, subjects were required to remember pattern-location associations 
(fig. 2.3a). Each box was uncovered for a total of 3 s and then closed again before 
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the next box opened in a randomized sequence. Participants were required to 
remember the object located inside each box. Subjects then viewed each object on 
the centre of the screen after which participants were required to respond by clicking 
the box in the location in which that object had appeared.  Task difficulty increased 
(+1 box) on consecutive trials, beginning with two boxes being uncovered.  Feedback 
was not provided after each response, although if the choice was correct then the 
task automatically continued to increase in difficulty, by the addition of another open 
box.  Participants could make three errors in total before the test was terminated.  
Following an error, task difficulty decreased, and continued to increase on successful 
trials. Performance was assessed according to the average number of correct object-
place associations (‘paired associates’) in the trials that were successfully completed.  
The maximum number of possible correct associations was 25. 
2.1.5.3. Behavioural Pattern Separation Task – Object Version (BPS-O)
The BPS-O task was chosen to assess Pattern Separation, a type of recognition 
memory, known to implicate the hippocampus (Yassa et al., 2011).   The BPS-O task 
has been shown to be a sensitive measure for observing changes in memory 
performance across the lifespan and may be useful for the early detection of memory 
impairments (Stark et al., 2013). Better performance and has also been associated 
with wheel running in mice (Creer et al., 2010b). 
Renamed to the Mnemonic Similarity Task (MST) in 2015, this task was designed 
and validated at the University of California and made freely available at online at 
http://faculty.sites.uci.edu/starklab/mnemonic-similarity-task-mst. 
In the first part of the experiment (implicit encoding), participants were presented 128 
pictures (duration=2s) of everyday items and participants were asked to make an 
arbitrary judgement, by deciding whether the item was an OUTDOOR or an INDOOR 
item (fig. 2.3b).  In the second part of the experiment, participants were presented 
with 64 of the previously seen pictures (targets), 64 of very similar items (lures), and 
64 new items (foils).  Participants were instructed to categorize the items as old (‘O’), 
new (‘N’), or similar (‘S’) within 2s.  The outcome measure was a score of recognition 
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memory, quantified as the percent of targets endorsed as ‘‘Old’’ minus the percent 
of foils endorsed as ‘‘Old’’ (Hits - false alarms). 
2.1.6. Statistical Analysis
To assess whether fitness could predict individual measures of cerebrovascular 
function and neurocognitive performance linear regression was carried with O2MAX
as the predictor variable. Pearson correlation coefficients were used to assess the 
relationships between MCAC, CVR and CBF where a predictor variable was not 
predetermined.  Repeated-measures analysis of variance (ANOVA) was used to 
assess differences between ROIs and for cognitive data where there were multiple 
levels and to assess differences in arterial parameters between systole and diastole. 
The significance threshold was set at 0.05.
2.1.6.1. Data Quality
Data quality was visually inspected and assessed for outliers using Cook’s distance.  
Outliers were removed where stated in the Results.  Statistical assumptions of 
parametric testing were assessed (SPSS, version 20) using the Shapiro-Wilks test 
Figure 2.3 Computerised cognitive paradigms. (a) Example screen view of the 
Paired Associate Learning (PAL) task.  Participants viewed the contents of each box 
sequentially after which participants were shown a cue image (e.g. cat) and required 
to retrieve the location (box) where that image had been seen previously.  This task 
increased in difficulty until a total of 3 errors were made.  (b) Behavioural Pattern 
Separation – Object (BPS-O) task.  During the encoding phase participants were 
required to make an arbitrary indoor/outdoor judgement.  During the test phase, 
participants were required to decide whether a series of images were old, new or 
similar.
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to confirm distribution normality and visual inspection of residual values was 
performed to ensure homogeneity of variance. 
2.1.6.2. Bootstrapping
Unless stated otherwise, bootstrapped confidence intervals (95%) were computed, 
whereby all linear regressions and Pearson’s correlations were bootstrapped to 1000 
samples. 
Bootstrapping was used as it enables more accurate inferences when the sample 
size is small and where such that data is not normally distributed. This method 
depends upon resampling of the sample data such that it is possible to make 
inference about the population even when the sample data is skewed.  For a given 
sample of data, a bootstrap sample is taken from the original sample and replaced 
multiple times, with a new mean being calculated for each sample.  When this is done 
repeatedly, i.e.1000 times, a population distribution can be calculated such that the 
reliance upon assuming normality is removed.  Computation of the bootstrap 
distribution of a parameter-estimator enables calculation confidence intervals for its 
population-parameter.  Samples can subsequently be corrected for bias and 
skewness between the bootstrap distribution and the sample distribution using 
statistical software packages i.e. SPSS, such that bias-corrected and accelerated 
(BCa) confidence intervals (CIs) and adjusted p-values can be calculated.
2.3. Results
2.3.1. O2MAX, Heart rate, Blood Pressure and Body Mass
O2MAX ranged from 38-76 ml/min/kg (57.3 ± 12.7 ml/kg/min) with body mass (76.6± 
8.3), systolic BP (122 ±4), diastolic BP (72 ±9), heart rate (63.9 ± 9.5).  Participants 
with higher  O2MAX had a lower heart rate, but this was not significant (r (11) =-0.44, 
p>0.05).  There was no relationship between fitness and systolic/diastolic blood 
pressure, body mass or age in this sample (p-values < 0.05).
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2.3.2. O2MAX and Middle cerebral arterial compliance (MCAC)
Nine participants contributed to the MCAC analysis as two were removed due to 
severe head movement.  
Averaged over all participants, we calculated bilateral MCAC to be 0.41 ± 
0.16 %/mmHg.  Linear regression revealed a significant relationship between O2MAX
and MCAC, whereby fitter individuals showed the hypothesised increase in 
compliance of the middle cerebral arteries (fig. 2.4a) and this relationship was 
significant (r2 = 0.64, =0.01, F (1, 8) =12.6, p=0.03, 95% CI [0.003, 0.018]).  These 
values indicate that arterial compliance in the MCA increased by 0.01%/mmHg for 
each ml/min/kg increase in O2MAX.  
A second linear regression was performed to rule out the possibility that the 
relationship between MCAC and O2MAX could be explained solely by differences in 
resting heart rate. MCAC was not inversely correlated with heart rate (r2 = 0.31, =-
0.01, F (1, 8) =0.75, p=0.31, 95% CI [-0.02, 0.03]) as would be hypothesised if a 
higher stroke volume through the MCAs was mediating this effect.
Retrospective synchronisation of images across the cardiac cycle was inspected to 
ensure that there was not a bias between the number of tag and control images for 
a particular TI or phase.  A repeated-measures ANOVA revealed that the number of 
tag and control images did not differ significantly between TI (F (6,48) =1.3, p=0.30, 
Figure 2.4. Relationship between VO2MAX and cerebrovascular MRI measures.
Increased VO2MAX is associated with (a) increased arterial compliance within the 
bilateral middle cerebral arteries (MCA) (b) decreased GM CBF at rest (c) 
decreased GM CVR.
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n.s.) or phase (F (1,8) =0.7, p=0.43, n.s.), nor was there an interaction between the 
number of images within each phase at each TI (F (6,48) =0.54, p=0.78, n.s.). On 
average, for a single TI there were 6 tag and 7 control images in diastole, and 6 tag 
and 6 control images in systole.
Individual parameter maps for aBV (%v) as well as arterial arrival time (Δt), and 
dispersion (σ) calculated for five different cardiac phases were acquired by fitting the 
model on a voxel-by-voxel basis. Median values were calculated within the bilateral 
middle cerebral arteries just above the Circle of Willis in systole and diastole (figure 
2.5.) To investigate differences in aBV, Δt, and σ between systolic and diastolic 
phases, repeated-measures ANOVA was carried out on aBV, Δt, and σ in a single 
slice above the Circle of Willis.   On average aBVSys (3.8±2.9) was 60% higher than 
aBVDia (2.3±1.5) (range 48-89%) although this was not significant when collapsed 
across participants (F (1,8) =0.33, p=0.58, n.s.).  
On average ΔtSys (501±64) was 41ms longer than ΔtDia (460±96), however this was 
also not significant (F (1,8) =1.5, p=0.26, n.s.). In addition, σDia (117±37) was on 
average 1.4ms larger than, σSys (188±35) although this was also not significant (F 
(1,8) =0.1, p=0.91, n.s.).  To address whether variance within the parameter 
estimates for aBV, Δt, and σ could be attributable to individual differences related to 
cardiorespiratory fitness, a repeated-measures ANOVA was repeated with O2MAX
as a covariate.  The interaction term showed that fitness was unable explain the 
variance in Sys and Dias in aBV (F (1,7) =1.6, p=0.25, n.s.), Δt (F (1,7) =2.5, p=0.16, 
n.s.) or σ (F (1,7) =1.4, p=0.27, n.s.).
Figure 2.5 Arterial Flow Metrics. Regional median results for aBV, Δt, σ for the 
slice just above the circle of Willis (averaged across subjects). Arterial blood 
volume, Δt and σ are given for systole (pattern) and diastole (black). Mean ± S.E.M.
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2.3.3. O2MAX and resting grey matter perfusion (CBF)
Whole-brain GM averaged CBF values ranged from 53.8 - 73.1 ml/100g/min (59.4 ± 
6.7). Eight participants contributed to baseline CBF analysis (3 were excluded due 
to severe head motion). Linear regression revealed a significant inverse relationship 
between O2MAX and resting whole-brain GM CBF (r2 = 0.75, =-0.47, F (1,7) =18.3, 
p= 0.03, 95% CI [-0.68, -0.24]; fig 2.3.1b).  Whole-brain grey matter CBF decreased 
0.47 ml/100g/min for each ml/min/kg increase in O2MAX.  An inverse relationship 
was observed within each cortical ROI, however none of these were significant 
(p>0.05; fig. 2.6). 
2.3.4. O2MAX and Cerebrovascular Reactivity (CVR)
Cerebrovascular reactivity data was excluded for one participant because the subject 
was unable to breathe through his nose, so that 10 subjects contributed to the CVR 
analysis. BOLD data (fig. 2.7a) demonstrated better signal-to-noise (SNR) than CBF 
measurements (fig. 2.7b) in response to breath-holding, however, CBF CVR was 
positively correlated with the BOLD CVR measurements across whole brain GM (r²= 
0.52, =12, F (1,9) =8.8, p=0.01, 95% CI [0.034, 0.078]; fig. 2.7c).  CBF CVR, like 
Figure 2.6 Regional 
GM CBF
Absolute grey matter 
CBF (ml/100/g/min) is 
negatively associated 
with VO2MAX across the 
whole brain and within 
lobular ROI’s (n.s).
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BOLD CVR showed a decline in CVR with increased O2MAX within whole-brain grey 
matter (fig. 2.4c) and cortical ROIs (fig. 2.8). Linear regression did not find this to be 
significant for either the BOLD or CBF response (p-values>0.05). Neither BOLD CVR 
(F (3,24) =0.69, p=0.57, n.s.) or CBF CVR (F (3,24) =0.56, p=0.65, n.s.) was found 
to vary between cortical ROIs in relation to fitness (p-values>0.05). 
Figure 2.7 Grey matter BOLD CVR and CBF CVR are correlated. Individual subject’s 
BOLD (a) and CBF (b) responses to the breath-hold task.  Black lines reflect the 
average response across participants.  BOLD time-series showed better signal-to-
noise than CBF, but were significantly correlated (c).
Figure 2.8 Relationship between VO2MAX and regional CVR. Percent CBF (top row) 
and % BOLD (bottom row) CVR was negatively associated with VO2MAX within a 
grey matter whole brain and lobular regions of interest, however these relationships 
were not significant.
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2.3.5. Relationship between measures of cerebrovascular health
Arterial compliance was not correlated with either BOLD CVR (r (7) =-0.20, p=0.68, 
n.s, 95% CI [-0.89, 0.44]), CBF CVR (r (7) =-0.14, p=0.78, n.s, 95% CI [-0.54, 0.39]), 
nor with resting grey matter perfusion (r (7) =-0.45, p=0.30, n.s, 95% CI [-0.73, -0.33]). 
There was, however, a significant correlation between resting grey matter perfusion 
with both CBF CVR (r (7) =0.76, p<0.05, 95% CI [0.04, 0.95]; fig. 2.9) and BOLD 
CVR (r (7) =0.78, p=0.04, 95% CI [-0.35, 0.97]) after bootstrapping. 
2.3.6. O2MAX and Cognition
N-Back 
A repeated-measures ANOVA revealed that accuracy decreased as working 
memory load increased across the group (F (2,20) = 63, p<0.001). Post-hoc t-tests 
indicated that accuracy for each load significantly differed from accuracy for each of 
the other loads (means: 0-back 97.3  2, 1-back 81.9  8, 2-back 66.7  9).  However, 
performance did not differ with O2MAX on either the 0 –back (r2 (9) = 0.03, =-0.05, 
F (1,9) = 0.25, p= 0.51, n.s, 95% CI [-.47, 0.34]), 1-back (r2 (9)= 0.01, =-0.002, F
Figure 2.9 Whole-brain GM CBF 
and CVR are related. Grey matter 
resting CBF and %CBF CVR were 
significantly correlated (N=7).
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(1,9) = 0.001, p= 0.99, n.s, 95% CI [-0.45, 0.45]), or 2-back (r2 (9) = 0.08, =0.21, F
(1,9) = 0.79, p= 0.41, n.s, 95% CI [-2.5, 0.56] fig. 2.10a).
Paired Associates
Participants remembered an average of 5.3 ( 1) object locations.  O2MAX was not 
associated with performance on the PAL task (r2 (9) = 0.06, =0.007, F (1,9) = 0.61, 
p= 0.36, n.s., 95% CI [-0.06, 0.11] fig. 2.10b).
Pattern Separation
Recognition memory across participants averaged 138 ( 16) objects out of a 
maximum 192 objects, however, was not associated with O2MAX (r2 = 0.06, =0.30, 
F (1,9) = 0.53, n.s, p= 0.5, 95% CI [-0.42, 1.31]).  Behavioural pattern separation 
accuracy, after correcting for response bias, averaged 76( 7) %, but this was also 
not associated with O2MAX (r2(9) = 0.33, =0.37, F (1,9) = 1.07, p= 0.4, n.s, 95% CI 
[-0.20, 0.70], fig. 2.10).  
2.3.7. Cognition and cerebrovascular function
To assess whether cognition was related to cerebrovascular function, Pearson’s 
correlations were run to assess whether individual scores on the 2-back, PAL task 
and BPS-O task were related to MCAC, resting CBF and CBF CVR.  There was no 
Figure 2.10  Neurocognitive differences did not differ significantly with VO2MAX.
Working memory performance on the a) N-back task (2-back block), b) spatial object 
memory on the Paired Associate Learning task (PAL) nor c) object recognition 
memory on the Behavioural Pattern Separation – Object (BPS-O) task were 
associated with cardiorespiratory fitness (VO2MAX).
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relationship between performance on either the paired associate learning and 2-back 
tests and any of the cerebrovascular measures. However, a two-tailed test revealed 
an inverse relationship between CBF CVR and pattern separation performance (r 
(10) =-0.66, p=0.04, n.s., 95% CI [-0.95, 0.60]; fig. 2.11) such that reduced CBF CVR 
predicted better performance on the BPS-O task, however this was no longer 
significant after FDR correcting for multiple comparisons (p=0.11, n.s).
2.4. Discussion
Key Findings:
• MCA compliance is positively and significantly associated with O2MAX.
• Absolute resting perfusion is inversely and significantly related to O2MAX.
• CBF CVR is positively and significantly associated with BOLD CVR
• CBF CVR does not vary significantly with  O2MAX although a negative trend 
was evident, 
• Cognitive performance does not vary significantly with O2MAX.
• Cognitive performance does not vary significantly with cerebrovascular 
health.
Figure 2.11 Relationship 
between CBF CVR and pattern 
separation performance.
CBF Cerebrovascular reactivity 
(CBF CVR) showed an inverse 
relationship with pattern 
separation performance on the 
BPS-O task, but this was not 
significant after correction for 
multiple comparisons (p>0.05).
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Whilst the benefits of physical activity on cognition and mental health are well 
established, the physiological mechanisms by which exercise exerts its beneficial 
effects on the young adult brain remain poorly understood.  In this study, we 
demonstrate that arterial spin labelling MRI is a useful tool for understanding local 
and absolute changes in blood flow that may shed new light on the exercise-related 
changes reported previously using alternative methods.   We also demonstrate that 
fitness-related cerebrovascular differences are detectable in the absence of any 
measured differences in cognitive performance.
2.3.8. Compliance of the Middle Cerebral Artery
One proposed mechanism by which exercise is thought to improve cerebral health 
is by increasing compliance of the cerebral arteries to changes in blood pressure.  
To date, measures of compliance in relation to exercise have relied upon ultrasound 
imaging of cerebral arteries, where compliance within the brain can only be inferred.  
The present study utilised a novel, non-invasive, measure of middle cerebral arterial 
compliance using PASL MRI to demonstrate the link between cardiorespiratory 
fitness and MCA compliance in a sample of young males across the spectrum of 
cardiorespiratory fitness.  It was observed that arterial compliance within the middle 
cerebral arteries is higher in individuals with higher O2MAX, consistent with other 
non-MRI methods in other major arteries throughout the body (Tabara et al., 2007; 
Tanaka et al., 2000).  The present study is the first to use MRI to measure fitness 
related changes in MCAC and provides promising evidence towards the 
cerebrovascular benefits of physical activity, as well as insight into the mechanisms 
at play.  
The ability of cerebral arteries to dampen changes in pulse pressure in order to 
maintain a continuous flow prevents downstream tissue damage where vessels are 
vulnerable to deterioration (Poels et al., 2012).  Arterial compliance, as measured 
here, can be thought to reflect healthy, more ‘elastic’ vessel walls,  providing efficient 
blood supply and delivery of nutrients to metabolising tissue (Prins et al., 2005). 
Improving arterial compliance or preventing age-related arterial stiffening through 
physical exercise is thought to contribute to the cognitive benefits that have been 
reported as a result of exercise (Davenport et al., 2012; Mitchell et al., 2011). More 
compliant cerebral arteries could act to buffer pressure pulses, preventing rupture of 
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the small vessels and thereby continuing to perfuse neural tissue, such that cognitive 
function is preserved.   Whilst a relationship between MCAC and cognitive function 
was not observed in the present study, it is possible that preserving cerebral 
compliance throughout the lifespan by engaging in regular exercise is necessary 
before these differences in cognitive performance can be detected.
The present findings corroborate indirect evidence from TCD literature that suggests 
an increase in extracranial compliance with cardiorespiratory fitness (Tanaka et al., 
1998).  Validation of this link, lends support for future interventional exercise studies, 
where the mechanisms underpinning this link can be explored further.   Such studies 
should take care to control for how MCAC varies in subjects who perform different 
types of exercise.  For example, resistance training has been found previously to 
reduce AC of the carotid artery where aerobic training leads to increased AC (Miyachi 
et al., 2003).  The present study utilised O2MAX as an index of aerobic fitness, 
however it would have been interesting to investigate, in the same sample, whether 
an index of strength, such as a maximum isometric strength test, had an inverse 
relationship with MCAC, reflecting a decrease in MCAC.  Further research into the 
effects of different types of exercise on AC using this novel MRI method to elucidate 
this dichotomy is warranted.   Current guidelines recommend a combination or 
resistance and aerobic exercises in order to reduce sarcopenia (age-related loss of 
muscle mass and strength) and preserve functional capacity however a full 
understanding of the clinical trade-off between these exercise types is still unclear. 
Moderate or higher load of training may be required to influence endothelial function 
in healthy asymptomatic subjects (Green et al., 2004) where repeated shear stress 
stimulation is required to drive adaptation (Green et al., 2005). Average compliance 
across participants in the present study was 0.41%/mmHg (± 0.16) which is 
consistent with the literature although the range is wider in our sample (0.2-
0.7%/mmHg) than reported previously (Warnert et al., 2015b) possibly due to the 
wide range of fitness levels in our sample.  Aerobic exercise is associated with 
systemic changes in pulse pressure and heart rate, which generate recurrent 
changes in hemodynamic and shear stress patterns.  These differing patterns may 
differentially affect arterial remodelling (Newcomer et al., 2011) of endothelial and 
vascular smooth muscle cells that are located within the medial layer of the artery 
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walls, which regulate the physiological function and the pathological changes that 
take place within the arterial wall (Peterson et al., 2011). Whilst resting heart rate 
was lower in fitter subjects, this was not significant in this modest cohort.  MCAC was 
also not related to resting heart rate, suggesting that resting MCAC in fitter subjects 
is not explained simply by a reduction in heart rate and higher stroke volume through 
the arteries. It would be interesting to explore the association between MCAC and 
maximal heart rate when shear stress is thought to occur, however, this data was not 
available for this thesis.  A caveat of the present study was that a full history of the 
type, duration and intensity of physical activity was not taken.  As such it is not 
possible to determine whether activity type was driving the changes in MCAC 
observed.  Future research may wish to investigate MCAC differences in individuals 
who perform different activity types e.g. resistance exercise or high intensity training 
(HIT). 
The present study did not find any differences between aBV, arterial arrival times or 
dispersion between systole and diastole, evidence that has been shown previously 
as evidence of cardiac pulsatility (Warnert et al., 2015b).  Reasons for this difference 
in findings is likely due to the noise within the present dataset.  In the paper by 
Warnert et al. (2015b) image acquisition was longer such that the number of images 
acquired was sufficient for retrospective division across 8 cardiac phases, each with 
sufficient SNR to characterise aBV.  In the present study, acquisition was shorter 
such that images were binned into just 5 phases to maximise signal within each 
phase, at the expense of accuracy in characterising aBV across the entire cardiac 
cycle.  Whilst the calculated range of aBV, ∆t and σ are within the ranges reported 
elsewhere (Warnert et al., 2014a; Warnert et al., 2015b), the variance across 
subjects and across the cardiac phase are greater, and is likely to be attributed to 
noise in the signal.  
The current findings demonstrate improvements in cerebral arterial compliance only 
in the MCA. Using MRI it is also possible to investigate changes within the posterior 
and anterior cerebral arteries that branch from the Circle of Willis (CoW) (Warnert et 
al., 2014a, 2014b; Warnert et al., 2015a).  In the present study, a compromise was 
made between acquisition time and the number of scans run in the session.  As such, 
SNR was too low in these smaller arteries and therefore the data has not been 
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investigated here.  Increasing the number of images acquired during the short TIs, 
would improve the signal quality and allow more accurate investigation of compliance 
in these smaller cerebral arteries.  Furthermore, the present method is not 
appropriate for measurement of arteriole compliance, distal from the CoW, where 
850ms may be too short to measure labelled blood travelling from the neck into these 
more distal arterioles.  Development of this method in this respect could yield insight 
into the additional role that arterioles play in maintaining cerebral perfusion (Warnert 
et al., 2015b).
The present study used peripheral blood pressure (brachial BP) as a surrogate for 
intracranial blood pressure.  The assumption that BP is consistent between the arm 
and the head is not optimal since pulse pressure in young adults is lower in the 
carotid than in the brachial artery because the latter is located closer to reflection 
sites of the pressure wave through the vascular tree (Laurent et al., 2012).  It is 
possible that using brachial BP could result in an underestimation of AC, where pulse 
pressure within cerebral arteries positioned between the carotid and the capillary bed 
is likely to be decreased.  Invasive measurement would therefore be necessary to 
obtain local pulse pressures. 
2.3.9. Grey Matter Perfusion
Contrary to our hypothesis, we report a reduction in resting CBF with increased 
fitness levels, an effect which is in conflict with much of the existing literature, 
whereby fitness has been positively associated with blood velocity or flow (Ainslie et 
al., 2008; Bailey et al., 2013; Zimmerman et al., 2014).  
There is a shortage of reported studies that examine cerebral perfusion with ASL in 
healthy young adults, especially with such a high O2MAX range.  Whole-brain GM 
averaged CBF values ranged from 53.8 - 73.1 ml/100g/min (59.4 ± 6.7 ml/100g/min), 
which are physiologically consistent, although slightly higher, than the range reported 
elsewhere in other healthy male cohorts.  We attribute this finding to the broader 
range of fitness levels recruited into our sample.  Our study measured CBF 
throughout the grey matter of the brain, where the signal is derived from the perfusion 
occurring within the capillaries of the local tissue.  This regional sensitivity within the 
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tissue itself is informative above and beyond TCD measures of arterial velocity in 
which exercise research has been primarily focussed.
With so few studies measuring baseline grey matter CBF with MRI in young healthy 
adults with exercise, it is open to speculation as to what may be driving the negative 
relationship seen in the present study.  Possible differences in resting CBF could 
arise for many reasons such as constriction of the arterioles, changes in capillary 
density, or an alteration of tissue oxygen utilization.  Since exercise has been shown 
to decrease the intima media thickness (IMT) of the artery wall, thereby increasing 
lumen diameter and allowing for an increase in blood flow through the artery 
(Sandrock et al., 2008), our observation is unlikely to be due to constriction of 
arterioles. However, the increase in lumen diameter is not a consistent observation 
in young subjects (Popovic et al., 2011) and has not been explored in the cerebral 
arteries, making it worthy of further investigation.  It is also unlikely that lower CBF 
with O2MAX is due to capillary reduction, since a number of preclinical studies have 
provided evidence for an increase in angiogenesis in the rodent brain with exercise 
(Swain et al., 2003; van Praag et al., 2005). Conversely, it is possible that 
angiogenesis could in fact reduce the demand for CBF, in a situation where shorter 
diffusion distances mean nutrient extraction is preserved, thereby requiring less 
blood flow to the metabolising tissue bed.  To investigate this further ex vivo
preclinical work is needed to validate this link.   This raises a useful question as to 
whether healthy individuals have more efficient mechanisms for oxygen utilization, 
whereby efficient gas exchange from the capillary bed necessitates a reduction in 
the amount of flow needed to supply the metabolizing tissue with adequate oxygen.  
It has been shown previously, that a reduction in CBF seen during exercise was 
accompanied by an increase in oxygen extraction, resulting in a maintained cerebral 
metabolic rate of oxygen consumption (CMRO2; Trangmar et al., 2014).  The equation 
CMRO2= CA× CBF× OEF (where CA is the arterial concentration of oxygen and OEF 
is the oxygen extraction fraction in tissue) states that if OEF is fixed, then increases 
in metabolic demands can be met by a proportionate increase in CBF or arterial 
oxygen concentration. Should OEF and/or arterial oxygen content be increased in 
athletes, then CBF increase may not be necessary for a given increase in oxygen 
metabolism.  
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Future research could use calibrated 
fMRI measures of oxygen extraction 
and CMRO2 (Germuska et al., 2016; 
Merola et al., 2016; Wise et al., 
2013) in highly fit individuals, to 
assess whether metabolic efficiency 
can explain the inverse relationship 
between O2MAX and CBF.  To 
assess this hypothesis, datasets 
from common subjects in which 
VO2MAX and OEF had been 
independently measured, were 
analysed (data permissions from 
Catherine Foster and Dr Alberto 
Merola respectively).  In this dataset, 
it was found that OEF was positively 
associated with VO2MAX, although this only approached significance in this sample of 
7 subjects (R²= 0.33, F (1,95) =2.5, p=0.17, n.s., 95% CI [-0.001, 0.015]; fig. 2.12).  
The software package G*Power (v3.1.9.2) estimated that a sample size of 15 
subjects is needed to achieve satisfactory power based on the effect size observed 
in this pilot study.  This can be deemed as a promising explanation and useful avenue 
for future research.  
Further to this, where arterial concentration of oxygen is known to influence rate of 
oxygen consumption, future research should consider measuring haematocrit in the 
blood to compliment these measures, where haematocrit is reported to be less in 
athletes (Sharpe, 2002), known as ‘sports anaemia’, compared to sedentary controls 
due to elevated plasma volume and increased total mass of red blood cells (Mairbäurl, 
2013) although, haematocrit may be increased in over-trained and/or iron deficient 
athletes (Brun et al., 2000).
Figure 2.12 Preliminary evidence linking 
VO2MAX with increased OEF. Preliminary 
data suggesting a potential link between 
cardiorespiratory fitness (VO2MAX) and 
oxygen extraction fraction (OEF) within the 
same participants, measured on different 
days (N=7). Data permissions received 
from Alberto Merola and Catherine Foster.
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2.3.10. Cerebrovascular Reactivity
Another aim of the current study was to explore whether physical fitness predicted 
the reactive capacity of the cerebrovasculature to transient increases in blood flow 
with hypercapnia (Murphy et al., 2011b), otherwise known as CVR. To date, studies 
that have investigated the relationship between CVR and fitness have relied upon 
either ultrasound methods (Ainslie et al., 2008; Bailey et al., 2013) or BOLD 
measurements (Gauthier et al., 2014b; Thomas et al., 2013b). Since the BOLD 
response is a complex haemodynamic measurement, BOLD CVR alone is not 
sufficient for understanding the mechanisms at play (Buxton et al., 2004).  The 
current study used pulsed ASL methods that allowed simultaneous measurement of 
BOLD and CBF, to assess whether differences in BOLD previously reported are likely 
due to a change in blood flow, a solely hemodynamic measurement.  As 
hypothesised, both whole brain and regional CVR was lower in fitter subjects in the 
present cohort, although this was not statistically significant for either BOLD or CBF 
measures.  
Within the healthy brain, an increase in arterial carbon dioxide is expected to produce 
a rapid vasodilatory response, yielding an elevation in blood flow.  Where a decline 
in CVR with age and disease is deemed to mark a decline in vascular health, studies 
showing a similar trend to that observed in the present study warrant it worthy of 
further investigation. For example BOLD CVR was found to decrease in a study of 
elderly masters athletes with increased O2MAX in response to a 5% CO2 hypercapnic 
challenge (Thomas et al., 2013b).  Similarly, a separate study found reductions in 
frontal BOLD CVR with increased O2MAX, after co-varying for the effects of age 
(Gauthier et al., 2014b).  A possible explanation for their findings, is that chronic 
elevations in venous carbon dioxide during prolonged periods of exercise over years 
of training lead to desensitisation of the vasodilatory signalling pathways such as NO, 
that mediate the reactivity of the blood vessels and regulate blood flow (Green et al., 
2004). 
There are several methodological considerations that may explain these non-
significant results. It is possible that the breath-hold paradigm used here was not 
sensitive enough to detect a significant difference in CVR, where forced gas 
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challenges has been shown previously to yield more robust results (Tancredi and 
Hoge, 2013).  Targeted gas challenges, in which subjects breath a predetermined 
level of CO2 over a stable period of time, tend to provide a more robust measure of 
CVR (Tancredi and Hoge, 2013). Confidence that subjects are experiencing a 
comparable level of hypercapnia means that data is more reliable and less noisy.    
Nonetheless, these designs are problematic when it comes to testing patient groups 
who may experience discomfort both physically, due to the presence of a face mask, 
or psychologically, where the hypercapnic periods cannot be controlled by the 
participants themselves.  
A breath-hold task was used such that we could assess the feasibility for use in 
patients.  It has been previously shown that breath-holds are a reliable measure of 
BOLD CVR, even when breath-holding is poor (Bright and Murphy, 2013), however, 
SNR is inherently low in CBF data.  To our knowledge, this experiment is the first 
time that the breath-hold paradigm has been used to measure CBF CVR in relation 
to fitness.  We observed that whilst the relationship between CBF (or BOLD) CVR 
and fitness was not significant, there was a significant relationship between BOLD 
and CBF CVR measures.  We interpret this evidence to suggest that using a breath-
hold task, albeit noisy, can be used as a feasible, more direct, measure of 
cerebrovascular health.
2.3.11. Neurocognitive Function
Whereas exercise is thought to prevent typical age-related decline throughout the 
lifespan, particularly in tasks of executive function and spatial memory (Colcombe 
and Kramer, 2003), there is little evidence to demonstrate an association between 
fitness and cognition in young adults.  In this study, we did not find an association 
between O2MAX and performance on tests of working memory, pattern recognition 
or spatial memory despite alterations in cerebrovascular health. It is possible that the 
cognitive benefits of exercise are less apparent due to ‘ceiling effects’, where 
performance is clustered around the maximum and more sensitive tests should be 
adopted. Increasing sample size would increase our confidence in accepting the null 
hypothesis, since our sample size is too small to detect true differences in cognition 
within healthy functioning adults.  Nonetheless, the absence of a cognitive effect 
considering differences in cerebrovascular health is interesting as it supports the 
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hypothesis that physiological effects of exercise may take place earlier in the lifespan, 
before functional outcomes are observed.    
We observed a correlation between pattern separation performance and CBF CVR 
across whole-brain grey matter. However, this did not reach significance after 
correcting for multiple comparisons.  Nonetheless, this can be interpreted as a 
promising link between cerebrovascular health and cognition as shown previously 
(Chapman et al., 2013).  Where fitness did not appear to mediate this effect in our 
cohort, expanding the sample size and repeating these tests later in life would be 
interesting.  Future research should also consider looking at sub-regional changes in 
CBF, such as in the hippocampus, which is known to be primarily affected by ageing 
and to underpin performance on pattern separation (Creer et al., 2010a; Erickson et 
al., 2011).
2.3.12. Limitations
Care should be taken when generalizing these findings since the cohort used here 
was small.  These results are preliminary and should be expanded upon in a sample 
of equally well-trained subjects.  It is also important to consider that this study is 
limited by its cross-sectional design where cause and effect cannot easily be 
determined. Whilst randomized trials involving a specified mode, intensity, frequency 
and duration of exercise would be ideal, such studies are expensive and time-
consuming and have their own limitations (Smith et al., 2011). 
An implicit challenge of non-invasive imaging methods of assessing cerebrovascular 
function is the inability to tap into the biological mechanisms driving these changes.  
It is important to use complementary measures to support this MRI evidence, 
focusing on markers of endothelial function, including growth factors and signalling 
pathways known to influence vascular physiology.  Exploring these changes in 
preclinical studies can bring us closer to achieving this goal and Chapter 3 will probe 
this in more detail, by addressing some of the possible mechanisms driving changes 
seen here.
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2.3.13. Conclusions
In conclusion, O2MAX was found to be associated with several cerebrovascular 
parameters, including an elevation in arterial compliance, a decline in resting 
perfusion and an apparent but non-significant trend in grey matter CVR.  This is the 
first time an association has been reported between O2MAX and arterial compliance 
within the brain using this novel MRI technique (Warnert et al., 2014).  The 
relationship between fitness and MCA compliance in this, albeit modest, group of 
healthy young males, suggests that exercise may exert its beneficial effects early in 
life by protecting vessel compliance, even before cognitive decline becomes evident.  
An inverse relationship between CBF and O2MAX points towards adaptation effects 
such as differences in the efficiency of oxygen metabolism and is worthy of further 
investigation using MR techniques (Wise et al., 2013) and replication using preclinical 
MRI where mechanisms can be probed ex vivo. Whilst CVR did not vary in this cohort, 
use of breath-hold MRI for measuring CBF CVR is sufficient where gas challenges 
may not be appropriate. 
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Chapter 3
Investigating the cerebrovascular effects of 
voluntary wheel running in young male mice.
Chapter Summary
In Chapter 2, the early cerebrovascular benefits of cardiorespiratory fitness were 
explored in healthy male adults.  The present study was interested in whether these 
benefits would translate to young healthy male C57/BL6 mice following 6 weeks of 
voluntary wheel running. Histological changes were explored in mice following 6 
weeks of running wheel exposure, of which 8 mice had unlimited access to a running 
wheel, and 8 mice to a stationary wheel inside the home cage.  Histological analysis 
included measurements of vascular density and astrocyte number, two factors 
previously thought to be affected by exercise and to mediate the cerebral blood flow 
response measured by MRI.  As hypothesised, running animals had an increased 
vessel density within the hippocampus, motor cortex and striatum after 6-weeks of 
exercise, which can be interpreted as exercise induced angiogenesis. Astrocyte 
number was not significantly different in running animals.  These findings corroborate 
the general pattern of results seen following exercise, although these findings extend 
previous work as it was found that angiogenesis was observed even after 5 days 
following exercise cessation.
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3.1. Introduction
As highlighted in Chapter 2 the relevance of exercise in young adults, where 
cognitive function appears unchanged, means that the early physiological changes 
that take place within the brain have not been thoroughly assessed. Understanding 
the physiological mechanisms, with focus on the cerebrovascular changes, that 
underlie macroscopic differences in blood flow and blood volume detected by MRI is 
a challenge that has motivated a few studies in non-human animals, particularly 
rodents, to explain these changes.
Several animal studies, predominantly in rats and mice, have demonstrated that 
running activity significantly increases the number of hippocampal cells born within 
the granule cell layer of the dentate gyrus.  This region is known to be critical for 
memory formation and is one of the few regions of the brain, alongside the sub-
ventricular zone of the striatum, that can generate new neurons throughout the 
lifespan.  This process, known as neurogenesis (Kempermann et al., 1997) can be 
detected by injecting live animals using BrdU (5-bromo-2'-deoxyuridine) to label DNA 
in proliferating cells at the time of running compared to non-running controls (van 
Praag et al., 1999b).  
Numerous studies have replicated and developed these findings, whereby both 
voluntary and forced running paradigms (Van Praag, 2008) have been shown to 
affect learning on a range of hippocampal tasks such as spatial memory (Clark et al., 
2009) and pattern separation (Creer et al., 2010b).  The latter study made a number 
of interesting observations.  As expected, visualisation of BrdU delivered daily over 
5 days during voluntary wheel running, revealed an increase in neurogenesis within 
the dentate gyrus and, interestingly, this was highly correlated with pattern separation 
performance on a touch screen task, analogous to the task described in Chapter 2 
(Stark et al., 2013).  More interesting still, was the finding that adult running mice had 
significantly greater blood vessel density within the hippocampus than non-running 
controls.  This increase in blood vessel density can be thought to reflect a process 
known as angiogenesis, as a result of exercise, in which new blood vessels form 
from pre-existing vessels and will be the focus of this chapter.
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Staining  blood vessels with dyes such as Lycopersicon esculentum (tomato) lectin 
(Creer et al., 2010b; van Praag et al., 2005) or vascular endothelial antibodies such 
as collagen-IV (Clark et al., 2009), Glut-1 (Allen and Messier, 2013; Van der Borght 
et al., 2009) and RECA-1 (Ekstrand et al., 2008) have repeatedly demonstrated that 
an increase in blood vessel density and vascular morphology can co-occur alongside 
elevations in neurogenesis in running rodents compared to non-running controls, 
within the dentate gyrus. Angiogenesis is not however limited to areas in which 
neurogenesis occurs, although these regions have received more scientific attention. 
Rather, it seems to be linked to where neuronal activation is elevated. In a seminal 
study, a specific increase in capillary density was observed in the molecular layer of 
the cerebellum in running animals that could not be generalised to animals 
performing motor skills (‘acrobatics’) only (Black et al., 1990).  This was replicated 
and extended in a study by Isaacs et al. (1992) who reported that an expansion of 
the vascular compartment within the cerebellum of exercising animals meant a 
shorter diffusion distance from the blood vessel to the neuropil.  Whilst animals 
undergoing a control motor learning task showed an expansion of cells within the 
molecular layer, the density of the vasculature remained constant.  They found 
therefore that the ratio of blood vessel volume to other components of the layer had 
increased as a result of exercise but not due to motor learning alone.
The lateral ventricle walls, or ‘sub-ventricular zone’ (SVZ) of the striatum, is another 
neurogenic region which may depend on angiogenesis for improved cell survival and 
integration (Al-Jarrah et al., 2010; Ernst et al., 2014).  Exercise in rodents has been 
linked to increased production and secretion of striatal BDNF (Aguiar et al., 2008; 
Marais et al., 2009) as well as neural activity (Shi et al., 2004) in the striatum. 
Furthermore, like the hippocampus, this coincides with an exercise-induced increase 
in angiogenesis (Ding et al., 2006).  Vascular alterations within the striatum, may 
have functional cognitive significance (Chaddock et al., 2010). The dorsal striatum is 
implicated in a number of cognitive functions including stimulus-response challenges 
that require response selection demands, response resolution, motor integration, 
cognitive flexibility and the execution of learned behaviours.   Whilst the striatum is 
historically more associated with motor dysfunction it has strong connectivity with 
cortical regions including the frontal lobe, temporal lobe and insula, as well as 
subcortical regions such as the amygdala and hippocampus (Haber, 2003).  It is 
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therefore unsurprising that an increasing body of evidence is pointing towards the 
importance of striatal regions in influencing behaviour and cognition. These functions 
are jeopardised in a number of neurodegenerative diseases including Alzheimer’s, 
Parkinson’s and Huntington’s disease (O’Callaghan et al., 2014) where 
cerebrovascular health is thought to be at risk (Al-Jarrah et al., 2010; Hsiao et al., 
2015; Wells et al., 2014).  Further still, evidence shows that function in these areas 
improves with exercise (Yau et al., 2014).
Vessel density increases have been reported anywhere between 20 (Black et al., 
1990) -1000% (Thomas et al., 2012), depending upon the brain region being 
investigated and the duration of exercise. Increases in the vascular compartment 
could account for structural changes in grey matter volume that have been reported.  
For example, volumetric increases in anterior hippocampal volume following a 1-year 
aerobic exercise intervention in elderly adults, compared to matched subjects in a 
stretching-only control group (Erickson et al., 2011) have been shown, whilst clusters 
within the prefrontal cortex, a region implicated in task of executive function, also 
showed volumetric increases after 6 months of exercise in elderly subjects 
(Colcombe et al., 2006).  MRI is currently unable to tease apart the contribution of 
different tissue components, yet differences in functionally relevant regions of the 
brain known to be implicated in cognitive enhancement following exercise may still 
be useful for localising regions of interest, where cerebrovascular function may be 
particularly affected.
Neuronal health is known to be tightly coupled to vascular health for efficient delivery 
of oxygen and nutrients to the metabolising cells; a process known as ‘neurovascular 
coupling’ (Palmer et al., 2000).  While neurogenesis has received a great deal of 
scientific attention, the importance of flow metabolism coupling i.e. the process by 
which the brain regulated blood flow to meet functional metabolic demand, means 
that cerebrovascular health is essential for supporting neuronal health. It has been 
shown that angiogenesis may even precede neurogenesis. A study by Van der 
Borght et al. (2009) demonstrated that an increase in capillary density within the 
dentate gyrus occurred within 3 days from the onset of voluntary running and 
returned to baseline after just 24 hours following wheel removal. Neurogenesis on 
the other hand, took up to 10 days before a significant increase was observed in 
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running animals, however unlike vascular changes, neuronal survival persisted for 
up to 6 days after running cessation.  
Astrocytic volume is also thought to respond to exercise (Kleim et al., 2002). Direct 
contact between endothelial cells and astrocytes, via the astrocytic end feet that 
envelope capillaries, are necessary to generate an optimal blood brain barrier (BBB)
and through numerous signalling processes are thought to influence blood flow and 
other neuro-metabolic processes in the brain (Figley and Stroman, 2011). 
Astrocytosis after exercise, coupled with angiogenesis is thought to provide strength 
to the neurovascular unit (including the microvascular endothelium, astroglia, 
neurons and the extracellular matrix), thereby protecting the blood-brain-barrier 
(BBB). Evidence explaining exactly how exercise alters astrocytosis however is 
unclear.  Brain tissues of exercised and non-exercised rats processed for expression 
of glial fibrillary acidic protein (GFAP), an astrocyte specific marker, have been 
shown to increase in the number following 6 weeks of exercise (Li et al., 2005).  Other 
evidence, however, has described a decrease in astrocyte (GFAP) density following 
treadmill exercise and interestingly, a reduction in the production of nitrous oxide 
(Bernardi et al., 2013), an important vasodilator that drives cerebrovascular reactivity 
in the brain.  High levels of NO released due to the high expression of inducible NO 
synthase (iNOS) has been shown to mediate a number of inflammatory 
neurodegenerative disease (Brown, 2007) and might be one mechanism by which 
exercise mediates the beneficial effects of exercise.  Astrocytosis differs from 
neurogenic growth however, in that they are thought to return to baseline volume as 
soon as the animal is removed from the stimulating environment (Kleim et al., 2002) 
and evidence in the cerebellum has suggested that astroglial density varied with 
synaptogenesis, but not angiogenesis.  
Nonetheless, the functional involvement of astrocytes in angiogenesis is well 
recognised, in part through production of a growth hormone called vascular 
endothelial growth factor (VEGF), which is also upregulated as a result of both acute 
and chronic physical activity (Bloor, 2005; Fabel et al., 2003).  The interaction 
between astrocytes and cerebral blood vessels has a strong influence on the 
measurements we detect with MRI. Through active participation in capillary formation 
via VEGF signalling, angiogenesis increases the surface area by which cerebral 
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perfusion can take place. Astrocytes, which vastly outnumber neurons, also serve a 
number of functions throughout the CNS.  They are critically involved in uptake and 
recycling of neurotransmitters such as GABA and glutamate, as well as the metabolic 
(both oxidative and glycolytic (Prichard et al., 1991) and hemodynamic processes 
that are detected by MRI (Kullmann and Asztely, 1998).  Astrocytes circumscribe 
nearly all neuronal synapses and more than 99% of the total cerebrovascular surface 
area (Agulhon et al., 2008).  They are responsible for regulating vasodilation in 
response to neuronal metabolic demand, a process known as functional hyperaemia, 
by a process of Ca2+ signalling between 1-2s following stimulus onset (Winship et al., 
2007).  Astrocytes signal to vascular smooth muscle (VSM) in intraparenchymal 
arterioles, whereby a change in VSM tone following widespread neuronal activation, 
leads to dilation or constriction of pial arteries and intraparenchymal arterioles which 
alter CBF.  It has been suggested that since astrocytes directly control vascular tone, 
and therefore cerebral microcirculation, the basis for fMRI neuroimaging techniques 
may be more closely related to astrocytic than to neuronal activity (Figley and 
Stroman, 2011). Exercise as a modulator of astrocytic function, likely yields some of 
its cerebrovascular effects through this pathway, such that astrocytes are essential 
for understanding mechanisms underlying the beneficial effects of exercise on the 
brain.
The focus of the present study was to investigate whether increases in vascular 
density (angiogenesis) are detectable following 6 weeks of voluntary exercise in 
young adult mice.  It was hypothesised that elevations in vessel density would be 
seen in the hippocampus, striatum and motor cortex, as reported previously.  As an 
extension to previous research, we wanted to assess whether 6 weeks of running, 
would lead to more long-lasting changes in vascular density than those reported 
previously after just 10 days of running (Van der Borght et al., 2009) by assessing 
vascular density 5 days after wheel removal.  Where astrocytes are thought to 
mediate a number of the cerebrovascular changes induced by exercise and influence 
the hemodynamic response measured by MRI, we investigated whether differences 
in astrocyte number could also be detected after 5 days of running cessation. Whilst 
BrdU was injected for detection of cell proliferation during wheel exposure, data has 
not been presented here due to time-restraints, where BrdU antibody optimisation 
and image analysis pipelines have not been previously established in this lab.  
Chapter 3
88
Immunohistological differences in vessel density and astrocytic number because of 
voluntary exercise, may help to interpret differences in CBF seen in physically active 
human subjects.
3.2. Methods
3.2.1. Animals
Sixteen male 8-week-old C57Bl/6 mice (Charles River, UK), individually housed in 
temperature-controlled rooms under a 12-h light/12-h dark cycle (lights on at 6:00 
am). A C57BL/6J mouse strain was chosen because they are well known to display 
enhanced behavioural performance from wheel running exercise, and thereby serve 
as a useful model to explore any neurobiological correlates (Clark et al., 2009).  Mice 
had free access to water and food throughout the experiment and were weighed 
weekly to control for changes in body weight.  All procedures were run in accordance 
with the United Kingdom Animals (Scientific Procedures Act of 1986), and subject to 
local ethical review.
3.2.2. Voluntary wheel running
Mice were housed in large standard mouse cages (25 x 12 x 42cm) equipped with a 
free-standing running wheel (ENV-044 Mouse Low-Profile Wireless Running Wheel, 
Med Associates Inc.; 37.82cm circumference, 25° from horizontal plane).
Wheel running activity was recorded via a wireless transmitter system that signalled 
to a hub located in the same animal holding room. Wireless Running Wheel Manager 
Data Acquisition Software (SOF-860; Med Associates Inc.) recorded and time-
stamped each wheel rotation for subsequent analysis.  Although revolutions were 
monitored continuously, activity occurred primarily during the dark phase.  Mice were 
singularly housed such that wheel running could be recorded independently for each 
animal and to avoid fighting between littermates.
All mice had unlimited access to a running wheel 7 days a week for 6 weeks.  Whilst 
exercising mice (N=8) could run freely on the wheels, mice in the control condition 
(N=8) had wheels that were fixed in position with a pin so that the environmental 
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conditions were identical except that the wheel was stationary.  Wheel access was 
uninterrupted during the following weeks except for removal for BrdU injection on the 
second week as well as weekly health checks and animal maintenance.
3.2.3. BrdU
After one week of habituation to the wheel, i.p. BrdU injections (50µg/g; Sigma) were 
carried out at the same time daily (11:30-12:30) for 5 days (as described previously 
by Creer et al. (2010)) during the second week of wheel exposure.  BrdU was freshly 
prepared daily over the 5-day injection period.  Preparation was carried out according 
to manufacturer’s instructions, whereby BrdU was dissolved in saline at a 
temperature of 50°C inside a water-bath.
3.2.4. Histology and Immunohistochemistry
Animals were deeply anaesthetised with 0.02ml sodium pentobarbital (Euthatal) and 
perfused trans-cardially with PBS, followed by ~110ml 4% paraformaldehyde (PFA), 
in 0.01M PBS at pH 7.4 at a flow rate of ~23ml/min for 5mins.  Brains were post-fixed 
for 5h followed by equilibrium in 30% sucrose. Tissue was sectioned coronally at a 
thickness of 40 μm on a freezing microtome (Leica).  A thickness of 40 μm has been 
recommended previously in order to obtain reliable 3D information about the vascular 
tree for quantification (Wälchli et al., 2014).  Free-floating sections were stored as a 
1:12 series in cryoprotectant solution and stored at −20°C until staining. 
Assessment of striatal and motor cortex were taken from coronal sections located 
between +1.18mm and -0.26mm from bregma. Assessment of hippocampal tissue 
was taken from coronal sections in which dorsal dentate gyrus was most apparent, 
namely sections between -1.34mm and -2.8mm from bregma.  Immunofluorescence 
was performed on a 1:12 series of sections, whereby sections were first washed in 
pH = 7.4 Tris buffered saline (TBS) three times (5mins x 3).  After washing, a 3% 
normal horse serum (NHS) solution (Invitrogen, Paisley, UK) in TBS + 0.2% Triton 
X100 (TXTBS; pH=7.4) was applied to the sections for 1 hour to block non-specific 
binding sites.  Primary antibody was applied immediately after blocking, in a solution 
of 1% NHS and TXTBS according to individual antibody concentrations (specified 
elsewhere) and left at room temperature overnight or at 4°C for 72hours.  Tomato 
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Lectin was added at the same stage as the primary antibody.  Sections were then 
washed in TBS (3 x 5mins) and incubated with either a species-specific Alexa Fluor-
conjugated secondary antibodies (488, 555, 594) (Invitrogen) or Streptavidin Cy3 
(Jackson) at 1:200 concentrations with 1% horse serum and TBS for 3 hours at room 
temperature or overnight at 4°C.  All immunofluorescence experiments were co-
stained with the nuclear marker Hoetsche (1:10,000) in TBS with 1% NHS for 10mins.  
Slides were washed again in TBS (3 x 5mins) and transferred to Tris non-saline 
(TNS) prior to mounting.  Free-floating sections were mounted onto gelatinised slides.  
Finally, slides were dehydrated in a graded alcohol series (70, 95, 100% IMS for 
5mins respectively) and cleared in xylene (~20mins) and cover-slipped using DPX 
mounting medium (RA Lamb, Eastbourne, UK).
3.2.5. Microscopy Parameters
3.2.5.1. Vascular Density (Tomato Lectin)
Tomato lectin is thought to provide the best labelling of CNS vasculature (Robertson 
et al., 2014) for labelling of the endothelial cells on capillaries and other small 
vascular elements (Mazzetti et al., 2004).  This is supported by its correspondence 
to other markers of endothelial cells e.g. immunoreactivity to CD31 (Gee et al., 2003) 
with the added benefit of its non-specificity to blood vessel type and its’ reliability.  It 
is a member of the Lectin family, which are carbohydrate-binding proteins, distinct 
from antibodies, enzymes, and transport proteins (Barondes, 1988).  Lectins label 
vascular elements in fixed tissue sections, by binding to carbohydrate components 
of endothelial plasmalemma (Jilani et al., 2003).  Tomato lectin binds to complex-
type N-glycans glycoproteins, particularly the poly-N-acetyllactosamine residues of 
complex carbohydrates including oligosaccharide sequences that contain the i and 
l— antigenic structures (Kawashima et al., 1990). 
3.2.5.2. Blood Vessel Quantification
Lectin staining (Lycopersicon esculentum; Vector) was used to visualize blood 
vessels as described previously (Creer et al., 2010b) where group differences in 
blood vessel density was used as a surrogate measure of angiogenesis.  
All images were acquired at ×20 magnification with identical parameters for each 
image using inverted microscopy (Axio Imager Z2, Carl Zeiss) for fluorescence, using 
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Zeiss AxioVision software (v4.8.2, Carl Zeiss).  Specifically, 3 equidistant sections 
(480 μm apart) per brain.  Images were acquired from sub-regions within our gross 
regions of interest including 1) dorsal striatum (dorsal SVZ/ ventral SVZ/ Caudate 
Putamen) 2) dorsal hippocampus (Dentate Gyrus / CA1) and 3) motor cortex (no 
sub-regions) (figure 3.1a).  Images were acquired (450 x 340mm) and quantification 
was performed using Image J software (1.48v). Assessment of striatal and motor 
cortex were taken from coronal sections located between +1.18mm and -0.26mm 
from bregma. Assessment of hippocampal tissue was taken from coronal sections in 
which dorsal dentate gyrus was most apparent, namely sections between -1.34mm 
and -2.8mm from bregma (figure 3.1b).
Whole images were divided into quadrants in which vessel density was quantified. 
Vessel area within each image was measured since vessel counting within tissue is 
affected by vessel trajectory through the tissue.  Images were initially binarised using 
Image J’s Auto Thresholding tool (figure 3.1c), such that imaged pixels containing 
vessels were coded as 1 and all background noise as 0. Vessel area within each 
sub-region therefore reflects the percentage area within each quadrant that 
contained blood vessels (figure 3.1).  Results were averaged within each sub-region 
and across hemispheres, such that vessel density within each section reflected the 
average of 8 measurements, which was then averaged across all sections to yield 
one sub-regional value of ‘Area (%)’ per region for each subject. 
Linear regression was carried out to assess whether a dose response relationship 
exists between running distance over the 6 weeks and blood vessel density. Average 
daily running distance carried out by mice exposed to the free-turning wheel were 
entered into a linear regression with running as the predictor and vessel density as 
the dependent variable.  All values were accelerated bootstrap corrected.
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3.2.5.3. Astrocytosis (GFAP)
GFAP (Glial fibrillary acidic protein) is a protein that is encoded by the GFAP gene in 
humans. Glial fibrillary acidic protein is an intermediate filament (IF) protein that is 
expressed by astrocytes within the CNS and widely used as an astrocytic marker.
3.2.5.3.1. Astrocytic Quantification
Images were acquired at x 10 magnification within (FOV = 450 x 340 mm) within the 
3 striatal ROIs (DSVZ, VSVZ and CP).  Image J was used to count cells that were 
co-labelled as positive for expression of the astrocytic marker GFAP and the nuclear 
marker Hoetsche (figure 3.2).  Due to the difficulty of counting overlapping astrocytes 
in tissue sections, counts were performed on the entire image, where nuclei of the 
astrocytes were co-labelled and the absolute number of astrocytes counted per 
region (450 x 340 mm).  One image per ROI, per section was acquired bilaterally.  
Figure 3.1 Vessel density quantification a) Regions of interest included the 
hippocampus, striatum and motor cortex.  Three whole-brain equidistant sections were 
imaged at x2 0 magnification. b) Regions were subdivided into sub-regions for further 
analysis. c) Binarised vessel masks were created using Image J’s Threshold tool and 
vessel density was quantified as % vessel area. Regions of interest included the 
hippocampus (top), striatum (middle row), primary motor cortex (bottom row) imaged 
at x10 and x20 magnification.
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Counts were averaged across hemispheres and sections and expressed in arbitrary 
units.
3.3. Results
3.3.1. Running wheel activity
Following habituation to the presence of wheel in the home cage, running activity 
increased to approximately 25,000 (±6700) rotations/day equivalent to 8.7(±2.6) 
km/day. During BrdU administration, running activity dipped but returned to baseline 
level throughout the remaining 30-day running period (25,500 ± 4000 rotations/day) 
equivalent to 9.6 (± 1.5) km/day (fig. 3.3).
Figure 3.2 Representative 
morphology of an astrocyte  
within the striatum. Blue = 
Hoetsche, Red = GFAP = (x40 
magnification).
Figure 3.3 Voluntary wheel running. a) Wheel running activity in running mice 
(N=8) b) Average daily running activity during BrdU administration (22,203 ± 2,540 
rotations/day) was similar to the average running activity across the remaining 
30days after injection (25,489 ± 1,112 rotations/day). Error bars = S.E.M.
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3.3.2. Vascular density
3.3.2.1. Sub-regional Analysis
To investigate whether exercise enhances angiogenesis, blood vessel density was 
calculated within the dorsal striatum, dorsal hippocampus and M1. Repeated 
measures ANOVA within sub-regions of the striatum (Dorsal SVZ, Ventral SVZ and 
Caudate Putamen) and hippocampus (Dentate Gyrus and CA1) were performed with 
GROUP (running vs. non-running) as the between-subject variable. The M1 was not 
divided into sub regions.  One-tailed tests are used as running is known to increase 
vessel density in healthy animals.
Striatum. An example image from a running and non-running animal from the striatum 
can be seen in figure 3.4.  Clear visual differences were evident in the tissue of 
running animals, where vessels were appeared denser and larger than that of non-
running animals.  Indeed, the mean vessel density was higher in running animals (fig 
3.5), and this was supported by a significant main effect of Group (F (1,14) =21.9, 
p<0.001, partial η 2 = 0.61).  However, no main effect (F (1.3,19) = 3.1, p=0.09, n.s., 
partial η 2 = 0.18) or interaction (F (1.3, 19) =0.89, p=0.84, n.s.., partial η 2 = 0.01) 
Figure 3.4 Vessel quantification in running and non-running mice.  Example 
images from a dorsal striatal section in a non-running (top) and running (bottom) 
mouse (x20 magnification).  Running animals visually demonstrated a greater 
number vessel density than non-running animals.  Image quantification was 
performed by binarising original images using ImageJ using the Auto Threshold tool 
and %Area was quantified within each quadrant of the final binarised image (red 
square). 
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was seen between sub-regions within the striatum (Greenhouse-Geisser corrected 
for violation of the sphericity assumption).
Hippocampus. Within the hippocampus, a similar trend was seen whereby the 
runners had an increased vessel density compared to non-runners (F (1,14) =4.1, 
p=0.03, partial η 2 = 0.23; figure 3.6).  There was no overall difference between 
vessel density in the DG and CA1 (F (1,14) =1.9, p=0.19, n.s.).
Motor cortex.  Only one ROI was imaged within the motor cortex, and so a between-
subject ANOVA was performed.  Again, a trend was observed whereby by runners 
showed greater vascular density within the M1, but this was not significant (F (1,14) 
= 3, p=0.06, n.s., partial η 2 effect size = 0.17; figure 3.7). 
Figure 3.5 Vessel density in the 
striatum after 6-weeks wheel 
exposure. Wheel running mice 
(N=8) had a significantly higher 
vascular density of tomato lectin
stained vessels than non-running 
mice (N=8) in the striatum and a 
similar difference was present in 
all striatal sub-regions. Mean ± 
S.E.M.
Figure 3.6 Vessel density in the 
hippocampus after 6-weeks wheel 
exposure. Wheel running mice 
(N=8) had higher vessel density of 
tomato lectin stained vessels than 
non-running mice (N=8). Both sub-
regions showed this trend, such that 
a similar difference was present
both the DG and CA1. Mean ± 
S.E.M.
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3.3.2.2. Between-region Analysis
Because there were no significant sub-regional differences within the striatum and 
the hippocampus, data were collapsed across regions. Vessel density was compared 
across gross bilateral ROI’s (striatum x hippocampus x motor cortex) with Group 
(running x non-running) as the between-subject variable was performed, to address 
whether exercise has more of an effect in one region in particular. 
Running animals had greater blood vessel density across all regions than non-
running controls (Group; F (1,14) =7.45, p=0.02, partial η 2 = 0.35; figure 3.8). The 
greatest vascular density was observed in M1 and this was significant (ROI; F (1,14) 
= 285.06, p<0.001, partial η 2 = 0.95) although ROI did not interact with Group, such 
that the density was greater in all running animals, across all regions (Group x ROI; 
F (1,14) =0.17, p=0.69, partial η 2 = 0.01).
Figure 3.7 Vessel density in M1 
after 6-weeks wheel exposure.
Wheel running mice (N=8) had 
higher vascular density of tomato 
lectin stained vessels than non-
running mice (N=8) in the motor 
cortex but this was not significant. 
Mean ± S.E.M.
Figure 3.8 Regional vessel density 
differences after 6-weeks wheel 
exposure. Running mice showed 
increased vessel density in all 
three regions. Vessel density was 
higher in the motor cortex than the 
hippocampus or striatum, ROI 
differences did not interact with 
GROUP.  Mean ± S.E.M.
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3.3.3. Dose-response relationship
A dose relationship was not observed between individual subject’s daily running 
activity and vessel density and was not found in the striatum (R2 =0.03, F (1,6) =0.17, 
=-4.21 x105, p=0.73, CI [0.00-0.001 x105]), hippocampus (R2 =0.08, F (1,6)=0.51, 
=<0.001, p=0.62, CI [-0.001-0.001]) or motor cortex (R2 =0.02, F(1,6)=0.11, =-726 
x105 p=0.61) (figure 3.9). 
3.3.4. Astrocyte Counts
Visual trends suggested an increase in astrocytes in runners compared to non-
runners but this was non-significant between groups (F (1,14) = 0.59, p=0.46, partial 
η 2= 0.04).  A repeated-measures ANOVA was performed to assess whether the 
number of GFAP+ cells within the striatum differed between runners and non-runners. 
No interaction was observed between groups within different sub-regions (F (2,28) = 
0.3, p=0.75, partial η 2 = 0.02, figure 3.3.6.) although a significant effect of sub-region 
(F (2,28) = 8.1, p= 0.002, partial η 2 = 0.37) showed that in general there were 
significantly fewer astrocytes away from the lateral ventricle wall, within the caudate 
putamen.
Figure 3.9 Dose relationship between running distance and vessel density. A dose 
response relationship was not observed between average daily running (N=8) and 
vessel density within the striatum, hippocampus or motor cortex.
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3.4. Discussion
Key Findings:
• Increased vessel density is significantly greater in the striatum and 
hippocampus of voluntary wheel-running mice compared to non-running 
mice, thought to reflect angiogenesis.
• Vessel density was increased in the motor cortex but this was not significant.
• Elevations in vascular density are significantly higher in runners even 5 days 
after running cessation, suggesting a longer-term effect of exercise upon 
cerebrovasculature than previously reported in mice.
• An effect of exercise on astrocyte number was not evident in this study.
This study aimed to establish whether 6 weeks of voluntary wheel running led to 
alterations in blood vessel density in the young adult mouse brain, specifically in 
regions of the brain that have previously shown changes in angiogenesis as a result 
of exercise, namely the hippocampus (Van der Borght et al., 2009) and striatum 
(Rhyu et al., 2010). It was found that running animals showed an overall increase in 
vascular density across all regions compared to non-runners, with the largest 
increase being seen within the striatum.  Whilst running-induced increases in 
vascular density and angiogenesis have been reported previously within the motor 
cortex (Swain et al., 2003), this was not significant in the present study.  An increase 
Figure 3.10 Group differences 
in regional astrocyte count.
Wheel running mice (N=8) 
revealed showed had more 
astrocytes (GFAP+) than non-
running mice, particularly within 
the Caudate Putamen, but this 
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in vascular density 5 days after exercise cessation adds to the literature, suggesting 
that cerebrovascular effects of exercise are more chronic than previously thought 
(Van der Borght et al., 2009). The present study did not observe a difference in the 
number of GFAP+ cells between runners and non-runners, which suggests that 
exercise does not have a stable impact on astrocyte proliferation within the striatum. 
3.4.1. Exercise and angiogenesis
In the present study we applied tomato lectin which is known to reliably stain the 
endothelial cells in the vessel wall, for analysis of micro-vessel density (Robertson et 
al., 2014). Our findings support those found previously by studies whereby running-
induced increases in vascular density, measured using tomato lectin, were attributed 
to the process of angiogenesis in the hippocampus (Creer et al., 2010a).  Whilst a 
group difference in M1 vessel density did not reach statistical significance (p=0.06), 
there was a strong effect in the striatum and hippocampus.  
The hippocampus is known to be critical for spatial working memory (Smith et al., 
2013) and pattern separation (Sahay et al., 2011), whilst the striatum is increasingly 
being acknowledged a critical hub for tasks of executive function due to its broad 
connectivity that makes up the cortico-striatal circuitry (O’Callaghan et al., 2014).  In, 
a meta-analysis of interventional studies that have reported cognitive benefits as 
result of exercise, performance on tasks of executive control and spatial memory had 
the largest effect sizes. Our findings contribute to a widening field in which the 
neurobiological basis of cognitive health is beginning to unfold, with a recent 
emphasis on the importance of cerebrovascular health. Animal behaviour was not 
measured in the current study, however it would have been interesting to explore the 
relationship between running, vessel density and behavioural function as others have 
done (Creer et al., 2010a; van Praag et al., 2005).
The present study extends previous findings in which the effects of exercise on 
vessel density have been described as transient. A previous study by Van der Borght 
et al. (2009) observed a significant increase in vessel density after just 10 days of 
voluntary wheel running, but that this returned to baseline after just 3 days of exercise 
cessation.  It is possible that the much longer exercise duration applied in this study, 
can explain the prolonged period after exercise cessation in which these group 
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differences were observed. Since this experiment was not designed to assess 
duration or dose of exercise or ‘detraining’ we can only speculate, however this may 
explain why a significant difference was not observed in the M1, as cerebral 
morphology may have returned towards baseline. 
Well-designed dose response studies are needed to unpick the cerebral dynamics 
of exercise duration and duration of ‘detraining’ in mice, and how this relates to 
humans is even less clear.  In humans, 14days of physical deconditioning in highly 
trained subjects has been found to yield a reduction in VO2MAX of ~4% (Houmard et 
al., 1992), plasma volume, and endothelial function (Watts et al., 2004).  Longitudinal 
studies in which cerebrovasculature is measured before and after a fixed exercise 
period is needed to unpick these differences.  This is impossible using histology in 
the mouse, and prompts the use of MRI imaging as a non-invasive biomarker from 
which to assess longitudinal change. In combination with human MRI, questions 
regarding the exact time course of training and detraining on the brain can begin to 
be answered. 
In this study, tomato lectin was used to visualise blood vessels since it 
indiscriminately stains endothelial cells regardless of vessel subtype. Furthermore, 
staining with lectins does not come with many of the caveats of 
immunohistochemistry, such as the specificity of the site to which it binds.  Only one 
other study has used tomato lectin to visualise blood vessel ex vivo following a 
running intervention, where other studies have used antibodies such as CD31 (Rhyu 
et al., 2010) and collagen-IV (Clark et al., 2009).  A further caveat of these antibodies, 
is that they may be affected by the intervention itself, for example, Co-IV relies upon 
the presence of collagen in the vessel wall, which is known to be influenced by age 
(Kang et al., 2015) and may itself be influenced by exercise (Fleenor et al., 2010). 
3.4.2. Neurobiology of angiogenesis
There are several mechanisms which may explain the observed exercise-induced 
angiogenesis, particularly elevations in the levels of growth factors.   Elevations in 
insulin-like growth factor 1 (IGF-1) appear to be a pre-requisite for the effects of 
exercise on the remodelling of vessels, as exercise promotes uptake of IGF-1 from 
the blood into the brain (Trejo et al., 2001). Indeed, the benefits of physical activity 
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on the cerebro-vasculature are absent in mice expressing low levels of IGF-1 (Lopez-
Lopez et al., 2004).  Other increasingly acknowledged angiogenic factors such as 
VEGF and angiopoietin 1 and 2, for example are known to be upregulated in the 
brain following physical activity (Bloor, 2005; Ding et al., 2006) and regulated by IGF-
1 (Lopez-Lopez et al., 2004) . Expression of these growth factors requires un-fixed 
brain tissue to measure protein expression, which was unavailable in the present 
study.  Nonetheless, the relationship between exercise and VEGF upregulation has 
been observed before in mice and humans (Vital et al., 2014).
3.4.3. Angiogenesis, astrocytosis and CBF regulation
One key aim of this study was to address some of the possible mechanisms that 
underpin the gross changes seen using MRI in humans. The present findings support 
previous research whereby angiogenesis is a marker of cerebrovascular health.  
Exactly how differences in vessel density maps onto the perfusion signals detected 
by MRI however is unclear. Two possible mechanisms were addressed in this study, 
angiogenesis and astrocyte function.
Angiogenesis in rodent studies has been used to explain observed increases in 
cerebral blood volume (CBV) MRI, and these findings have been interpreted as a 
sign of increased M1 (Swain et al., 2003) and hippocampal (Pereira et al., 2007) 
perfusion. Where hemodynamic processes are extremely complex, an increase in 
CBV masks multiple underlying processes.  Increases in CBF as a result of exercise 
have been documented in rats using laser-speckle flowmetry and this has been 
shown to map onto increases in vessel density following MCA occlusion (Zheng et 
al., 2011).  Where CBF measurements with MRI are thought to measure perfusion 
changes within the capillary bed, investigating differences in CBF with ASL methods 
could be a more translational approach from which to compare and assess exercise 
related differences between mice and humans.   The relationship between CBF and 
angiogenesis has been established in preclinical studies, where CBF was able to 
predict the location of increased vessel density (angiogenesis) in post-ischemic rats 
using PASL MRI (Jiang et al., 2005) and laser speckle flowmetry (Zhang et al., 2013).
Astrocyte function is thought to contribute to differences in CBF detected by MRI 
(Figley and Stroman, 2011) since astrocytes express receptors or neuromodulators 
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known to regulate vascular tone (Bekar et al., 2012).  They have also been shown to 
possess their own calcium dynamics which do not correspond to neuronal activity in 
response to visual stimuli (Schummers et al., 2008), which could in turn generate 
their own functional signals.  In the present study, we did not detect a difference in 
in the number of astrocytes in running animals.  A caveat of ex vivo studies is that 
detection of the real-time functional contribution of astrocytes in the living brain is 
challenging, and indeed have been shown return to normal rapidly after exercise 
(Kleim et al., 2002). 
3.4.4. Limitations
In this pilot study, sample size was low and may have jeopardised the statistical 
power, particularly within the M1 where there was a clear visual increase in vascular 
density.  Nonetheless, our results corroborate those found previously such that it is 
possible to be confident in the effects seen. 
A caveat of the present study, is the inability of tomato lectin to differentiate between 
vessel type. In Chapter 2, the role of compliant arterioles in mediating 
cerebrovascular control was discussed (Peterson et al., 2011).  An interesting 
question is whether there is a dichotomy in the type of vessel that drives the 
alterations in vessel density that has been so widely reported.  It is thought that grey 
matter tissue is primarily made up of capillaries and small arterioles, of which only 
the latter are thought to control regional cerebral blood flow (Hill et al., 2015).  
Understanding the type of vessel that contributes to these exercise-induced effects, 
may shed light on the global benefits expected.  Future research will extend the 
present findings to visualise vessels that possess smooth muscle actin (SMA), 
which is located in the walls of compliant arterioles.  In addition, this may lead us 
closer to understanding the mechanism by which fitness or exercise leads to the 
increased compliance of major arteries reported in Chapter 2.  
It is acknowledged that where the term angiogenesis is used, we have not addressed 
this directly, rather we have used an indirect surrogate marker, vessel density, as 
others have done. It was intended that this question would be more accurately 
acknowledged by designing the experiment such that mice underwent injection with 
the proliferative DNA marker BrdU during the first week of wheel running.  Future 
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analysis will use immunofluorescence to co-stain for BrdU+ endothelial cells, such 
that proliferating vascular cells at the time of running can be directly quantified. 
No behavioural measures were carried out in the present study, such that the 
functional outcome in young adult mice was not assessed.  Unlike human studies 
where cognitive improvements are rarely seen with exercise in young adults, rodent 
studies tend to report a cognitive enhancing effect in subjects of an analogous age 
(Creer et al., 2010a). Training on behavioural tasks, particularly operant tasks, is 
time-consuming, requires high levels of handling and water deprivation to motivate 
subject learning.  Since our major question was related to the cerebro-physiological 
differences between animals rather than cognition per se, we did not want to 
confound our results by introducing further environmental enrichment and handling 
stress that may influence our results, beyond that attributable to wheel running.  
Quick behavioural tasks such as the balance beam test of motor coordination, 
initiation and balance may be a feasible candidate for future experiments.
Finally, it has been noted that immunofluorescent imaging of GFAP+ cells may not 
be optimal for counting astrocytes in thick tissue sections (40m).  Whereas cultured 
astrocytes reveal a defined morphology with fluorescence, thick overlapping sections 
make the nuclei of astrocytes difficult to detect.  Quantifying density of astrocytes 
using DAB stereology may be a better way of imaging sections in future (Li et al., 
2005).  Future work would also consider quantifying morphological changes in situ 
using high-resolution microscopy or live imaging (Escartin and Murai, 2014).
3.4.5. Conclusion
In this chapter, we show a significant difference in vessel density in the striatum and 
hippocampus, 5 days following exposure to a running wheel for 6 weeks. These 
changes were not accompanied by differences in astrocyte number within the 
striatum. M1 vessel density showed a non-significant elevation in running animals, 
and we hypothesise that a 5-day period of detraining may have masked an exercise 
related increase that has been reported elsewhere.  Future work will utilise ASL MRI 
to assess whether the morphological differences in cerebrovasculature observed 
here, are related to in vivo differences in cerebral blood flow.  Given the striking 
increases in striatal vasculature observed in this study with exercise, this led to the 
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question of whether exercise would be beneficial in Huntington’s Disease, a 
neurodegenerative disease driven by striatal dysfunction.
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Chapter 4
Investigating the relationship between aerobic 
fitness and cerebrovascular health in pre-
/early-symptomatic HD patients using PASL 
MRI.
Chapter Summary
Alterations in patterns of resting CBF have previously been observed in pre-/early-
symptomatic HD patients compared to healthy controls using ASL methods including 
hypoperfusion of basal ganglia regions known to be involved in HD progression.  In 
the absence of any pharmacological treatments, exercise is being explored as a 
possible therapeutic intervention by which to alleviate symptoms and improve quality 
of life.  In this cross-sectional study, the relationship between cardiorespiratory 
fitness and cerebrovascular health was addressed.  Fifteen pre-/early-symptomatic 
patients and 15 matched controls underwent a O2MAX test to assess aerobic fitness.  
On a separate session, participants underwent MRI scanning and cognitive testing.  
Resting CBF and cerebrovascular reactivity was measured using pulsed arterial spin 
labelling (PASL).  Disease severity in HD patients was associated with decreased 
grey matter CBF, reflecting significant progressive global hypoperfusion in HD, 
although hyperperfusion in the left putamen was associated with significantly poorer 
functional capacity.  Between-group differences were less clear, whereby CBF in the 
basal ganglia, particularly the left caudate, was lower in patients than controls, which 
was in line with previous studies, although this was not significant.  Tissue arrival 
times across the whole-brain were also associated with a significantly higher disease 
burden. Executive function was significantly poorer in HD patients compared to 
controls and CBF in the thalamus was negatively related to performance on tasks of 
executive function, supporting its important role in the early pathology if HD.  O2PEAK 
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across groups was not found to be related to regional CBF in any of the brain regions 
assessed, however a group difference in the relationship between O2PEAK and CBF 
was observed in the left caudate, in which lower CBF was seen in patients with higher 
O2PEAK.  CBF CVR was lower in HD patients than controls and appeared to interact 
with O2PEAK although this was also not significant, possibly due to the small number 
of subjects who completed the breath-hold challenge effectively.  From the present 
data, it is not clear that cardiorespiratory fitness is beneficial in HD.  An interaction in 
the left caudate nucleus between O2PEAK and resting CBF does suggest that CBF 
may in fact be reduced in fitter patients but increased in fitter controls.  Future work 
is required to investigate the implications of this relationship, and explore 
cerebrovascular health using preclinical MRI which may shed light on the mechanism 
at play in pre-/early-stage HD. 
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4.1. Introduction
Huntington’s disease (HD) is an autosomal dominant inherited neurodegenerative 
disorder caused by a CAG repeat expansion mutation in the HTT gene on 
chromosome 4 (Vonsattel and DiFiglia, 1998).  HD is characterized by progressive 
motor dysfunction, psychiatric disturbances, and cognitive decline, and there is 
currently no cure.  Present efforts are focussed upon identifying therapeutic targets
and developing treatments that may delay onset or slow the progression of the 
disease once clinical signs are manifest. Furthermore, there are currently very few 
objective measures of disease progression during the pre-manifest phase of the 
disease where patients are apparently asymptomatic.  
People with Huntington’s disease (HD) are known to be weaker (Busse et al., 2008), 
walk less and fall more (Busse et al., 2009) than age-matched healthy controls.  
Given the increased levels of apathy and anhedonia with disease progression 
(Tabrizi et al., 2013), HD sufferers will often reduce their activity patterns substantially 
as symptoms manifest.  This passive lifestyle has been suggested to influence 
symptom onset in patients with Huntington’s disease (Trembath et al., 2010).  
Moreover, as described in previous chapters, the evidence from exercise studies in 
animals (van Praag et al., 1999b), in healthy people (Ainslie et al., 2008) and people 
with other neurological conditions (Goodwin et al., 2008) suggest that exercise can 
be highly beneficial; improving mobility, cognition, general health and wellbeing such 
that administration of exercise programmes in HD may act to slow disease 
progression (Khalil et al., 2013b; Quinn et al., 2016b).  
Prescribing aerobic and anaerobic exercises using principles based on healthy 
individuals has been shown to be safe and feasible in HD patients (Khalil et al., 
2013b). Should exercise begin to exert its beneficial effects on the brain early in life, 
as described in Chapter 2, it is possible that this may delay the onset of 
neurodegeneration and cognitive decline. Exercise recommendations are a cost-
effective and globally beneficial recommendation that could be encouraged by 
healthcare professionals, to those at genetic risk for HD prior to HD diagnosis, as 
Chapter 4
109
well as those post-diagnosis, prior to symptom onset, where mobility is less 
compromised.
To date, there have been no studies to investigate the benefits of physical activity on 
the brain in HD patients.  Assessment using reliable non-invasive measures such as 
MRI, could be invaluable in determining the therapeutic potential of interventions 
(Aylward, 2007).  Where it may be possible to detect changes early in the lifespan 
using sensitive imaging biomarkers, the ability to track early signs of degeneration 
prior to symptom onset would be invaluable for monitoring individual responses to a 
wide range of treatments, including exercise interventions.  Before integrating 
neuroimaging into such complex interventions, however, it is necessary to review 
what is already known regarding the differences between the early-diseased brain 
and healthy controls, and whether a cross-sectional measure of fitness can predict 
these differences. 
A number of neuroimaging studies have detected disease related differences 
between preclinical HD cases and gene-negative controls, including alterations in 
brain structure (Aylward, 2007; Tabrizi et al., 2009) , metabolism (Feigin et al., 2014) 
and perfusion (Harris et al., 1999; Tabrizi et al., 2009; Wolf et al., 2011).  Interestingly, 
brain activation and perfusion differences in preHD have been demonstrated even in 
the absence of structural changes (Chen et al., 2012).  It is possible that changes in 
cerebral blood flow and metabolism may be a more sensitive marker of cerebral 
health in subjects with early or pre-symptomatic HD (preHD) than volumetric 
measures alone.  Studies using SPECT and PET, have demonstrated striatal and 
cortical changes in baseline rCBF (Harris et al, 1999) in both manifest HD and pre-
manifest HD subjects. In their study, they observed that altered rCBF was associated 
with cognitive changes including changes in memory and executive function, even in 
preHD patients.  An ASL study by Wolf and colleagues (2011) reported that preHD 
participants had lower rCBF than controls in the lateral and medial prefrontal cortex 
and left putamen, whilst in addition showing increased CBF in the left precuneus and 
right hippocampus.  Hypoperfusion in the striatum was absent in those far from onset, 
but became significant in the precuneus as they approached motor onset.  From this 
evidence, it is clear that the pattern of CBF changes may be region specific and could 
pinpoint regions which are more sensitive to therapeutic interventions.  
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Cerebrovascular reactivity is an informative measure of cerebral health, as it shows 
the ability of the brain to mount a flow response to areas in the brain that need it.  
Where cerebrovascular reactivity is jeopardized, there is a potential for chronic 
undersupply and that can threaten the neuronal tissue. To date, there have not been 
any studies to investigate whether vascular reactivity is jeopardized in HD patients.  
Human studies have observed hyporeactivity in AD (Cantin et al., 2011) whilst a 
preclinical MRI investigation has reported a similar decline in reactivity to a carbogen 
gas challenge in an HD mouse model (Hsiao et al., 2015). The absence of CVR 
research in HD patients may be due to the methodological challenges involved in 
delivering combined hypercapnic challenges with MRI.  Dynamic end-tidal forcing 
(Wise et al., 2007) or prospective CO2 targeting (Slessarev et al., 2007) gas 
challenges, require participants to breathe CO2 enriched gas through a mask inside 
the scanner.  This is not only uncomfortable for patients, but also requires thorough 
screening and exclusion criteria often apply to smokers and those with respiratory 
difficulties.  Where patient recruitment is already challenging, additional exclusion 
criteria is not ideal. The present study used a breath-hold challenge, like that used in 
Chapter 2, to get around this issue since breathing is self-paced and participants can 
stop if they feel any discomfort.  A caveat, is that for accurate end-tidal CO2
measurement, participants are required to follow a series of instructions.  Given the 
cognitive difficulties present in HD, it is unknown whether this paradigm is feasible in 
HD patients. However, this question is worthy of exploration since the development 
of new and feasible imaging biomarkers in HD is important for assessing disease 
progression and treatment efficacy. 
HD is an exceptional disease, whereby diagnosis is possible years prior to symptom 
onset. This provides us with a unique window in which to recommend lifestyle 
changes that may improve prognosis, delay manifestation and slow decline. In 
previous chapters, the relationship between physical activity and cerebrovascular 
markers were observed, even early in the lifespan. Whether physical activity can 
mediate group differences in cerebral blood flow that have been previously reported 
in HD remains unexplored.  The purpose of the present study is to assess whether 
differences in resting CBF and CBF CVR can be predicted by cardiorespiratory 
fitness in the same way for pre-/early-symptomatic HD patients as controls.  
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Participants took part in a O2MAX protocol on a cycle ergometer, like that performed 
in Chapter 2 but tailored to accommodate safety and feasibility in patients. O2PEAK
was measured as a surrogate of O2MAX where patients were unable to reach the 
strict physiological boundaries associated with a true O2MAX.  On a second session, 
participants were scanned with PASL MRI at 3T.  The relationship between fitness 
and CBF in pre-/early-symptomatic patients and healthy matched controls was 
investigated by acquiring measures of cerebrovascular function including baseline 
CBF, tissue arrival time (TAT) and CBF-CVR to a breath hold challenge. It was 
hypothesised that pre-/early-symptomatic HD patients would demonstrate locally 
distributed differences in CBF in frontal striatal regions, reflective of an early 
pathological process and that performance on a cardiorespiratory fitness test 
( O2PEAK) would be predictive of cerebrovascular and neurocognitive outcome
measures.
4.2. Methods
4.2.1 Participants
21 patients (8 pre-symptomatic, 9 early-stage, 5 mid-stage) and 19 controls were 
initially recruited from the Cardiff Huntington’s Disease Centre based at Cardiff 
University. All patients recruited were currently registered on the ongoing global 
longitudinal study of Huntington’s Disease patients (ENROLL-HD) in which baseline 
motor, cognitive, psychiatric, demographic and CAG repeat data is collected annually 
and made centrally available to scientists working within participating sites.  
Recruitment was targeted towards HD patients with impaired cognition, 
operationalised as a score below 200 (indicative of mild impairment) on the Unified 
Huntington’s Disease Rating Scale (UHDRS) whilst a control group was recruited 
based upon age, gender and education matching.  All participants were deemed by 
their neurologist to have full capacity to consent and were informed of their right to 
withdraw at any time without giving reason, and that data would be held confidentially.
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Inclusion criteria:
❖ Genetically-confirmed Huntington’s disease (for patient group only)
❖ Aged 18-65 years
❖ Able to understand and communicate in spoken English (for consent 
purposes and cognitive testing)
❖ If regular medication is taken, the medication regime must have been stable 
for four weeks prior to initiation of the study and between sessions.
Exclusion criteria:
❖ Any physical or psychiatric condition that would prohibit the participant from 
completing the intervention or the full battery of assessments (including 
sports injuries where moderate exercise is not recommended, rest angina, 
hypotension or hypertension, ankle oedema, shortness of breath at rest, 
dizziness, epilepsy and/or any psychiatric condition that affects the ability to 
comprehend verbal or written instructions).
❖ A (self-reported) blood-borne disease and/or haemophilia.
❖ Inability to independently use the cycle ergometer.
❖ Currently actively involved in any interventional trial (i.e. have begun the 
intervention) or within four weeks of completing an interventional trial.
❖ MRI contraindications (e.g. a pacemaker) as established using CUBRIC’s 
standard screening procedures.
❖ Any known neurological condition or abnormality (other than HD).
❖ Pregnancy or childbirth in the last 6 weeks.
❖ Current and/or history of cardiac (heart), vascular (blood vessel) or 
respiratory/pulmonary (breathing/lung) conditions, including high blood 
pressure.
❖ Currently experiencing dizziness or fainting on a regular basis.
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4.2.2 Demographic Information
Education
The International Standard Classification of Education (ISCED) scale was used to 
determine years of education and education level, since educated people are thought 
to maintain a greater cognitive reserve than those with lower education status (Stern, 
2009).  
Disease Burden
The Disease Burden index is a measure of disease severity that estimates the 
cumulative toxicity of mutant Huntingtin based upon the number of polyglutamine 
(CAG) repeats and age, using the formula (age × [CAG-35.5]) (Penney et al., 1997), 
where higher scores indicate a greater level of impairment.  This measure of disease 
severity was derived from a post-mortem study, in which a correlation between CAG 
repeat length and striatal atrophy was observed (Penney et al., 1997).  Where older 
patients with the same repeat length will have had greater exposure to the effects of 
the CAG expansion, disease severity typically worsens over the lifespan in those 
who have a CAG repeat length greater than 35.5. Disease burden has been adopted 
by a number of studies, including the large-scale multi-centre TRACK-HD study 
(Tabrizi et al., 2009) which revealed strong associations between disease burden 
scores and several phenotypical features, including neurophysiological, oculomotor, 
cognitive, neuropsychiatric and brain atrophy in pre-manifest HD gene carriers.  As 
a result, it was decided that this measure would be adopted in this thesis.
UHDRS Score
The Unified Huntington’s Disease Rating Scale ’99 (UHDRS) had been conducted 
by a research nurse at the Cardiff Huntington’s Disease Centre as part of the 
ENROLL-HD within the year leading up to assessment in this study. The UHDRS 
was developed to assess the clinical features of HD and includes motor, cognitive, 
behavioural, and functional subscales ("Unified Huntington's Disease Rating Scale: 
reliability and consistency. Huntington Study Group," 1996).  The UHDRS has been 
well validated with high inter-rater reliability and internal consistency. The availability 
of these assessment results is useful in terms of characterising the HD group in terms 
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of heterogeneity of symptoms and their severity, and for comparison with other study 
cohorts. (See Table 4.1. for participant UHDRS and Demographic scores).
Motor. The motor assessment examines 15 motor behaviours with a maximum score 
of 60 indicating maximum motor disability.
Functional Assessment Scale. The functional assessment contains 25 questions 
relating to daily functioning with a maximum score of 20 indicating functional 
capacity. 
Independence. The independence scale is measured in percentage, with 100% 
representing no special care needed, and 10% representing tube fed / total bed care. 
Total Functional Capacity scale. The Total Functional Capacity scale (Shoulson and 
Fahn, 1979) is the main assessment tool of functional status in HD clinical care and 
research, designed to assess progression of HD in symptomatic patients with 
emphasis on self-care, mobility, and independence. A maximum score of 13 
indicates full capacity in all domains assessed. However, this scale may be less 
sensitive to functional changes in patients far from symptom onset. 
Cognitive assessment score. Summed performance on the verbal fluency test 
(letters and categories), symbol digit modality test, and Stroop interference test, with
a score > 200 indicating cognition in the normal range.  This score was independent 
from the cognitive testing that took place during this study.
4.2.3 Participant preparation
Participants were asked to refrain from the consumption of alcohol and/or caffeine, 
and to refrain from moderate to high intensity exercise for 24 hours prior to the scan 
session since it is known that these factors affect cerebral perfusion. Participants 
were also asked to refrain from the consumption of cigarettes, caffeine and to avoid
moderate intensity exercise for a period of three hours prior to the testing session. 
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All participants were screened for contraindications to: 
❖ Exercise. High blood pressure, completion of the Physical Activity Readiness 
Questionnaire the American College of Sports Medicine (ACSM) checklist to 
identify cardiovascular risk for exercise and a 12-lead ECG electrocardiogram 
(ECG) assessment to ensure safety to initiate exercise. 
❖ MRI. Comprehensive screening for MRI contraindications carried out during 
recruitment and on the day of scanning and immediately before each MRI 
scan.
4.2.4 Fitness test ( O2MAX)
The O2MAX aerobic exercise assessment was conducted on a Lode Corival cycle 
ergometer (1000 watts, Cranlea Human Performance Ltd, Birmingham).  Saddle 
heights were adjusted to accommodate knee flexion (170° to 175°) and feet were 
supported in the pedals by Velcro straps and taping where necessary to ensure feet 
were secure (Dawes et al., 2014).  For the graded exercise test, the equipment used 
was the same as that used in the EXERT-HD study (South East Wales Research 
Ethics Committee, 06/11/2014, ref.:13/WA/0315) at Cardiff University. 
4.2.4.1. Physiological Measurements
The following measurement were taken at rest and then every 2 minutes throughout 
exercise and 10mins following cessation of exercise to track recovery.1. Heart rate was monitored using a heart rate monitor worn as a strap around 
the chest with transmission to a watch on the patient’s wrist Polar Equine 
InZone Heart Rate Monitor (Polar, UK). 2. End-tidal O2 and CO2 was measured on a breath-by breath basis using a face 
mask connected to a gas analyser system (Metamax, Cortex Biophysik, 
Leipzig, Germany) from which physiological measurements including the 
respiratory exchange ratio (RER), ventilation volume (VE) and oxygen 
consumption ( O2).  The gas analysis system was calibrated according to 
manufacturer’s instructions on the day of testing.
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3. Borg’s rating of perceived exertion (RPE) CR10 Scale (0-10) (Borg and 
Kaijser, 2006) was used to measure perceived fatigue of both the legs and 
breathing to self-monitor work rate.4. Blood lactate concentration was used as an additional measure of exercise 
intensity, as it has been used previously as a reliable measure of aerobic 
exercise. Real time lactate measurements were taken every 2 minutes at the 
end of each work-load using a sterile lancet to take a pinprick of blood from 
the earlobe and gain an immediate reading using a Lactate Plus portable 
lactate analyser (Laktate, Donostia).
4.2.4.2. O2MAX Criteria
Baseline measurements were acquired prior to cycling, after which participants 
began a warm-up including 3 minutes of unloaded pedalling.  Following this warm-
up, load was increased to 50 watts and increased by 25 watts every 2 minutes (max 
15mins) until subject met at least 3 of the following established criteria:
1. A plateau in O2 with increasing load
2. Volitional exhaustion (Borg CR10 score ≥8)
3. Unable to maintain work rate above 40 rpm.
4. Heart rate above 95% of predicted maximum
5. RER above 1.1
6. Lactate above 8mM
4.2.5 Storer Maximal Bicycle Test for Predicted O2MAX
Where it is not feasible to carry out a full O2MAX and to account for gender 
differences, the Storer Maximal Bicycle Test (Storer et al., 1990) has been used to 
predict O2MAX.  This test has been used previously in exercise tests of HD patients 
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(Dawes et al., 2014; Quinn et al., 2013) and was calculated in addition to the more 
robust O2MAX measure using Equation 1.
Equation 1
Males:
VO2MAX ml.min-1 =10.51 W +6.35 Kg -10.49 years +519.3
Females:
VO2MAX ml.min-1 =9.39 W +7.7 Kg -5.88 years +136
4.2.6 Cognitive, Mood and Disease severity assessments
Participants completed a number of cognitive tasks and questionnaires relating to 
mood and daily activity levels. 
4.2.6.1. Cognitive tests
Speed and Capacity of Language Processing (SCOLP): This short test of information 
processing speed required participants to verify as many sentences as possible in 
two minutes. Outcome measures included the number or correct answers within a 
time limit and error rate. 
Forward digit span: This task of working memory required participants to read a 
sequence of numbers and recall the numbers in the order they heard them, from 2-
9 digits in length. 
Symbol Digit Modalities Test (SDMT):  This substitution task of executive functioning 
required participants to use a reference key to pair specific numbers with given 
geometric figures in a 90 second period. 
Letter Fluency task: Participants were required to generate words beginning with a 
given letter (e.g. words beginning with the letter F). Participants were given one 
minute to retrieve as many words as possible, avoiding repetitions and proper nouns 
(e.g. Friday or Fred).  Outcome measures included the number of correct words, 
number of intrusions (i.e. inappropriate word) and number of perseverations (i.e. 
repeated word). The task was conducted three times, for the letters F, A and S.
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Stroop task (colour and word reading, interference components):  The full test 
included baseline measures for speed of colour naming and word reading as well as 
the interference task in which subjects were shown the names of colours, written in 
an incongruent colour (e.g. RED) and instructed to recall the colour that the word 
was written in. Outcome measures included number of accurate responses, errors 
and self-corrected errors made in 45 secs.
Trail Making Test Parts A & B:  This pencil and paper task uses randomly placed 
letters (and numbers for part B) as stimuli which participants were required to connect 
in sequence by drawing a continuous line with a pencil (e.g. A-1-B-2-C-3 for part B).  
Outcomes included speed of completion and number of errors. 
4.2.6.2. Questionnaires
Hospital Anxiety Depression Scale (HADS): This short scale was used to screen for 
depression and anxiety symptoms.
World Health Organisation Quality of Life Questionnaire (WHO-QL; Short version):
A 26-item instrument to measure the following broad domains: physical health, 
psychological health, social relationships and environment. 
International Physical Activity Questionnaire (IPAQ) 7-days SHORT:  This short-form 
instrument assessed subjective physical activity undertaken during a representative 
week such that an average MET score can be computed by summation of the 
duration (in minutes) and frequency (days) of walking, moderate-intensity and 
vigorous-intensity (Craig et al., 2003).
Sociodemographic questionnaire: Participants were asked to report their gender, 
age, height, weight, ethnicity, handedness, alcohol and caffeine use, years in 
education, and occupation to determine confounding variables and to determine 
sample heterogeneity.
4.2.7 MRI Acquisition
All scanning was carried out using a 3T GE HDx scanner (GE Healthcare, Milwaukee, 
WI, USA) equipped with an 8-channel receive-only head coil. 
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4.2.7.1. Structural Imaging
All participants underwent whole brain T1-weighted structural scans (3D FSPGR, in-
plane resolution = 1x1mm, slice thickness = 1mm, TI= 450ms, TR =7.8ms, TE = 3ms, 
matrix size= 256 x 192) for registration and structural segmentation purposes.  An 
array spatial sensitivity encoding (ASSET) factor was applied to assess the sensitivity 
of the 8 coils so that fewer phase encoding directions could be sampled.  This 
enables the use of a shorter TE with fewer distortions, which is advantageous as it 
speeds up acquisition time which is beneficial in HD patients.  It was considered that 
faster acquisition was worth the trade-off in signal to noise ratio (SNR).
4.2.7.2. Baseline CBF 
Baseline CBF at rest was quantified as described in Chapter 2, using a multi-
inversion time PASL sequence (PICORE with a QUIPSS II cut-off at 700ms (Wong 
et al., 1998)).  Different inversion times were adopted for the present study whereby 
short (TI’s = 400, 500, 600, 700) and long TI’s (TIs = 900, 1000, 1500, 2,000ms) were 
acquired as separate scans in which the label (width 200mm) was applied 10mm 
below the most proximal slice.  Images were acquired with the same parameters to 
those described previously in Chapter 2 but with, eight control–tag pairs per TI, 15 
slices, slice gap=1.5mm, FOV=198mm, voxel size=3x3x7mm3. Total acquisition for 
both short and long TI scans was ~7 minutes.  As before, an M0 CSF scan was 
acquired for calibration without labelling in which the same acquisition parameters 
were applied as above except for the TR=4s. 
4.2.7.3. Cerebrovascular reactivity
A breath-hold paradigm was carried out as described in Chapter 2 according to the 
methods of (Bright and Murphy, 2013).  Imaging parameters were identical, except 
participants were required to complete 10 end-expiration breath-holds (15s each) 
interleaved with 30s periods of paced breathing at rate of 12 breaths per minute 
(Murphy et al., 2011b). 
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Total scan duration was ~8 minutes during which quantitative arterial spin labelling 
(PASL) and BOLD-weighted images were acquired with a single-shot PICORE 
QUIPSS II (Wong et al., 1998) pulse sequence (TR=2.4 s, TI1=700ms, TI2=1500ms, 
20-cm tag width, and a 1-cm gap between the distal end of the tag and the most 
proximal imaging slice) with a dual-echo gradient echo (GRE) readout (Liu et al., 
2002) and spiral acquisition of k-space (TE1=2.7ms, TE2= 29ms, flip angle=90°, field 
of view (FOV)=20 cm, 64×64 matrix, ).  Fifteen slices of 7mm thickness were imaged, 
with an inter-slice gap of 1mm. 
4.2.8 MRI Image Analysis
4.2.8.1. Baseline CBF
Quality control was performed on the raw data, by visual inspection for gross 
movement prior to group matching.  Subjects were excluded where gross movement 
was observed during either the short or long TI scans that could not be satisfactorily 
removed after motion correction.
Resting CBF was acquired using identical methods to those described in Chapter 2, 
with the addition of a partial volume correction step described in detail below. Briefly, 
tag-control difference images over full MTI time-series were calculated and used for 
quantification of resting CBF.  Signal within the ventricles (M0 CSF) was used to 
estimate M0 blood (Lu et al., 2004) and modelled to calculate whole brain perfusion 
maps using FSL BASIL toolbox (FMRIB Software Library, Oxford, UK).  
Partial volume correction was carried out as described previously (Chappell et al., 
2011).   Different tissue types within the same voxel influence the estimation of grey 
matter CBF in this type multi-TI ASL data where SNR is low.  This method exploits 
differences in the kinetics between grey and white matter signals, and performs 
partial volume estimates of tissue type and spatially regularises the data such that 
the appropriate degree of smoothing is estimated from the data itself.   In the case of 
ageing or atrophy, as would be expected in HD patients, the effects of PV (PVEs) 
are particularly problematic.  Estimating the appropriate degree of smoothing is 
important since rapid spatial variations in the GM CBF means that smoothing is more 
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likely to result in contaminated voxels.  In order to correct for partial volume of tissue, 
an additional step (Chappell et al., 2011) was added into the MTI CBF quantification 
performed in Chapter 2, using the oxford_asl tool within the FSL BASIL toolbox for 
quantification of CBF from ASL data (Chappell et al., 2009).  For each subject, GM 
and WM masks were first segmented from individual T1 structural images using FSL 
FAST (Zhang et al., 2001) and transformed into low-resolution space of the ASL data 
using FSL FLIRT (Jenkinson et al., 2002; Jenkinson and Smith, 2001).  Low 
resolution GM and WM masks were subsequently applied to the data, whereby the 
signal arising from GM and WM were modelled using the general kinetic model 
(Buxton et al., 1998).
4.2.8.1.1 Baseline CBF in Regions of Interest
4.2.8.1.1.1 Cortical Masks
Whole-brain and Frontal lobe grey matter masks were applied to voxel-wise CBF 
maps to produce average GM CBF estimates within each region as described 
previously, by performing individual T1 tissue segmentation to calculate a subject 
specific GM mask and deriving a Frontal Lobe mask based upon an MNI standard 
template. Raw data was screened for outliers, and values >3 S.D from the mean 
were removed.  Assumptions were tested for normality, homogeneity of variance 
using Levene’s Test, and collinearity in the case of multiple regression. FDR-
corrected p-values (q values) are reported where applicable. 
4.2.8.1.1.2 Sub-cortical Masks
To investigate CBF differences in subcortical regions, subcortical segmentation was 
performed on a subject by subject basis, using FSL FIRST (Patenaude et al., 2012) 
in which a surface mesh is created for each subcortical structure using a deformable 
mesh model.  Subcortical masks were applied to individual Grey Matter CBF images, 
and the median CBF signal was derived for each ROI, for each hemisphere 
independently.  ROIs of interest included the basal ganglia (caudate, pallidum, 
putamen, thalamus and accumbens) as well as the hippocampus (Fig 4.1).  Raw 
data was screened for outliers, and values >3 S.D from the mean were removed.  
Assumptions were tested as described above and FDR-corrected p-values (q values) 
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are reported where applicable (p<0.05).  Volumetric data will not be presented since 
it is not the focus of this thesis.
4.2.8.2. Cerebrovascular Reactivity
4.2.8.2.1. Breath-hold paradigm and quantifying feasibility in HD patients
Cerebrovascular reactivity was measured by quantifying absolute CBF in response 
to a hypercapnic stimulus, which in this experiment utilised the breath-hold task as 
described in Chapter 2, since it is easier to administer in patients, where a face-mask 
may be restrictive and exclusion criteria, such as smoking, would limit the number of 
eligible patients for this experiment.  Despite an increase in comfort, this task requires 
the ability to remember and follow instructions. Since cognitive impairment is 
common in patients at this stage, it was unknown how well subjects would perform 
on this challenge.  
Since this is the first time such this breath-hold paradigm has been carried out in 
Huntington’s Disease, a secondary interest was to assess feasibility for informing 
future studies.  This was done by measuring the number of breath-holds that 
demonstrated a clear end-tidal peak immediately before resuming paced breathing.  
It is important that the peak end-tidal CO2 measurement is recorded immediately 
Figure 4.1 Subcortical masks created by FSL FIRST. Bilateral subcortical masks 
were created using FSL FIRST for masking ASL images to extract region specific 
CBF values. Green = thalamus, Pink = putamen, Light blue = Caudate, Yellow = 
hippocampus, Blue = pallidum, Orange = Accumbens.   
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following the breath-hold to get the best CVR measurements, as this is used as a 
surrogate measure of arterial CO2. Instructions were given on the screen inside the 
scanner, but due to the cognitive impairment experienced by HD patients, a video 
(~4mins) was shown immediately prior to entering the scanner, in which they 
observed the instructions of the task and were instructed to practice outside the 
scanner, with emphasis on holding breath with empty lungs. The video can be viewed 
by following this link https://youtu.be/k6RF4bFN0vU.  The paradigm was conducted 
identically to that in Chapter 2, except 10 breath-holds instead of 4, were used to 
achieve greater SNR.
4.2.8.2.2. CVR Quantification
Cerebrovascular reactivity was quantified in a similar way to that described in 
Chapter 2.  Briefly, dual-echo data was separated into the CBF and BOLD echoes 
respectively.  Because CBF reactivity was the primary interest in this study and 
because BOLD and CBF CVR were highly correlated in Chapter 2, only absolute 
second-echo CBF data was analysed. However, due to the better SNR of the BOLD 
data compared to CBF, BOLD time-series data were motion corrected in MCFLIRT 
(Jenkinson et al., 2002) and these parameters were applied to the CBF time-series. 
The first echo data were used to calculate a subtraction time-series (Murphy et al., 
2011a) from which CBF was quantified to the standard single-compartment CBF 
model (Wong et al., 1998). Two-dimensional time-series were extracted by averaging 
across a whole-brain GM and frontal cortical mask. 
CO2 data was pre-processed by manually validating end-tidal CO2 values.  CO2 data 
was removed where the trace was too noisy to observe the breathing trace, due to 
chorea (figure 4.2.), and where the task was obviously not being performed, possibly 
due to cognitive difficulties following the task.  The number of accurate end-tidal 
expirations prior to paced breathing were recorded out of a maximum of 10 possible 
breath-holds.  Data was included in cases where the subject was holding their breath 
in-time with the on-screen instructions and at least 3 end-tidal expirations were 
performed accurately.  Example CO2 traces can be seen in figure 4.2 including one 
subject who carried out the end-tidal expirations perfectly (10/10) or poorly (1/10).  
Where <10 and >3 end-tidal expirations were performed accurately, end-tidal CO2
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peaks were manually added to the time-series by extrapolation based on the 
accurate end-tidal expirations during the task.
Finally, a regression analysis was performed to measure absΔCBF per mmHg 
change in absolute end-tidal CO2 with a 3rd order polynomial included to remove 
slow signal drift.  Temporal lag-fitting (time-shift steps of 0.1s) was also carried out, 
to account for the delay between end-tidal CO2 increase in response to breath-
holding and the subsequent blood flow response (Bright and Murphy, 2013).  
4.3. Results
Out of a total of 21 patients and 19 controls, a matched sample of 15 patients (6 pre-
symptomatic, 9 early-stage) and 15 controls was selected based upon meeting 
inclusion criteria, for age matching and for data quality (Table 4.1).  Data from these 
will be presented for the remainder of this thesis.  
Figure 4.2 Example end-tidal 
CO2 recordings. End-tidal CO2 
trace for three subjects.  Top) A 
good CO2 trace in which end-
tidal CO2 peaks can be 
observed at the end of each 
hold; Middle) A poor trace with 
only one accurate end-tidal 
breath, such that end-tidal CO2
could not be reliably quantified; 
Bottom) A poor end-tidal trace 
from a subject who exhibited 
mild chorea, such that the end-
tidal trace appeared extremely 
noisy.  X-axis = scanner 
volumes, Y-axis = End-tidal 
CO2 trace (mmHg x 15.2).
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4.3.1 Fitness Test ( O2PEAK)
It was predicted that many patients would be unable to reach their true O2MAX, such 
that their peak activity level ( O2PEAK) would be considered for the following 
experiment. Nonetheless, established O2MAX criteria were applied to each 
individual’s exercise test individually and the results can be seen in Table 4.2.  Of 
the cohort 8/15 (53%) patients and 12/15 (80%) healthy controls met at least 3 of the 
defined criteria, whilst 11/15 (73%) patients and 15/15 (100%) healthy controls met 
2 of the defined criteria.   
A trend between O2PEAK and disease burden was observed (figure 4.3) however this 
did not meet statistical significance (r (15) = -0.41, p=0.06).  Whether fitness improves 
disease burden, or whether greater disease burden impacts fitness cannot be 
disentangled from this analysis.
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The HD group had a mean O2PEAK of 36 (±10) ml/min/kg compared to healthy 
matched controls who had a mean O2PEAK of 37 (± 11) ml/min/kg, such that the 
groups did not significantly differ in terms of fitness (t (28) =0.38, p= 0.70, n.s.).  
Groups also did not differ on the Storer measure of predicted O2MAX (t (28) =0.76, 
p= 0.45, n.s.) nor on the IPAQ measure of self-reported measure of physical activity 
levels (t (27) =-0.03, p=0.98, n.s.).  Bivariate one-tailed Pearson correlation revealed 
that both the Storer (r (30) =0.60, p<0.001) and Self-reported IPAQ measures (r (29) 
= 0.46, p<0.01) were both highly correlated with the true O2PEAK values assessed in 
this study (Figure 4.4).
Figure 4.3 Relationship 
between disease burden 
score and VO2PEAK.
Disease Burden Score was 
inversely related to 
cardiorespiratory fitness 
(VO2PEAK) in Huntington’s 
Disease, although this was 
significant.  Disease burden 
=  (age × [CAG-35.5]) 
(Penney et al., 1997) 
Figure 4.4 Genotype differences assessed by subjective, predictive and quantitative 
fitness measures. HD patients did not differ from matched controls in fitness as 
determined by a) O2PEAK b) Predicted O2MAX (Storer) or 3) Self-report (IPAQ) (Error 
bars = S.E.M d) Predicted and e) Self-reported fitness was significantly associated with 
the O2PEAK assessment.
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4.3.2 Mood and Neurocognitive Function
4.3.1.1. Quality of Life
In a linear regression model, HD subjects scored significantly poorer than controls 
on several domains on the WHOQOL-BREF Quality of Life scale, including domains 
of physical health, psychology and social relationships but not environment (Table 
4.3). In HD patients, these scores appeared to get worse with disease burden, 
however these associations were not significant (p-values >0.05, n.s.).
In a multiple regression with O2PEAK included as a covariate, no interactions were 
observed (p-values>0.05, n.s.), suggesting that the relationship between O2PEAK
and Quality of life was the same in HD patients and controls.  
4.3.1.2. Mood 
HD patients scored more highly on reported depressive symptoms than controls, 
(Table 4.3) and disease burden appeared to be associated with more symptoms of 
depression and anxiety but these relationships were not significant (p>0.05, n.s.). 
O2PEAK was associated with reduced anxiety and depressive symptoms, although 
this was not statistically significant and this relationship appeared to be similar for 
both HD patients and controls (p>0.05, n.s; Table 4.3). 
4.3.1.3. Cognition
4.3.1.3.1. Group differences in Cognition
Linear regression was carried out to address group differences on cognitive function. 
HD subjects performed worse than controls on all tasks including Verbal Fluency, 
Symbol Digits Modalities, Speed of Comprehension, Forward Digit Span, STROOP 
interference, and Trailmaking A and B tasks (p-values<0.05) and these were 
significant after FDR correction for multiple comparisons (Table 4.3).  
4.3.1.3.2. Disease Burden and Cognition
One tailed Pearson’s correlations were carried out to assess the relationship 
between disease burden and cognitive task performance, where cognition was 
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expected to decline with disease burden.  Disease burden was associated with worse 
performance on most tasks, including STROOP (r (13) =-0.6, p=0.01), SCOLP (r (12) 
= -0.79, p <0.001), Trailmaking A (r (13) = 0.59, p= 0.02) and B (r (13) =0.70, p<0.01), 
and SDMT (r (13) =-0.62, p=0.01) but not Verbal Fluency (r (13) =-0.38, p=0.09, n.s.) 
or Forward Digit Span (r (13) =-0.20, p=0.18, n.s.).  Reported p-values are FDR 
corrected for multiple comparisons.
4.3.1.3.3. O2PEAK and cognition
Across subjects, the strongest relationship was observed between O2PEAK and 
performance on the Trailmaking B task but this was not significant (r2 = F (1,28) = 
2.22, p=0.15, n.s.).  In HD subjects, a trend towards faster performance on the 
Trailmaking B task was associated with higher fitness (p=0.15, n.s.; Table 4.3.), 
whereas this association was not present in controls. Nonetheless, this interaction 
was not significant.  In a multiple regression with fitness as a covariate, O2PEAK did 
not explain any additional variance between groups, such that the relationship 
between O2PEAK and performance on all cognitive tasks did not differ for HD patients 
and controls (p-values >0.05, n.s.; Table 4.3). 
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4.3.3 Baseline CBF 
4.3.3.1. PVC versus non-PVC CBF estimation in whole-brain GM
Cerebral blood flow measurements can be seen in Figure 4.5, both before and after 
partial volume correction.  Partial volume corrected images yielded significantly 
higher estimates of whole-brain grey matter CBF (Method; F (1,28) = 299.00, 
p<0.001 partial 2= 0.90) than images that had not been partial volume corrected.  
PVC CBF estimates were significantly higher in patients (70%) than controls (59%) 
(F (1,28) =4.60, p=0.04, partial 2= 0.14).  This would be expected where partial 
volume effects typically seen in atrophied brains are reduced due to the improved 
spatial accuracy gained using this method.
This relationship was similar for aBV and TAT estimates (p-values <0.001).  Non-
PVC data yielded outliers >2 S.D, in the control group such that data did not meet 
the assumption of normality (Shapiro Wilks; p<0.05).   Since the relationship between 
groups appeared preserved and yielded fewer outliers when partial volume 
correcting the data, PVC data will be reported for the remainder of this thesis.  
4.3.3.2. GM CBF estimates in HD patients compared to matched controls
Initial analysis aimed to rule out the impact of age on CBF, as CBF is known to 
decline with age.  In an ANCOVA model, with age as a covariate and genotype as a 
between subjects factor, age was not associated with CBF in any of the regions 
studied (p-values > 0.05) and was not found to moderate group differences in CBF.  
Figure 4.5 Genotype differences in cerebral blood flow, volume and arrival time.  
Bar graphs showing group differences between a) CBF b) aBV c) TAT (tissue arrival 
time), with and without PVC (partial volume correction). Error bars = S.E.M.
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This was expected since groups were matched for age, and therefore age was not 
considered as a covariate in further analysis.
Independent t-tests were performed to assess differences in cortical and sub-cortical 
CBF (Figure 4.6) between HD patients and controls. There were no significant 
differences in resting CBF in any of the cortical or subcortical regions alone (p>0.05; 
Table 4.4), however a trend was evident, whereby HD patients appeared to have 
higher CBF in the cortex (Figure 4.7) and lower CBF in most subcortical regions 
within the basal ganglia, in particular, the left caudate which approached significance 
(p=0.06, n.s.).  Both hemispheres showed a similar pattern of effects such that a 
repeated measures ANOVA revealed no difference between CBF in either 
hemisphere overall (Hemisphere; F (1,25) = 0.68, p=0.42, n.s.) and although this 
discrepancy appeared greater in the caudate of control subjects, there was no 
interaction between hemisphere and group (Hemisphere x Genotype; F (1,25) =0.42, 
p=0.52, n.s.).
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Figure 4.6 Partial volume corrected grey matter CBF in cortical and subcortical 
ROIs. Bars represent mean CBF in patients and controls.  Groups did not differ 
significantly in any of the ROIs assessed, although a trend towards hypoperfusion in 
basal ganglia regions was observed. Error bars = SEM. 
Figure 4.7 Voxel-wise CBF maps in two representative subjects. Grey matter CBF 
map in an example HD patient (bottom) and matched control (top) aged Age=~45 
years, O2PEAK = ~45, Education ~ 20 years. Cortical hyperperfusion can be 
observed in HD patients compared to controls but this was not significant.
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Further analysis was performed to address whether groups differed in tissue arrival 
times (TAT) in the cortical or subcortical regions studied.  HD patients had similar 
TAT to controls (p-values <0.05), although visual trends revealed a slight increase in 
tissue arrival time in the HD group.
4.3.3.3. GM CBF Relationship with Disease Burden
In HD patients, the relationship between Disease burden, CBF and tissue arrival time 
was assessed using Pearson’s correlation.  UHDRS total motor score (TMS), 
functional capacity (TFS), independence score (IS) and cognition (TCS) were also 
assessed for their relationship with regional rCBF. 
4.3.3.3.1. CBF
In participants with HD, disease burden was negatively correlated with whole-brain 
grey matter CBF (r (13) =-0.68, p<0.01), however no correlations were observed 
between CBF in the subcortical regions or frontal cortex (p-values>0.05).   
4.3.3.3.1.1. Cortical ROIs
Whole-brain GM CBF was also positively associated with UHDRS scores including 
TFS (r (13) =0.64, p=0.01, q=0.03) indicating better functional capacity, IS (r (13) 
=0.54, p=0.04, q=0.07, n.s.) indicating greater independence, CS (r (13) =0.59, 
p=0.02, q<0.04) indicating better cognitive functioning, and FAS (r (13) =0.65, 
p<0.01, q<0.01) indicating a wider degree of function, but not TMS (r (13) =-0.48, 
p=0.07, q=0.09, n.s.) in those with higher global CBF. 
Frontal cortex CBF was positively associated with TMS (r (13) =0.64, p=0.02) such 
that those with higher motor dysfunction had elevated CBF in the frontal cortex.  
Frontal cortex CBF was also associated with lower functional capacity (TFC; r (13) 
=-0.63, p=0.01, q=0.02), lower independence (IS; (r (13) =-0.62, p=0.01, q=0.02) and 
a lower functional score (FAS; r (13) =-0.58, p=0.02, q=0.03).  
4.3.3.3.1.2. Subcortical ROIs
Higher CBF the left (r (15) =0.61, p=0.08, q=0.10, n.s.) and right (r (13) =0.59, p=0.02, 
q=0.11, n.s) thalamus was associated with motor function (TMS), and the left 
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thalamus was also associated with lower levels of independence (IS; r (13) =-0.55, 
p=0.03, q=0.11, n.s.). CBF in left putamen was associated with lower functional 
capacity (TFC; r (13) =-0.53, p=0.04, q=0.01) and lower functional assessment 
scores (FAS; r (13) =-0.55, p=0.04, q=0.09, n.s). 
4.3.3.3.2. TAT
There was a strong negative association between disease burden and tissue arrival 
time within whole-brain GM TAT (r (13) =-0.68, p<0.01).  A similar association was 
seen within the left hippocampus (r (13) =-0.56, p=0.03, q=0.16) and right caudate (r 
(12) =-0.59, p=0.03, q=0.16), such that greater disease burden in HD was associated 
with shorter arrival times, however p-values (q) were no longer significant after FDR 
correction for multiple comparisons. 
4.3.3.4. Group differences between CBF parameters and cognition
To explore these changes further, group differences were investigated to assess 
whether these relationships were the same for HD patients and controls.
4.3.3.4.1. CBF
4.3.3.4.1.1. Cortical ROIs
In controls, cognitive performance was positively associated with elevated CBF in 
several regions.   Higher global GM was associated with performance on the SCOLP 
(r (12) =0.54, p=0.04) and forward digit span (r (12) =0.54, p=0.04). In controls, 
negative associations were observed between CBF in the frontal cortex and 
performance on the Trailmaking task (r (13) =-0.53, p=0.04, q=0.10, n.s.), SCOLP (r 
(13) =0.55, p=0.04, q=0.10, n.s.), and SDMT (r (13) =0.53, p=0.04, q=0.10, n.s.), but 
relationships were not significant after FDR correction.
In patients, neither whole-brain nor frontal GM CBF was associated with cognitive 
performance on any of the tasks assessed (p-values>0.05).
4.3.3.4.1.2. Subcortical ROIs
CBF in controls was positively associated with cognitive performance on a number 
of tasks.  CBF in the left accumbens was associated with better performance on the 
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verbal fluency task (r (15) =0.73, p<0.01, q=0.01), forward digit span (r (13) =0.63, 
p=0.01, q=0.03), and SDMT (r (12) =0.68, p=0.008, q=0.02).  CBF in the right 
putamen was positively associated with performance on the forward digit span r (13) 
=0.65, p=0.009, q=0.03), SCOLP (r (15) =0.60, p=0.02, q=0.03) and SDMT (r (12) 
=0.72, p=0.004, q=0.02). CBF in the left caudate was associated with better 
performance on the SDMT (r (12) =0.71, p=0.004, q=0.02). 
In comparison, HD patients did not show the same widespread correlation between 
task performance and CBF in these regions. The only implicated subcortical region 
appeared to be in the left putamen, in which elevated CBF was associated with 
slower performance on the Trailmaking B task (r (13) =0.54, p=0.04, q=0.23, n.s), 
and the left thalamus which was associated with poorer performance on the SCOLP 
(r (13) =-0.54, p<0.05, q=0.11, n.s.) and the SDMT (r (13) =-0.55, p=0.03, q=0.11, 
n.s.) (Figure 4.8.). In contrast to the control group, our results suggest that elevated 
CBF in these regions was actually associated with poorer cognitive performance, 
although these results were no longer significant after FDR correction.
4.3.3.4.2. TAT
In controls, cognitive function correlated with TAT in a number of basal ganglia 
regions. Stroop task performance was positively associated with TAT in the left 
caudate (r (12) =0.64, p=0.01, q=0.08, n.s.) whilst SDMT (r (13) =-0.55, p=0.04, 
q=0.13, n.s) and SCOLP (r (13) =-0.67, p<0.01, q=0.04) was negatively associated 
with TAT in the left putamen.  Only the relationship between TAT in the left putamen 
Figure 4.8 Relationship between subcortical CBF and cognitive function in HD 
patients compared to controls. Left thalamic CBF was negatively associated with 
cognitive performance on the Speed of Comprehension and Language Processing 
(SCOLP) test and Symbol Digit Modalities Test (SDMT).  Left putamen CBF was 
associated with speed to complete the Trailmaking test, where longer times reflect 
poorer performance.
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and SCOLP performance was significant after FDR correction.  Interestingly, this 
relationship between basal ganglia regions and cognitive function was entirely 
absent in HD patients (p values >0.05).
4.3.3.5. Relationship between cardiorespiratory fitness and CBF 
4.3.3.5.1. CBF
Pearson’s correlation revealed that O2PEAK was not associated with CBF in any of 
the regions studied (p>0.05) when collapsed across groups (Table 4.5).
Next, we were interested to assess whether O2PEAK would predict CBF differently 
between HD patients and controls.  A linear regression with  O2PEAK as a continuous 
predictor, subject group as a categorical and regional CBF as the dependent variable 
was carried out, to assess whether HD status moderated the relationship between 
O2PEAK and CBF.  Regression analysis was performed with bootstrapping at 1000 
samples with 95% bias-corrected and accelerated confidence intervals.
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Overall, beta values consistently demonstrated a reduction in CBF with O2PEAK. 
Genotype did not interact with the relationship between CBF in most regions studied 
(p>0.05, Table 4.5), except the left caudate in which HD patients showed a negative 
relationship with fitness and CBF, whilst controls showed an increase in CBF with 
increased fitness (R2 (27) = 0.18, p=0.05, q=0.36; figure 4.9) however, this was no 
longer significant after FDR correction for multiple comparisons.
4.3.3.5.2. TAT
Pearson’s correlation revealed that O2PEAK was not associated with TAT in any of 
the regions studied (p>0.05) when collapsed across groups.  No interactions were 
found to suggest that TAT was affected differently by fitness between groups 
(p>0.05, n.s.)
4.3.4 Cerebrovascular Reactivity
4.3.4.1. Feasibility of Breath-hold Paradigm for CVR quantification
Out of 15 HD patients and 15 controls, breath-hold data was missing for 1 person 
within each group.  Out of the 14 remaining subjects for each group, 9/14 controls 
and 10/14 patients successfully completed the breath-hold task with at least 3 correct 
breath-holds.   Of those that did complete a valid task, HD patients and controls both 
performed the same number of end-exhalations correctly (Controls: 6 ± 1.6 holds, 
Patients: 6 ± 1.8 holds). 
Figure 4.9 VO2PEAK predicts CBF 
differently in HD patients in the 
caudate nucleus.
Group differences in the 
relationship between fitness 
( O2PEAK) and CBF in the left 
caudate nucleus. Fitter HD 
subjects had lower CBF than 
less fit subject, in contrast to the 
positive relationship seen in 
matched controls (N=15 per 
group).
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4.3.4.2. Group differences in CBF CVR
Partial volume corrected CBF CVR across the entire brain and within the frontal 
cortex can be seen in figure 4.10.  A trend can be seen in which patients had lower 
CVR than controls. Independent samples t-test was performed corrected for 
inequality of variance and bootstrapped to 1000 samples. Grey matter CVR did not 
differ significantly between HD patients (0.15 ± 0.4) and controls (0.39 ± 0.11) within 
whole-brain (t (16) =1.22, p=0.25) or frontal grey matter (t (16) =1.84, p=0.08).
4.3.4.3. Relationship between CVR and fitness
A negative relationship between whole-brain CVR and O2PEAK was visible such that 
higher O2PEAK was associated with lower CVR, but this was not significant (R2 = 
0.15, F (1,16) =2.9; β =-0.01, p=0.11, n.s).  Including GROUP as a moderator, 
explained an additional 6% of the variance between subjects but this was not 
significant (p=0.29). Nonetheless, simple relationships were explored using 
individual linear regression for each group independently. O2PEAK was unable to 
Figure 4.10 Genotype differences in CVR and relationship with VO2PEAK. Left) CBF 
CVR was lower in HD patients than controls across the whole-brain and Frontal 
Cortex, although results were not statistically significant (N=9 per group; Error bars 
= SEM).  Right) The relationship between CBF CVR and O2PEAK also did not differ 
between groups.
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predict Frontal CVR across subjects (R2 = 0.18, F (1,7) =1.5; β =-0.01, p=0.99, n.s.), 
however genotype could account for an additional 18% of the variance, although this 
interaction with fitness was not significant (p=0.09).  Frontal CVR in either HD 
patients, (R2 = 0.02, F (1,7) =0.15; β =0.02, p=0.71, n.s.) or controls (R2 = 0.01, F 
(1,7) =0.09; β =-0.016, p=0.79, n.s.) was not associated with cardiorespiratory fitness 
(Figure 4.9). 
4.3.4.4. Relationship between CVR and Disease Burden
Frontal CVR was negatively associated with UHDRS TMS score (r (9) =-0.69, 
p=0.04), such that higher CVR was observed in those with greater motor disability, 
although this did not survive FDR correction.  CVR was not associated with any other 
UHDRS scores or overall disease burden (p-values> 0.05). 
4.3.4.5. Relationship between CVR and Cognitive Function
Whole-brain CVR was associated with better SCOLP (r (18) = 0.49, p=0.04, q=0.01) 
and verbal fluency (r (18) = 0.57, p=0.01, q=0.08, n.s.) performance, whilst Frontal 
CVR was associated with better performance on verbal fluency (r (18) = 0.67, 
p=0.003, q=0.02) and Trailmaking test B (r (18) = -0.54, p=0.02, q=0.07,. n.s).  
Together these results suggest that CVR is beneficial for a number of tasks that 
require executive functioning, but only the relationship between verbal fluency and 
Frontal CVR was significant after FDR correction.
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4.4. Discussion
Key Findings
• HD subjects with higher disease burden had significantly lower whole brain 
GM CBF.
• Symptom severity according to a UHDRS scores was associated with 
significantly lower whole-brain grey matter CBF.
• CBF within basal ganglia regions was lower in HD patients compared to 
controls, particularly within the left caudate but this was not significant 
after FDR correction.
• Tissue arrival times within a whole-brain mask, were significantly shorter in 
those with a higher disease burden.
• O2PEAK appeared to be negatively correlated with CBF in most basal ganglia 
regions when collapsed across all subjects, but this was not significant.
• HD subjects differed from controls in the relationship between O2PEAK and 
CBF in the left caudate, whereby fitter HD subjects had lower CBF in the left 
caudate, whilst CBF was elevated in controls.  This interaction was no 
longer significant after correction for multiple comparisons between 
subcortical regions.
• HD subjects had lower whole-brain and frontal grey matter CVR than 
controls, in those subjects that completed the breath-hold task with 
reasonable efficacy, but was not significant.
• HD patients showed significantly poorer performance on a number of tasks 
that require executive functioning.
• Unlike controls, HD patients did not demonstrate a positive association 
between CBF and cognitive performance. Contrarily, they showed a 
negative relationship between CBF and executive function in the left 
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thalamus and left putamen, however these interactions were not significant 
after multiple comparisons.
• Pre-/early-HD patients reported having significantly poorer quality of life 
than controls in domains of physical health, psychology and Social 
Relationships.
• Partial volume correction yields significantly higher CBF estimates than 
without correction, and this discrepancy was greater for HD patients where 
atrophy is expected suggesting that PVC is a useful step when using ASL in 
neurodegenerative disease.
The present study looked to investigate previously reported alterations in CBF in the 
HD brain using PASL MRI and is the first time that the relationship between 
cardiorespiratory fitness and CBF has been assessed in HD.  Compared to a well-
matched group of healthy controls, HD subjects displayed hypoperfusion, shorter 
blood arrival times into grey-matter tissue, reduced CBF CVR to a breath-hold 
challenge and poorer performance on a range of tasks used to assess executive 
functioning that were associated hyperperfusion in the left thalamus and left putamen. 
The largest perfusion difference was seen in the left caudate, a region known to be 
heavily implicated in the progression of HD symptoms. Cardiorespiratory fitness 
appeared to be negatively associated with CBF across regions, although this was 
not significant in any region across groups. However, when considering HD status, 
this relationship differed between HD subjects and controls in the left caudate, where 
lower CBF in fitter HD patients differed from controls who had elevated CBF with 
higher O2PEAK. This is the first study to explore this question in HD.
4.4.1. CBF in Huntington’s Disease
Perturbations in microvascular flow, have been shown to precede the development 
of neuronal dysfunction, leading to speculations that alterations in CBF may play 
important roles in both progression and clinical expression of neurodegenerative 
disease.   In the present study, lower CBF was observed in all basal ganglia regions, 
but not the cortex or hippocampus, where CBF appeared elevated. Group differences 
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were not found to be statistically significant, although group differences were evident 
in the left caudate and right putamen.   Further analysis also revealed that disease 
severity, according to increased disease burden and UHDRS scores, was related to 
global CBF, where greater disease severity was associated with hypoperfusion 
throughout the brain.
Hypoperfusion of the left putamen has been found previously, in pre-symptomatic 
patients near to predicted disease onset (Harris et al., 1999 and Wolf et al., 2011), 
alongside hypoperfusion in the prefrontal cortex. However, unlike the present study, 
they did not observe group differences in the caudate.  Whilst we observed a 
widespread pattern of hypoperfusion across regions, these results were not 
statistically significant and interpretation should be treated carefully.  It is possible 
that the study by (Wolf et al., 2011) was more sensitive to these effects as their 
sample size was slightly larger (N=18) and variance reduced by tight recruitment 
regarding predicted time from onset.  Their study also utilized PCASL which has 
greater SNR than PASL methods (Y. F. Chen et al., 2011) such that their measures 
may have been more sensitive to detect changes.  Nonetheless, both the putamen 
and caudate are known to play key roles in the progression of HD, such that the 
results are likely to be reflective of real underlying physiological processes.  It is 
within the caudate nucleus and putamen that the largest degree of medium spiny 
neuronal loss occurs during HD. Although it is not known why it is so highly affected, 
it is thought that mitochondrial dysfunction in the caudate may jeopardise metabolism, 
thereby leading to neuronal death.   Blood flow in the caudate has been described 
as the single largest predictor of executive performance deficits in HD (Hasselbalch 
et al., 1992).  Despite the clearest differences in baseline CBF being observed in left 
caudate, we did not observe a relationship between left caudate CBF and 
performance on any of the cognitive tasks in this study.  
Although CBF differences in this study were not significant, it is possible, that the 
findings in the present study may be more sensitive to alterations in CBF than those 
reported previously.  Unlike any other studies that have explored CBF in HD, the 
present study included a partial volume correction step during CBF estimation, to 
reduce distortions caused by spatial inaccuracies introduced by other tissue types 
within each voxel. Where atrophy is known to occur, correction for partial volume 
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becomes more necessary, especially within smaller grey matter structures where 
apparent changes in signal can, at least partially, be attributed to PVEs (Dukart and 
Bertolino, 2014). These PVEs could potentially obscure patterns of disease that may 
be of interest when investigating biomarkers and underestimate the confounding 
effect of atrophy.  Studies that have shown more hypoperfusion than that observed 
in this study, may be attributable to the fact that less grey matter is present and thus 
the reported GM CBF signal is underestimated. Partial volume correction has been 
shown to inflate CBF estimates by up to 80% (Chappell et al., 2011) and in our study 
we observed a substantial difference between partial volume corrected and non-
partial volume corrected images within a whole-brain grey matter mask. Where HD 
subjects showed an CBF estimation increase of 70% compared to 59% in controls, 
it is likely that this is due to the improved spatial accuracy after accounting for PVEs 
induced by atrophy.  We did not assess these differences within smaller subcortical 
structures, although this would be worthy of further investigation to inform other ASL 
studies when attempting to draw conclusions about CBF differences in HD.
The present study also investigated the relationship between CBF and symptom 
severity based on clinical UHDRS scores.   Reduced whole-brain grey matter 
perfusion was observed in those who had higher disease burden, and greater 
symptom severity in terms of independence, functional capacity, cognition and range 
of functions.  Interestingly, this relationship was inverted in the frontal cortex where 
motor symptoms, functional capacity and independence was lower in those with 
higher frontal perfusion. Previous studies have also observed elevated in CBF in 
prefrontal regions, in pre-symptomatic HD, and this has been suggested to reflect 
increased metabolism and activation attributable to ‘compensatory’ neural processes 
paralleling striatal degeneration and a subsequent impairment of cortico-striatal 
circuits (Paulsen et al., 2004).   Future analysis will concentrate on subdividing the 
cortex into more specific ROI’s such that the pattern of cerebral perfusion can be 
assessed, with particular focus on the prefrontal and sensorimotor regions which are 
thought to be vulnerable in HD (Wolf et al., 2011).  Of all the subcortical regions 
assessed, the only sub-region to survive multiple comparison was the left putamen, 
in which higher CBF was associated with lower functional capacity.  Where CBF in 
the putamen is commonly thought to be reduced in HD (Harris et al., 1999; Wolf et 
al., 2011) and right putamen CBF appeared higher in patients than controls in the 
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current study, it is counterintuitive that higher CBF in the left putamen is related to 
worse diagnosis. This is not the first time that elevated basal ganglia perfusion has 
been noted in pre-symptomatic HD patients (Chen et al., 2012) and has been thought 
to reflect interesting compensatory processes where striatal hypo-perfusion is 
observed elsewhere.  Alternatively, this could be a methodological artefact as it has 
been recognised that this scale may be less sensitive to functional changes in 
patients far from symptom onset (Paulsen et al., 2010).
The importance of adequate perfusion of the basal ganglia to maintain executive 
function is supported in this study, whereby widespread regional CBF was positively 
correlated with performance on a range of cognitive tests which are known to be 
affect by HD.  Interestingly, this relationship was only true of controls. HD patients 
showed a negative relationship between CBF and executive function.  Elevated CBF 
in the left thalamus was associated with worse performance on the Speed of 
Comprehension and Language Processing Test and the Symbol Digit Modalities 
Test. The human thalamus has been shown to be crucially involved in executive 
functions (Marzinzik et al., 2008) due to its critical position and extensive reciprocal 
connections with almost all cortical regions (Behrens et al., 2003).  Whereas a 
positive relationship between thalamic perfusion and performance on executive 
function was observed in the current study, the opposite relationship in HD provides 
support for a pathological relationship between thalamic CBF and cognitive function 
in HD.  Despite its fundamental role in mediating the cognitive dysfunction known to 
occur in HD, this is the first time thalamic CBF differences have been observed in 
the ASL literature.  Elevated baseline CBF in those that perform poorly on executive 
tasks, may be explained by pathological angiogenesis, that has been reported in HD 
patients and HD rodent models (Drouin-Ouellet et al., 2015) in patients who are 
cognitively symptomatic.  Since these results are cross-sectional it is not possible to 
infer causation. However, further research would benefit from investigating the real-
time functional changes in thalamic CBF during a similar executive task using ASL 
fMRI, such that causation may be inferred.
The precise physiological underpinnings of cerebral perfusion changes in HD have 
not been addressed by this study. Disturbance of nitric oxide and nitric oxide 
synthase systems have been seen in the R6/2 transgenic HD mouse model (Deckel 
Chapter 4
145
et al, 2002), where initial elevations were seen in neuronal nitrous oxide synthase 
(nNOS) expression in ‘pre-symptomatic’ mice aged 3 weeks, but a decline in 
expression as the disease progressed (at age 6 and 11 weeks).  The most significant 
and early reductions in CBF are thought to occur in regions which have high 
metabolic activity relative to the global average (Leenders et al., 1990).  
Perturbations to microvascular flow regulation have been reported in AD models 
(Iadecola, 2004), where amyloid deposition is thought to actively exchange signalling 
mediators and trophic factors such as VEGF which may affect perfusion of the grey 
matter.  Whilst the impact of mutant huntingtin protein on the endothelium has not 
been clarified, mHTT was found to directly affect expression and activity of NOS and 
reduction in vascular velocity, and possibly, flow (Deckel, 2002).  The general pattern 
of hypoperfusion and the inverse relationship observed with disease burden may 
reflect a progressive reduction in nNOS expression observed with disease 
progression, such that CBF decreases with disease progression.   Another 
explanation for the spatial variations observed in this study, could be due to the 
growth and loss of blood vessels at different stages throughout the disease. 
Increased vessel density has been reported in HD R6/2 mice from 7 weeks of age, 
and is thought to underpin an increase in cerebral blood volume in both the cortex 
and striatum which increases with disease progression (Lin et al., 2013).
The present study is the first to investigate whether any differences in tissue arrival 
times exist in HD patients compared to controls.  Tissue arrival time is the time it 
takes for a tagged bolus of blood to reach the imaging voxel.  Estimation of the TAT 
is necessary as it reflects tissue dispersion, which in turn is known to influence 
estimation of cerebral blood flow.  Tissue dispersion can be influenced by a range of 
factors including the non-uniform cross-sectional flow profile of blood vessel, flow 
pulsatility and potential for multiple arterial supply routes and as such, differs 
throughout the brain where the caudate and putamen have been found to have the 
shortest arrival times (Gallichan and Jezzard, 2009).  In this experiment arrival times 
observed in the basal ganglia were comparable to those reported previously (~0.7s) 
(Gallichan and Jezzard, 2009). No group differences were observed between resting 
TAT, such that it is unlikely that CBF estimates would have been affected by group 
differences in perfusion speed, however individual differences in disease burden was 
negatively associated with TAT across the whole brain as well as the hippocampus 
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and caudate.  Whether tissue dispersion is reduced with disease progression is 
intriguing since arrival times are thought to increase in the normal ageing brain (Liu 
et al., 2011), however it may be attributable to extreme atrophy in these regions.  
Interestingly, basal ganglia TAT was related to cognitive scores in the control group, 
where shorter arrival times in the putamen were related to improved digit span and 
SCOLP performance, a result which was absent in HD subjects.  It is unclear whether 
TAT is a useful parameter of cerebrovascular health as it is rarely reported, and 
whether one would expect striatal TAT to be altered in HD is unknown, and may be 
related to angiogenesis known to occur in HD. Evidence that TAT was inversely 
correlated with cognition is further evidence for the link between disease 
neuropathology in HD. Since this experiment had not initially planned to investigate 
TAT, future work should expand upon this work, by modelling TAT in HD.  
4.4.2. Cardiorespiratory fitness in Huntington’s Disease
The present study is the first to address the relationship between cardiorespiratory 
fitness and cerebrovascular health in people with Huntington’s Disease.  In Chapter 
2, it was observed that fitness was negatively correlated with whole brain grey matter 
CBF in highly fit individuals. In the present study, whole group CBF appeared to be 
negatively related to O2PEAK but this was not significant for any of the sub-regions 
assessed.  Group differences however, yielded an interesting interaction within the 
left caudate alone which, as described above, is highly implicated in HD pathology 
and cortical function. Specifically, O2PEAK was associated with elevated caudate 
CBF in controls, which is in line with the pattern of results reported previously in 
studies of CBF in the general population (Bailey et al., 2013; Chapman et al., 2013).  
Assuming that this is a beneficial effect of fitness on the brain, then the inverse 
relationship between fitness and CBF in HD patients is alarming.  In the present study, 
the left caudate was the region in which the greatest hypoperfusion was observed 
relative to controls.  Should fitness indeed decrease CBF in this critical region even 
further, this may in fact reflect a negative effect of exercise on the brain.  This would 
not be the first study to report potentially negative effects of exercise on cerebral 
health.  In their mouse study, Potter et al. (2010) observed that N171-82Q transgenic 
HD running mice had an earlier onset of disease symptoms (shaking, hunched back 
and poor grooming), reduced striatal volume and impaired motor behaviour, 
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hyperglycaemia, Morris water maze learning deficits, diminished neurogenesis, 
deficits in immature neuronal morphology, and more intranuclear mHTT inclusions 
from 11 weeks of age.
Care should be taken when over-interpreting the effects of fitness on the brain, since 
this is a cross-sectional study and therefore amount and type of exercise could not 
be directly manipulated. Exercise interventions are thought to be a better way by 
which to infer causality, and such interventions have been shown to be feasible and 
without negative side effects (Khalil et al., 2013b).  Combining similar interventions 
with MRI would enable us to directly address the effects of exercise on the brain, 
although the timescale over which these changes are expected to occur is not known. 
Studies in rodent models of HD, where it is possible to directly manipulate and control 
for the amount of exercise are warranted to rule out the suggestion of negative effects 
of exercise on the brain. 
It was important for the sake of this study, that the fitness range was similar between 
patients and controls such that MRI results could be compared. In both groups, 
average O2PEAK reached 36-37 ml/min/kg. However, a proportion of participants 
was unable to reach its true O2MAX for several reasons, which may be useful 
considerations for future studies in which a fitness test is explored. Of note, was that 
apathy may have affected patients’ willingness to continue to exhaustion. Indeed, 
patients in this study did show elevated depressive symptoms relative to controls. 
Whilst this was not measured directly, this appeared to be the case in approximately 
3 patients.  In general, however, all participants were extremely motivated to push 
themselves to their limit.  More apparent, was the observation that a number of 
participants were unable to maintain a repetition rate above 45rpm because their 
legs were tired.  It appeared that muscle fatigue was reached before O2MAX was 
reached, such that it became more a test of muscle strength than aerobic capacity.  
The protocol was initially designed to include 25W step increases every two minutes 
since we were interested in taking regular measurements at each load.  Future 
experiments should consider incorporating more regular, gradual step changes, to 
avoid termination due to leg fatigue and so that it is possible to observe the typical 
O2 plateau used to qualify a O2, where O2 fails to increase with increasing load.  
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In the absence of a true O2MAX measurement in some subjects, it is possible that 
these methodological caveats could explain the absence of any clear relationship 
between fitness and CBF. Predicted and self-reported fitness were found to correlate 
strongly with O2PEAK although these measures remain less robust than the O2PEAK 
in the absence of physiological information.
4.4.3. CVR in Huntington’s Disease 
CBF change in response to increased CO2 during a breath-hold challenge was 
reduced in HD patients compared to controls in those that completed the task 
satisfactorily, although this was not significant across the whole brain, or more locally 
within the frontal cortex.  Averaged across whole-brain, an increase of 0.39 
ml/100g/min per mmHg increase in CO2 was observed in controls which is slightly 
higher than the result recorded in Chapter 2 in young healthy subjects (0.24 ± 1.2), 
compared to just 0.15 ml/100g/min/mmHg in HD patients.
To the best of my knowledge, this is the first study to measure cerebrovascular 
reactivity in patients with Huntington’s Disease, although this has been investigated 
in a couple of HD mouse models.  CBF CVR in the R6/2 mouse model, revealed 
decreased reactivity to a carbogen gas challenge at 7-weeks old, compared to wild-
type mice, which sits in line with the trending results observed in this study (Hsiao et 
al., 2015).  Impaired CVR may explain the hindered cerebral hemodynamics 
observed in this study and others, and may even precede the increase in brain 
atrophy during HD progression. It is not known how CVR is jeopardized in the HD
brain, although in their paper Hsiao et al., (2015) propose a mechanism by which 
increased endothelial cell proliferation via a VEGF-A–dependent pathway may 
compromise the survival of pericytes which envelope the blood vessel and alter 
vascular tone in response to demands for increased blood flow.  Impaired CVR has 
been reported in Alzheimer’s disease, whereby diffuse yet predominant impairment 
of CVR is observed in the posterior areas (Cantin et al., 2011) that is also associated 
with cognitive deterioration  (Silvestrini et al., 2006).  
Studies of CVR in other diseases tend to focus on BOLD reactivity.  As discussed in 
Chapter 2, CBF is a much more direct measure of vascular function, where the BOLD 
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signal is complex in its origin.  Although we observed a strong correlation between 
BOLD and CBF CVR in Chapter 2, this relationship has not been assessed in the 
present study.  Nonetheless, BOLD data was acquired and future work will take this 
investigation further by measuring BOLD reactivity in HD.
In the present study, we observed many subjects, particularly patients, and within 
the frontal cortex, who had a negative CVR response to the breath-hold task.   
Physiologically, this translates as a decrease in CBF with increased CO2.  It has been 
shown previously that rats with progressive hypertension exhibit reduced lumen 
diameter, increased arterial stenosis and a corresponding negative CBF CVR (Li et 
al., 2015).  The same study also found enlargement of downstream vessels and 
formation of collateral vessels as compensatory responses to stenosis of the 
upstream vessels.  In the context of HD this may in part explain the typical angiogenic 
response seen in the microvasculature in parallel with a reduction in artery number 
(Lin et al., 2013).  Where this is  the case, it reflects compromised cerebrovascular 
reserves, and is clinically relevant in HD as similar mechanisms have also been also 
associated with increased risk of stroke (Kuroda et al., 2001) and dementia (Marshall 
and Lazar, 2011). Future work will look more closely at the arterial blood volume, 
using the compliance measures (Warnert et al., 2015b) described in Chapter 2, to 
assess whether arterial stiffening can be detected in HD patients using ASL.  An 
alternative explanation for the reduction in CVR, is that this is a vascular artefact 
around the ventricles in HD patients.  It has been proposed previously that a 
reduction in the CSF volume fraction during hypercapnia, leading to blood vessel 
dilation, may cause a reduction in signal where the less intense blood signal replaces 
the more intense CSF signal (Thomas et al., 2013a).  This would yield a net decrease 
in the signal measured, which is likely to be greater in HD where registration around 
the atrophied ventricles can be poor. 
A peripheral research question in this study, was the feasibility of a breath-hold 
challenge for assessing CVR. In total, 10/14 patients and 9/14 controls were 
considered valid for inclusion, whereby they completed a minimum of 3 breath-holds 
effectively.  This arbitrary number was used because 3 end-tidal CO2 measurements 
was considered sufficient for extrapolation to the other breath-holds in which 
inhalation rather than exhalation followed the hold.   Of those that did complete a 
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valid task, HD patients and controls both performed the same number of end-
exhalations correctly (6 ± 2). The primary reason for excluding control data was due 
to consistent inhalations rather than exhalations following the hold, such that end-
tidal peaks in CO2 were not recorded. In addition, patient data were also excluded 
due to failure to do the task (possibly due to cognitive impairment) or due to obvious 
movement issues (chorea) whereby CO2 data were too noisy.  The fact that patients 
did not differ significantly from controls, suggests that real emphasis needs to be put 
into explaining the breath-hold task thoroughly to all participants, since even 
cognitively unimpaired controls did not follow the instructions perfectly.  In the current 
study, we went to great lengths to explain the task and showed them a video 
immediately prior to scanning, such that the instructions would be as clear as 
possible.  According to the present results, future research should consider including 
enough breath-hold challenges since this would increase the number of end-tidal 
measurements from which to extrapolate and consider increasing subject power to 
allow for subject removal where necessary. 
With thorough briefing and cognitive screening, CVR using the breath-hold paradigm 
appears feasible for use in pre-early symptomatic stage HD patients, however it is 
not recommended for more advanced HD where cognitive and motor symptoms may 
pose a challenge.   It should also be noted that extrapolating the end-tidal CO2 values 
is not ideal, and future work will develop this analysis pipeline further, to ensure the 
most robust measurements are acquired.
4.4.4. Determining disease severity 
In this Chapter, disease burden score was calculated in addition to clinical UHDRS 
scores as a measure if HD progression. First proposed by (Penney et al., 1997), the 
disease burden score used here is well established within the field of HD research, 
and is more suited for determining the discrete progression of the disease than the 
UHDRS scales, which require subjective assessment of ambiguous probabilities and 
can suggest a false dichotomy between sick and well (Ross et al., 2014).  In a sample 
of pre-/early-manifest HD patients, including age and genetic burden better reflects 
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the progression of disease over the lifespan, and is thought to be more sensitive to 
the effects of therapeutic interventions, such as exercise.
Variations in the way ‘disease burden’ or ‘genetic burden’ is estimated have been 
more thoroughly explored in recent years, including slightly different modelling 
procedures (Paulsen et al., 2014; CAP = age × (CAG – 33.66)).  In a cohort of 1,078 
HD gene carriers from the multi-site PREDICT-HD study, it was found that a variety 
of outcome measures including cognitive performance on the STROOP test, 
putamen volume using MRI and total motor score (TMS) were strong predictors of 
disease diagnosis beyond that of CAG repeat length and age alone (Paulsen et al., 
2014). Incorporation of these outcome measures is recommended, to glean the most 
accurate estimate of disease severity in a patient sample.   Whereas STROOP 
scores, total motor scores and volumetric data was acquired within this thesis, due 
to time limitations it was not possible to statistically probe these predictive 
contributions in greater depth.  Future work will further explore the use of composite 
scores to probe the relationship between physical activity and disease progression 
and will also consider the importance of MRI biomarkers of cerebrovascular health 
for improving predictive accuracy.  
4.4.5. Conclusion
In this study, we could replicate a pattern of hypoperfusion that has previously been 
observed in pre-symptomatic HD patients using PASL as well as impoverished 
performance in a wide range of cognitive tasks of executive function.  It is likely that 
our results were more robust than those reported previously, where CBF has not 
been corrected for partial volume effects and would be a recommendation to future 
studies.  Our main question was to address the impact of fitness on 
cerebrovascular health in HD to assess whether it may moderate the effects seen 
in controls.  Implication of the most severely affected region, the left caudate, was 
observed, suggesting that fitness may moderate CBF differently in HD patients to 
controls.  This study is cross-sectional such as the effects of exercise should be 
treated with care. Since this is not the first time controversial effects of exercise 
have been observed, further research in preclinical HD mouse models is warranted, 
to assess the impact of exercise more directly upon caudate function and to rule 
out any detrimental effects.   In this study, perfusion within the putamen, caudate 
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and thalamus appeared to be the most associated with disease severity and 
cognitive function which is in line with the atrophy and functional connectivity known 
to occur within these regions. This is the first study to assess CVR in human HD 
patients, where hypo-reactivity was observed in patients.  Future work will aim to 
improve the robustness of this pipeline, to account for non-compliance to the 
breath-hold challenge itself. Assessing cerebrovascular reactivity using the breath-
hold task is a challenge due to the cognitive demand of following task instructions. 
Nonetheless, we observed similar performance between patients and controls.  
Thorough briefing and screening for chorea and cognitive function would likely 
overcome these issues. 
Chapter 5
153
Chapter 5
154
Chapter 5
Investigating the cerebrovascular effects of 
voluntary wheel running in pre-symptomatic 
Q175 HD mice: combining PASL MRI and 
immunohistochemistry.
Chapter Summary
Evidence from human (Wolf et al., 2011) and rodent (Cepeda-Prado et al., 2012) 
studies have shown differences in cerebral blood flow (CBF) and cerebral blood 
volume (CBV), respectively, using MRI prior to onset of any behavioural or cognitive 
impairments. In Chapter 3 we observed clear running related increases in vessel 
density in the striatum, the primary region known to be affected in Huntington’s 
Disease. In this study, we hypothesised that exercise may interact with 
cerebrovascular health in a knock-in mouse model of HD.  The present study sought 
to investigate early cerebrovascular differences in the Q175 HD mouse model prior 
to symptom onset, compared to wild-type littermates.  Thirteen male heterozygous 
Q175 mice and 18 WT controls (age 11 weeks) were scanned, using a flow-
alternating inversion recovery (FAIR) EPI MRI pulsed ASL sequence (TR = 5 secs, 
TI’s = 100, 200, 400, 600, 800, 1000, 1200, 1400, 1600, 1800, 2000, 2500, 3000ms, 
shots = 2, slice thickness = 1mm, matrix size= 128 x 96 mm, segments =2, slices = 
5, bandwidth = 300,000Hz) before (Time 1) and after (Time 2) a 6-week voluntary 
wheel running intervention.  Mice were singularly housed with (Q175; N=7) or without 
(Q175; N=6) a free-turning running wheel.  All mice were assessed on a balance-
beam at both time points to test for any clear motor or behavioural impairments.  
Q175 mice displayed a hyperactive behavioural profile at 11 weeks of age, according 
to running wheel activity and the time to climb (TTC) parameter, but no other 
behavioural or motor symptoms were observed on the balance beam as would be 
expected at this early stage in the disease lifespan of the Q175 model.  CBF was 
slightly higher in HD mice but this was not significant, and there was no clear effect 
of the running intervention on CBF measured in the striatum, motor cortex or 
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hippocampus.  Animals were culled after Time 2, and histology was performed to 
assess vessel density as described in Chapter 3 (Lycopersicon esculentum) and 
expression of the toxic mutant huntingtin protein (mHTT) using an S830 antibody.  
Vessel density did not appear higher in Q175 mice at this early disease stage 
(Drouin-Ouellet et al., 2015), nor did exercise appear to increase vascular density in 
WT mice.  We conclude that it may be too early to detect vascular changes in this 
mouse model and that vascular differences may have returned to baseline levels 
following a prolonged period of exercise cessation.  Although cerebrovascular 
deficits were not clear, a decrease in diffuse S830 staining for mHTT in running mice 
was observed, which is suggestive of an early benefit of exercise upon HD pathology 
(Harrison et al., 2013).
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5.1. Introduction
Evidence is accumulating that vascular dysfunction plays a pivotal role in the 
degeneration of the nervous system (Zacchigna et al., 2008) such that any 
abnormality occurring in the cerebrovasculature is likely to compromise neuronal 
integrity.  Even small changes in the cerebrovasculature are thought to be associated 
with various brain pathologies (Farkas and Luiten, 2001; Pantoni, 2010), from 
structural modifications, such as changes in vascular size, density, and morphology, 
to functional changes, such as altered perfusion and blood–brain barrier (BBB) 
dysfunction (Backman et al., 1997; Meyer et al., 2008).  In Chapter 3, we discuss the 
potential benefits of physical exercise on cerebrovascular health in healthy young 
mice, by increasing vascular density within regions known to be affected by 
neurodegenerative diseases, including the hippocampus, motor cortex and striatum.   
Whether exercise can preserve vascular health and ameliorate disease progression 
in a mouse model of Huntington’s Disease remains unclear, and will be the focus of 
the current study.
It has been shown in healthy rodents and humans, that exercise benefits general 
health and brain function (Hillman et al., 2008).  In rodents, running increases 
hippocampal neurogenesis, spine density, vascularization, neurotrophin levels, 
learning and long-term potentiation (Cotman et al., 2007; Neeper et al., 1996; van 
Praag et al., 1999a).  However, it remains unclear whether exercise is able to delay 
or prevent symptom progression in neurodegenerative diseases, such as 
Huntington’s Disease, where neurovascular health is jeopardized (Drouin-Ouellet et 
al., 2015).  To address this question, the use of rodent HD models has allowed 
researchers to look inside the brain in a way that is not possible in the living patient 
brain.
Physical exercise is a form of environmental enrichment, which is proven to have a 
number of beneficial effects upon neuronal health (van Praag et al., 1999b).  
Environmental enrichment has been shown in the R6/1 transgenic HD mouse model, 
to delay symptom onset and reduce striatal atrophy (van Dellen et al., 2000). In 
addition however, R6/1 mice who engage specifically in running wheel activity, show 
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normalization in some aspects of motor function such as rearing behaviour and 
delaying deficits in rear-paw clasping (Pang et al., 2006) with major benefits 
occurring in clinically relevant measures of cognitive function including spatial 
working memory in the Morris water maze and procedural and reversal learning on 
a T-maze (Harrison et al., 2013; Pang et al., 2006; van Dellen et al., 2008). Neuronal 
inclusion size has also been shown to differ in the R6/1 mouse model, where 
intracellular neuronal inclusions were larger in exercising mice than non-exercising 
mice (Harrison et al., 2013).  It has been hypothesized previously, that larger 
inclusion size represents a compensatory mechanism where intracellular inclusions 
are neuroprotective.  It seems therefore, that exercise can improve both underlying 
pathological and behavioural phenotypes of HD, but how this ties in with alterations 
in cerebrovascular health is unclear.
In Chapter 3 we addressed the question of whether fitness, as a surrogate measure 
of exercise, might mediate any differences seen in baseline cerebrovascular function 
using PASL MRI. MRI is an advantageous technique since it is non-invasive and can 
be repeatedly carried out in vivo, such that it is possible to scan the same subject 
multiple times to address the impact of an intervention.  In human patients, we are 
limited to the use of imaging techniques such as MRI and PET, where post mortem 
tissue is scarce and may not accurately reflect the state of the living tissue. A caveat 
of MRI is that it is not possible to visualise directly the small-scale changes such as 
molecular signalling and morphological cellular changes that are taking place.  Pre-
clinical MRI imaging of rodents, where subsequent post-mortem evaluation can be 
carried out, allows us the benefit or translating what we see with MRI to humans 
whilst unpicking the mechanisms taking place on a more microscopic level ex vivo.  
To understand the changes observed in Chapter 3 therefore, we decided to address 
the influence of voluntary running on cerebrovascular health in a mouse model of HD 
using both MRI and histology. 
Higher blood vessel density has been observed in a number of HD rodent studies 
compared to control mice (Cisbani et al., 2013; Cisbani and Cicchetti, 2012; Franciosi 
et al., 2012; Lin et al., 2013).  Other morphological changes have been reported 
include an increase in wall thickness and decrease in lumen diameter (Franciosi et 
al., 2012) and a dichotomy in the type of blood vessel itself.  For example, it has been 
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shown that while the number of microvessels increases in the R6/2 mouse model, 
the number of arteries is fewer than in WT controls (Lin et al., 2013). Where oxygen 
diffusion differs between arterioles, venules, and capillaries most oxygen diffusion 
occurs within the capillary bed and it is the perfusion signal from within the capillaries 
and pre-capillary arterioles within the metabolizing tissue which is thought to drive 
the CBF signal measured by ASL MRI (Hall et al., 2014). Whether an increase in the 
density of capillaries is a compensatory mechanism by which to maintain sufficient 
oxygenation of the surrounding tissues in HD is unknown, since a pathological 
decrease in the number of large blood vessels would presumably reduce 
macrovascular flow to downstream capillaries. How disease related differences in 
vascular morphology map onto cerebrovascular function, therefore requires the use 
of in vivo techniques such as MRI to complement those observed with histology. 
Use of structural MRI has increased in recent years to study animal models of HD 
and has proven capable of detecting subtle variations in brain volume (Bohanna et 
al., 2008; Cepeda-Prado et al., 2012; Lin et al., 2013; Rattray et al., 2013). However, 
functional MRI for detection of cerebrovascular function has not been widely 
implemented to study mouse models, owing partly to its limited spatial resolution.  
Studies, that have measured cerebral blood volume (CBV) using contrast agents in 
HD mouse models, tend to show an increase in blood volume compared to WT 
controls, even at an early disease stage prior to demonstrating signs of disease 
(Cepeda-Prado et al., 2012). CBV increases within regions, including the neocortex, 
striatum, thalamus and hippocampus over time in the R6/2 transgenic mouse line 
suggest metabolic changes (Cepeda-Prado et al., 2012) which could not be 
attributed to a focal loss of tissue, since rCBV was not related to tissue loss in the 
same regions.  Lin et al. (2013), compared early regional increases of rCBV to 
differences in microvascular morphology, and showed that both microvascular 
density (using immunohistochemistry) and small vessel volume fraction (extracted 
from 3DΔR2-μMRA images) were also increased from 7 weeks in an R6/2 mice 
compared to WT controls that continued to increase with age (Lin et al., 2013). The 
small vessel abnormalities detected in this study suggest that this could be an 
authentic feature of HD.  Furthermore, the early onset of such abnormality in the 
brains of these HD mice suggest that imaging cerebrovasculature with MRI, 
independent from brain structure, could serve as a biomarker for detecting, as well 
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as providing a surrogate marker for detecting the benefits of therapies, including 
drugs and/or other interventions such as voluntary wheel running. 
Despite a mounting appreciation of the importance of the cerebrovascular changes 
in HD, there has only been one study to explore differences in cerebral blood flow 
non-invasively in the brains of HD mice using PASL.  In that study (Hsiao et al., 2015) 
flow alternating inversion recovery (FAIR) PASL was used to assess blood flow in 
response to a 5% CO2 (carbogen) challenge and revealed impaired CVR in HD R6/2 
suggestive of impaired cerebrovascular regulation and vasodilatory capacity, despite 
increases in angiogenesis.  Cerebral blood flow studies offer a more informative 
measure of physiological and metabolic function than changes in relative CBV, which 
require administration of an exogenous contrast agent, such that measurements can 
also be influenced by impaired blood brain barrier function and require complex 
assumptions in modelling.
In the present study, we aimed to measure resting CBF in anaesthetised animals, 
before (MRI 1) and after (MRI 2) a 6-week running intervention in a sample of young 
adult mice (aged ~11 weeks), comparable to those used in Chapter 3.   In addition 
to resting state measurements of CBF, we also subjected mice to a CO2 challenge  
in which inhalation gas was switched from medical air to 95% medical air and 5% 
CO2 at Time 2 to assess whether vascular reactivity was diminished in HD mice, as 
reported previously (Hsiao et al., 2015).  In contrast to the transgenic R6/2 model 
used in their study, the present study used the Q175 mouse model (zQ175).  This 
knock-in line has been shown to exhibit both motor and cognitive signs earlier in the 
lifespan than other KI lines such as the Q150 or Q111 strain, the repeat length of 
which are much shorter.  It is thought that this animal model is more representative 
of HD in humans from genetic, neural, and behavioural aspects since both 
homozygous (Q175+/Q175+) and heterozygous (Q175+/Q175-) mice exhibit first 
signs of motor symptoms from 3-4 months and behavioural deficits by 8 months of 
age, with a slow disease progression such that the symptom onset is thought to 
reflect the human condition more closely (Menalled et al., 2012).  The gradual 
symptom development also means that this strain is ideal for longitudinal 
investigations of pre-symptomatic therapies.
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Like studies reported previously, we aimed to relate any genotype differences in CBF 
to differences in histological measures including vessel density and number of mHTT 
inclusions.  We were interested in whether voluntary wheel running prior to the onset 
of cognitive or motor deficits would moderate these previously reported differences 
in HD mice. In the present study, we attempted to address functional differences in 
microvasculature in the Q175 knock-in mouse model of HD by measuring CBF and 
CVR, non-invasively, using MRI and combining this with histological differences in 
vessel density, balance beam performance and expression of the mutant huntingtin 
(mHTT) protein following a six-week exercise intervention.
5.2. Methods
5.2.1 Animals
Thirteen male heterozygous Q175 mice congenic to a C57BL/6J background and 18 
wild-type littermates, aged 11.5 (±0.3) weeks at the start of testing were chosen for 
the present study (Menalled et al., 2012).  Generation of the Q175 knock-in mouse 
line has been reported previously (Menalled et al., 2012) and was chosen for the 
present study due to the temporal profile of behavioural and pathological changes, 
in which we wished to 1) closely match the age of mice to the young adult cohort 
used in Chapter 3 and 2) are thought to analogously match the asymptomatic/pre-
symptomatic patient cohort used in Chapter 4. Neurodegeneration, according to 
histological measures of striatal / cortical volume, ventricle size and MSN counts, is 
not typically evident in this mouse model until 12 months of age (G. A. Smith et al., 
2014). A homogenous male sample was chosen in order to reduce gender 
differences in activity patterns, thought to vary with oestrous (Basterfield et al., 2009).  
The Q175 mice in this study carried between 188 and 210 (mean = 199) CAG repeats 
and were bred, tail-tipped and genotyped.  All genotyping was performed by Laragen 
Inc. using probe based qPCR to generate the length of the CAG repeat on both 
chromosomes.
Mice were individually housed to minimise the risks of fighting because of prolonged 
separation after scanning, and to gain individual recordings of running activity within 
the cage.  Mice were housed in temperature-controlled climate rooms under a 12-h 
light/12-h dark cycle (lights on at 8:00 am) and given free access to water and food 
Chapter 5
161
throughout the experiment.  Mice were weighed weekly to control for changes in body 
weight.  All procedures were run in accordance with the United Kingdom Animals 
(Scientific Procedures Act of 1986), and subject to local ethical review.  All mice 
survived until the end of the study.  
5.2.2 Behaviour
5.2.2.1. Voluntary wheel running
Identical procedures to that reported in Chapter 3, were used in the present study. 
To investigate the effects of exercise, mice were housed in large standard mouse 
cages equipped with a free-standing running wheel (ENV-044 Mouse Low-Profile 
Wireless Running Wheel, Med Associates Inc.; 37.82cm circumference, 25° from 
horizontal plane).  Wheel running activity was recorded via a wireless transmitter 
system that signalled to a hub located in the same animal holding room. Wireless 
Running Wheel Manager Data Acquisition Software (SOF-860; Med Associates Inc.) 
recorded and time-stamped each wheel rotation for subsequent analysis.
All mice had unlimited access to a running wheel for 7 days a week over 6 weeks.  
Whilst exercising mice (Het = 7; WT = 9) could run freely on the wheels, mice in the 
control condition (Het = 6; WT = 9) had wheels that were fixed in position to avoid 
any confounding influence of environmental enrichment provided by the wheel.  
Wheel access was uninterrupted during the following weeks except for removal 
during the administration of BrdU injections on the second week as well as weekly 
health checks and animal maintenance to limit enrichment introduced by excessive 
handling.
5.2.2.2. Balance beam
The balance beam apparatus was set up as described previously (Harrison et al., 
2013). A tapered balance beam was used (1.5 cm to 0.5 cm) with a ledge 2cm below 
the running surface along the length of the beam to prevent the animals from falling, 
and to aid in the identification of foot-slips (Schallert, 2006). The beam was 1m in 
length and angled at 17°with the start point 15cm from the lower end and a goal box 
at the high end, where the end was marked 10 cm from the top (figure 5.1). 
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Methods were adapted from those described by Harrison et al., (2013) whereby 
animals were trained for two days followed by testing on two trials, on the two 
subsequent days. On training Day 1, animals were initially acclimatised to a box at 
the top of an inclining beam for 30s before being removed and placed in position 1. 
Distance away from the house box was gradually increased (positions 2-4) until the 
animal was at the start area of the beam (position 5), whereby the animal was 
encouraged to traverse the beam until it could enter the box. Where animals stayed 
still for a prolonged period, they were encouraged to keep moving by touching their 
flank.  Finally, animals were positioned at the bottom of the incline, facing away from 
the box.  To reach the box, animals were required to turn around before climbing up 
towards the box.  After 10 seconds respite inside the box, animals were encouraged 
to traverse from 3 positions, incrementally further down the beam until the subject 
was comfortable traversing the entire length of the beam. Training Day 2 consisted 
of 2 trials where the animal was placed facing away from the ‘house’ box and needed 
to turn around and traverse the beam to enter the ‘house’ box at the top.
Training took place at the beginning of the experiment, followed by 2 days of testing 
at the pre- and post-exercise time-points.  Training was not repeated prior to the 
second (post-exercise) time-point.  On each test day, animals were given one 
practice run, followed by two experimental trials, separated by ~5 minute intervals. 
Ability (counting any foot slips) and speed to traverse the beam were recorded as 
measures of motor function, balance and coordination and time to turn 180° on the 
beam were used as a measure of motor initiation. Time-to-turn (TTT), time to climb
(TTC), as well as front and back paw foot slips were recorded as described previously 
(Brooks et al., 2012).  One side was scored live and the other video recorded for 
subsequent bilateral scoring.  Experimenters were blinded to subject condition.
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Animals were assigned to experimental condition according to performance on the 
first balance beam session, by ranking animals and assigning alternate animals to 
the running or non-running condition, to remove bias towards one condition in terms 
of behavioural performance.
5.2.3 BrdU Administration
Identical procedures were used to those described in Chapter 3.  After one week of 
habituation to the wheel, i.p. BrdU injections (50µg/g; Sigma) were carried out at the 
same time daily (11:30-12:30) for 5 days as described previously (Creer et al., 2010b) 
during the second week of wheel exposure.  BrdU data is not presented here due to 
time constraints.
5.2.4 Magnetic Resonance Imaging
5.2.4.1. Experimental Procedure
All animals were scanned twice, once at baseline and once following 6 weeks of 
wheel exposure.  At 11 weeks old, all 31 animals underwent a single baseline scan 
session (~45mins), followed by a second scan after 6 weeks of wheel exposure. 
Figure 5.1 Balance beam apparatus used for testing and training schedule.
A) The balance beam apparatus was constructed from wood painted black, with a 
goal ‘house’ located at the top of the beam. During training animals were initially 
placed at position 1 and encouraged to traverse the beam and enter the house 
located at the top. Mice were subsequently placed further down the beam (positions 
2, 3, 4 and 5) and similarly encouraged to run along the beam to enter the house 
at the top. (B) Time to climb was recorded as the time in which the back feet crossed 
the white line before entering the house.
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Scanning took place three days after exercise cessation to avoid measuring acute 
exercise-related effects (figure 5.2). 
5.2.4.2. MRI setup
Magnetic resonance imaging was performed with a 9.4 Tesla small bore (20 cm) 
Bruker Biospin system (Ettlingen, Germany) at EMRIC, Cardiff University.  A transmit 
1H 500W echo-planar imaging (EPI) volume coil was used along with a 4-channel 
array receive-only surface coil (Rapid Biomedical).  ParaVision software (version 5.0, 
Bruker Biospin) was used for data acquisition. Mice were anesthetized under 4% 
isofluorane in medical air (flow rate at 1L/min) and maintained at 1.8% throughout 
perfusion imaging.  Animals were free breathing for the duration of scanning. Core 
temperature and respiration rate were monitored using a rectal probe and pressure 
pad (SA Instruments, Stony Brook, NY, USA) respectively. Core temperature was 
maintained at ~36° C to 37°C using heated water tubing through the bed and a warm 
air blower with feedback system fed into the scanner bore (SA Instruments).  Image 
analysis was performed using FSL (FMRIB Software Library, Oxford, UK) and AFNI 
(Cox, 1996) software packages.
5.2.4.3. Resting Cerebral Blood Flow (CBF) 
To quantify cerebral blood flow, a flow-alternating inversion recovery (FAIR) EPI 
PASL scan was carried out (TR = 5 secs, TI’s = 100, 200, 400, 600, 800, 1000, 1200, 
1400, 1600, 1800, 2000, 2500, 3000ms, shots = 2, slice thickness = 1mm, matrix 
size= 128 x 96 mm, segments =2, slices = 5, bandwidth = 300,000Hz) such that 13 
images with increasing TI were obtained per slice, allowing determination of T1.  
Images with slice selective inversion were acquired, followed by those with a non-
Figure 5.2  Experimental design. Baseline MRI measurement and balance beam 
was assessed prior to wheel exposure for 6 weeks. Follow up MRI and Balance 
beam performance was measured after 3 and 5 days of wheel deprivation 
respectively.
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selective inversion, from which their respective T1  was calculated, using a non-linear 
least square fit (Leithner et al., 2008).  The total time for CBF measurement was ~10 
mins.  
CBF was quantified as described elsewhere (Leithner et al., 2008) on the basis of 
equation 2.1, with modification of the Bloch equation to include blood flow effects 
(Detre et al., 1992).
Equation 2.1
Where T1 is tissue T1, T1app is T1 in the presence of flow and λ is the brain blood 
partition coefficient of water. In a pulsed ASL experiment with nonselective inversion, 
it is considered that measured T1 reflects “true” tissue T1 and with slice selective, 
inversion measured T1 becomes T1app (Kwong et al., 1995).  Assuming a λ value of 
0.9 (Herscovitch and Raichle, 1985), CBF can therefore be quantified using equation 
2.2.
Equation 2.2 
Voxel-wise CBF was then averaged over ROI masks using FSL software, and 
median CBF values recorded per ROI to reduce the impact of outliers.  CBF 
estimates were calculated across two masks per ROI, created by each of the two 
experimenters.  CBF estimates within each ROI were averaged across 
experimenters and these values were used as the measure of interest.   
5.2.4.4. Cerebrovascular reactivity (CVR) 
To measure cerebrovascular reactivity, the FAIR ASL sequence was modified to 
include a single inversion time, such that image acquisition duration was shorter and 
thus changes in CBF in response to hypercapnia could be detected with greater 
temporal resolution.   Baseline acquisition was carried out for 5 minutes before the 
inhaled gas mixture was switched from 100% medical air to 95% medical air and 5% 
CO2 for 5 minutes.  Hypercapnic blocks were repeated twice, separated by 15 
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minutes of breathing medical air such that animals had time to recover from the 
previous challenge (TR = 3500ms, TI = 1500ms, shots =2, segments = 2, slice 
thickness = 1mm, matrix size = 128 x 96, voxel size = 0.17 x 0.17 x 1mm, slices = 5, 
bandwidth = 300kHz).  
The entire time-series were separated into selective and non-selective images and 
a simple subtraction performed, such that the difference in signal was related to the 
relative change in CBF on a voxel-wise basis.  Average rCBF values were recorded 
during the two hypercapnic (10 volumes x 2) and three normocapnic (10 volumes x 
3) periods, ignoring the first and last volumes to avoid noise introduced by gas-
switching. Relative CBF values for each block were computed on a voxel-wise basis 
and ROI masks of the striatum, hippocampus and M1 were applied as described 
above, to create an average rCBF for each ROI per block.  Median values were used 
to since mean values may be skewed by outliers where SNR is low. The normocapnic 
and hypercapnic blocks were then averaged together respectively, such that 
percentage change values could be calculated for estimating CVR in response to the 
CO2 challenge (Equation 2.3).
Equation 2.3 CVR = 
5.2.4.5. Regions of Interest
ROI’s were defined by two independent, blinded assessors (myself and an 
undergraduate research student).  All masks were drawn using FSL upon the raw 
non-selective images, where contrast was good enough to identify anatomical 
landmarks.  Bilateral hippocampi were drawn on the 2nd slice (located between -
1.34mm and -2.8mm from bregma), whilst masks of the motor cortex (M1) and 
striatum were drawn on the 4th slice acquired for each animal (+1.18mm and -
0.26mm from bregma) (figure 5.3).  Hippocampal masks were drawn ventral to the 
corpus callosum and constrained between the third and lateral ventricles to avoid 
contamination of the signal by CSF.  Striatal masks were drawn ventral to the corpus 
callosum, whereby the mask did not exceed the length of the lateral ventricle.  Square 
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shaped M1 masks were positioned above the corpus callosum, above the cingulum 
bundle.  
5.2.5 Histology and Immunohistochemistry
5.2.5.1.
5.2.5.2. Tissue Preparation
Animals were deeply anaesthetised with 0.02ml sodium pentobarbital (Euthatal) and 
perfused trans-cardially with PBS, followed by heparin ~110ml 4% paraformaldehyde 
(PFA), in 0.01M PBS at pH 7.4 at a flow rate of ~23ml/min for 5mins.  Brains were 
post-fixed for 5h followed by equilibrium in 30% sucrose. Tissue was sectioned 
coronally at a thickness of 40 μm on a freezing microtome (Leica).  A thickness of 40 
μm has been recommended previously in order to obtain reliable 3D information 
about the vascular tree for quantification (Wälchli et al., 2014).  Free-floating sections 
were stored as a 1:12 series in cryoprotectant solution and stored at −20°C until 
staining. 
5.2.5.3. Blood Vessel Visualisation and Quantification
Identical immunofluorescence parameters were used to those described in Chapter 
3.  Lectin staining (Lycopersicon esculentum; Vector) was used to visualize blood 
Figure 5.3 ROI mask placement overlayed on an example non-selective image from 
one mouse. Manually drawn ROI’s were carried out by two independent 
experimenters.  Representative slice location can be seen for the hippocampus 
positioned ~-1.34mm of bregma (left) and the motor cortex and striatum positioned 
~+0.86mm of bregma (right).  Masks were drawn on example raw non-selective 
images prior to CBF quantification from a single subject due to the higher image 
contrast.
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vessels as described previously (Creer et al., 2010b) where group differences in 
blood vessel density was used as a surrogate measure of angiogenesis (See 
Chapter 3 for methods). 
Quantification procedures were identical to that described in Chapter 3.  To 
investigate whether exercise alters angiogenesis in the HD brain, blood vessel 
density was calculated within the dorsal striatum, dorsal hippocampus and M1. 
Repeated measures ANOVA within sub-regions of the striatum (Dorsal SVZ x Ventral 
SVZ x Caudate Putamen) and hippocampus (Dentate Gyrus x CA1) were performed 
with Running and Genotype as the between-subject variables.  The M1 was not 
divided into sub regions.  
5.2.5.4. Mutant Huntingtin (mHTT) Visualisation and Quantification
Prior to immunohistochemistry, tissue sections were placed in TBS (pH 7.4) and 
washed three times, for 5 min. Pre-treatment with an antigen retrieval method was 
performed as described previously (Bayram-Weston et al., 2016) by incubation in 
citrate buffer (pH 6) for 20 min at 95C for 5minutes at room temperature. 
Endogenous peroxidase activity was inhibited by incubation in methanol containing 
3% H2O2 (VWR International, UK) for 5 min and non-specific binding sites were 
blocked with 3% horse serum in TBS for 1 h.  Sections were incubated with S830 
(Prof.G Bates, King's College, London University; 1: 20,000 concentration) in TXTBS 
containing 1% horse serum) overnight at room temperature (21°± 2°C), after which 
they were washed three times in TBS (3 x 5mins).  Sections were incubated in 
secondary antibody (raised in horse, anti-goat; Vector Laboratories) at a 1:200 
concentration for 2h at room temperature. Following several washes in TBS, the 
sections were incubated with a biotin-streptavidin kit according to the manufacturer’s 
instructions (Vector Laboratories) and rinsed three times in TBS. Peroxidase activity 
was visualized with 3,3’-diaminobenzidine (DAB; Sigma-Aldrich), and sections 
mounted on gelatin-coated slides, prior to dehydration and cover-slipping as 
described above.
Two-dimensional stereological quantification was conducted using Visiopharm 
Integrator System (VIS, version 4.4.6.9) software on an Olympus BX50 microscope 
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(Olympus Optical Co. Tokyo, Japan) with PC-based image analysis software 
(Olympus C.A.S. T. grid system v1.6.). Quantification was carried out as described 
previously (Bayram-Weston et al., 2016). 
For each mouse, counts were formed on a 1:12 series, such that between 3 striatal 
(bilateral) sections per mouse were imaged at 1.25 X magnification upon which 
outlines were manually drawn around the striatum of each hemisphere. Defined 
striatal sections were then sampled systematically, such that ~150 cells were 
counted per brain, which equated to ~14 samples per hemisphere. Cells were 
counted at a 100 X magnification (oil), within a 2D optical dissector 285µm2 counting 
frame.  Cell diameter was established by measuring the longest and shortest 
diameter and computing the average.  For consistency and to reduce bias, this was 
performed on the first cell counted within the first counting frame of each section. A 
representative image of the counting can be seen in figure 5.4. Cells located within 
the frame and all those touching the green lines were included in the count, whereas 
cells that touched either of the red lines were excluded. 
Affected cells were identified and the total numbers estimated in terms of positive 
immuno-reactive-labelling. Due to the young age of the subjects, we expected more 
diffuse staining.   Affected cells were further categorized in terms of whether they 
expressed 1) Diffuse nuclear staining alone 2) Frank nuclear inclusion bodies (IB’s) 
with additional diffuse nuclear staining 3) Frank IB’s without diffuse staining. For each 
section, one diffuse cell and one extracellular aggregate was systematically 
measured in size (length x width).
The total number of cells (C) in each striatal section was calculated using the 
equation 2.4.
Equation 2.4 C = Ʃc x (ƩA x (Ʃn x a)) x f
C = estimated total number of cells, Ʃc = total number of cells counted, ƩA = sum of 
all striatal areas, Ʃn = total number of frames allocated to the included striatal area, 
a = area of sampling user grid (285µm2), f = frequency of sectioning
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An Abercrombie correction factor was then applied to the total number of calculated 
cells using equation 2.5:
Equation 2.5 aC = C x (ST /(ST+D) (Abercrombie, 1946)
aC = Abercrombie corrected cell count, C = estimated total number of cells, ST = 
section thickness, D = cell diameter.
Figure 5.4 S830 counting methods for mHTT quantification. Representative image 
of stereological analysis conducted in Visiopharm Integrator System (VIS) software. 
The 285µm2 counting frame can be seen in the centre of the image. Cells located 
within the counting frame and not touching the red lines were counted as diffusely 
stained cells (letter ‘A’) and those that also possessed nuclear inclusion bodies (IB’s) 
were counted separately (letter ‘B’). Extracellular aggregates were also counted 
(letter ‘C’). 
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5.3. Results
5.3.1. CAG repeat length 
CAG repeat length is known to be positively related to disease burden and rate of 
progression.  Average number of CAG repeats did not differ between the running 
group 198.4 (±6.7) compared to the non-running group 198.8 (±6.5) such that CAG 
repeat length is unlikely to influence the interpretation of the group differences 
reported here.
5.3.2. Body Weight
All animals showed an increase in body weight over the duration of the experiment 
(TIME = F (1,27) = 5.06, p<0.001, partial η2= 0.37, figure 5.5).  Non-running mice 
gained weight to a greater degree than running mice (Running x Time; (F (1,27) = 
2.63, p=0.16, n.s., partial η2= 0.09) regardless of genotype. A significant interaction 
between genotype and running was observed (Genotype x Running; (F (1,27) =6, 
p=0.02, partial η2= 0.18), whereby WT mice differed more because of wheel 
exposure than HD mice. Nonetheless, an interaction including a repeated measure 
of time was not significant (Running x Genotype x Time; F (1,27) =0.24, p=0.63, n.s., 
partial η2= 0.01), suggesting that this relationship was an inherent group related 
difference and could not be attributable to the exercise intervention itself. 
Figure 5.5  Body weight change 
following intervention. Non-
runners increased in body weight 
more than running animals but 
this was not significant. There was 
no difference between weight 
change in HD mice compared to 
WT mice over time. Mean ± 
S.E.M.
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5.3.3. Behavioural Data
5.3.3.1. Weekly running wheel activity
On average, Q175 HD mice ran approximately 30% more (Mean = 533,125, SD = 
156,238.73) than WT mice (Mean = 382,981.30, SD = 286,326.034; figure 3.2), but 
a one-way ANOVA revealed that this group difference was not significant (F (1,15) = 
1.58, p=0.23, n.s, partial η2= 0.1).
5.3.3.2. Balance Beam 
HD mice did not appear to be obviously impaired on any aspects of balance beam 
performance compared to wild type animals (figure 5.7).  
Time to climb the balance beam revealed a borderline significant interaction effect 
(Time x Genotype; F (1,27) = 4.30, p<0.05, partial η2= 0.14).  Simple comparisons 
revealed that HD subjects climbed faster than WT mice at baseline, an effect that 
was no longer significant after 6 weeks.   There was no influence of running on this 
effect (Time x Running X Genotype; F (1,27) =0.15, p=0.70, n.s., partial η2= 0.01) 
such that this difference was not attributable to the running intervention, and is likely 
to be due to a disease phenotype progression over the 6 weeks. 
No effect of Time, Running or Genotype was found to significantly influence time to 
turn on the beam (p values >0.05), although in general time to turn around appeared 
to be faster at the 6-week time-point (Time; F (1,27) =1.6, p=0.21, partial η2= 0.06)
but this was not significant.
Figure 5.6 Running wheel activity over 6 weeks in Q175 mice and wild-type 
controls. HD mice (N=7) ran more overall (right) than WT mice (N=10; left), but 
this was not significant (p>0.05). Mean ± S.E.M.
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No clear trend was observed in the number of front foot-slips made by the animals, 
where number of foot slips made was minimal across trials at this age (p 
values>0.05).   More apparent trends could be observed in the back-foot slips made, 
where all animals seemed to slip more at 0 weeks than at 6weeks, which is likely due 
to a practice effect (Time; F (1,27) =6.00, p=0.02, partial η2= 0.18). HD animals 
appeared to produce fewer foot-slips than WT controls, although this did not meet 
significance (Genotype; F (1,27) = 2.40, p=0.13, partial η2= 0.08).
5.3.4. Baseline CBF Data
5.3.4.1. Data Quality
Prior to averaging across experimenters, data quality was assessed by removing 
outliers that exceeded rCBF estimates >2 SD’s from the group mean. Following 
outlier removal, CBF data was averaged across experimenters such that there was 
just one rCBF value per scan, per ROI, per subject.  Where noise was consistent 
across experimenters, this meant that there was missing pre-exercise data in the 
Figure 5.7 Group differences in balance beam performance.  Balance beam 
performance before (blue bars) and after (red bars) 6-weeks of wheel exposure in 
HD (Q175) mice compared to wild type (WT) controls. Bars indicate mean values 
over 4 experimental trials. Mean ± S.E.M.
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hippocampus for two subjects and motor cortex for one subject.  Two subjects had 
to be removed from the within-subject analysis because data for their pre-exercise 
scan was acquired with incorrect parameters.
5.3.4.2. Genotype differences in CBF at baseline
We initially wanted to assess whether a baseline difference in rCBF existed between 
HD and WT mice prior to any exercise intervention at 11 weeks of age.  In all regions 
of interest Q175 had very slightly higher baseline CBF than the WT mice and this 
was most prominent in the striatum (figure 5.8). Statistical differences between group 
were not found however, in the striatum (F (1,26) = 0.16, p=0.69, n.s., partial η2= 
0.06), hippocampus (F (1,24) = 0.01, p=0.92, n.s., partial η2< 0.001) or M1 (F (1,25) 
= 0.02, p=0.88, n.s., partial η2= 0.001). 
5.3.4.3. Regional differences in CBF at baseline
CBF differed significantly across regions (figure 5.8) with highest rCBF values 
detected in the motor cortex (Mean= 230ml/100g/min; SEM=4.3) and lowest in the 
hippocampus (Mean= 175.7ml/100g/min, S.E.M = 3.3ml/100g/min; ROI; F (2,42) = 
56.6, P<0.001, partial η2= 0.73).  Post hoc tests revealed significant FDR-corrected 
CBF differences between each region (q<0.017).  No interactions were found 
between CBF and Genotype across these regions (ROI x Genotype; F (2,42) = 0.57, 
p=0.57, n.s., partial η2= 0.03).
Figure 5.8 Genotype differences 
in regional CBF. CBF differences 
between Q175 and WT groups 
was not evident at 11 weeks of 
age in the primary motor cortex 
(M1), Hippocampus and 
Striatum. Mean ± S.E.M.
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5.3.4.4. Regional rCBF differences following 6-weeks wheel exposure
Absolute rCBF was quantified within manually drawn ROIs, and averaged across 
experimenters.  A repeated-measures ANOVA was performed with TIME (baseline 
vs 6weeks) and ROI (striatum vs hippocampus vs M1) as within-subject factors and 
Genotype and Running as between-subject factors.  
As can be seen in figure 5.9., an apparent, but non-significant decrease in CBF was 
seen after 6 weeks (Time; F (1,21) = 3.40, p=0.08, n.s., partial η2= 0.14), however, 
this did not vary between HD and WT groups (Time x Genotype; F (1,21) = 1.38, 
p=0.25, n.s., partial η2= 0.06) or in runners compared to non-runners (Time x 
Running; F (1,21) = 1.40, n.s., p=0.25, partial η2= 0.06), suggesting that a change 
over time could not be attributed to genotype or the effects of running.  Exercise did 
not affect HD mice differently to WT animals after 6 weeks of wheel exposure (Time 
x Running X Genotype; F (1,21) = 1.60, p=0.22, n.s., partial η2= 0.07) although a 
significant interaction between ROI and Time was observed (F (2,42) = 5.7, p=0.006, 
partial η2= 0.22) whereby post hoc t-tests revealed that the decrease in CBF was 
driven primarily by decreases in the hippocampus over time (t (25) = 5.6, p =0.002). 
5.3.4.5. The effects of a dose response of wheel running on rCBF.
Pearson’s correlations were carried out on regions independently, to assess whether 
total number of rotations could predict rCBF in running HD and WT animals. As can 
be seen in figure 5.10, there was no evident relationship between the total number 
of rotations and rCBF in the hippocampus (WT (r (10) = 0.03, p=0.94, n.s.); HD (r (7) 
=-0.37, p=0.41, n.s), striatum (WT (r (10) =0.44, p=0.20, n.s.); HD (r (7) = 0.07, 
p=0.87, n.s.) or motor cortex (WT (r (10)=0.15, p=0.68, n.s.); HD (r (7)=0.20, p=0.66, 
Figure 5.9  Regional CBF (rCBF) differences across the hippocampus, M1 and 
striatum in running vs. non-running HD mice compared to WT controls. Coloured 
bars represent CBF values before and after 6-weeks of wheel exposure in the home 
cage. Mean ± S.E.M.
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n.s.) although the strongest decoupling could be seen in the hippocampus, where 
running was negatively correlated with rCBF in HD mice.  
5.3.5. Physiological monitoring
5.3.5.1. Anaesthetic Dose
Isofluorane dose was targeted at 1.7% for the first scan but was adjusted to achieve 
stable physiological readings. Isofluorane dose was adjusted on a subject-by-subject 
basis, to ensure that isofluorane was consistent across scans to achieve within-
subject repeatability.  A repeated-measures ANOVA was performed to ensure that 
dose did not differ between Genotype or Running.  Mean dose was 1.73±0.08% 
during the first scan and 1.74±0.1% during the second scan (Table 5.1).  There was 
not a significant dose difference between scans (Time; F (1,25) = 0.40, p=0.53, n.s., 
partial η2= 0.02), nor did dose vary between Genotype x Time (F (1,25) =0.33, p=0.57, 
n.s., partial η2= 0.01) or Running x Time (F (1,25) =2.6, p=0.12, n.s., partial η2= 0.10). 
Individual physiological parameters were explored using repeated measures 
ANOVAs and can be seen in Table 5.1. 
Figure 5.10 Regional dose relationships between running distance-CBF and running 
distance-vessel density. Dose response relationship between voluntary wheel 
running and cerebral blood flow (CBF) as measured with FAIR-EPI pASL (top row) 
and blood vessel density as measured using tomato lectin staining (bottom row) in 
the hippocampus, striatum and motor cortex (M1). 
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5.3.5.2. Temperature
As can be seen in Table 5.2, average temperature was ~37C in all groups.  There 
was no main effect of temperature between scans (F (1,25) =2.35, p=0.14, n.s., 
partial η2= 0.09).  No significant interactions were found between Running (F (1,25) 
= 0.25, p=0.14, n.s., partial η2= 0.01) or Genotype (F (1,25) = 2.4, p=0.14, n.s., partial 
η2= 0.09) across the pre- and post- exercise sessions.
5.3.5.3. Pulse Rate
Average pulse rate was slightly higher during Scan 1 519 (± 40) bpm than during 
Scan 2 500 (± 65), although data during scanning was very noisy. There was no 
difference in pulse rate (F (1,25) =0.90, p=0.18, n.s., partial η2= 0.07) between scans, 
although it was slightly more variable in Scan 2, possibly due to the prospective 
targeting of anaesthetic dose.  No difference was observed in pulse rate between 
Running (F (1,25) = 1.10, p=0.30, n.s., partial η2= 0.04) or Genotype (F (1,25) = 0.26, 
p=0.62, n.s., partial η2= 0.01) across the pre- and post-exercise sessions.
5.3.5.4. Respiration
There was not a significant main effect of Time on respiration (F (1,25) =2.7, p=0.11, 
n.s., partial η2= 0.10).  Non-significant interactions with RUNNING (F (1,25) =2.5, 
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p=0.13, n.s., partial η2= 0.06) and Genotype (F (1,25) =1.7, p=0.21, n.s., partial η2= 
0.06) suggest there were no differences between experimental groups.
5.3.5.5. Effect of depth of anaesthesia on rCBF
Depth of anaesthesia is known to influence vasodilation in the brain as well as 
subsequent CBF.  The relationships between regional CBF values and physiological 
parameters including mean temperature, isofluorane dose, respiration rate and pulse 
rate recorded during pre-exercise and post-exercise scans, were tested using 
Pearson’s correlation. No relationship was found between rCBF and anaesthetic 
dose, temperature, respiration or pulse rate during Scan 1 or Scan 2 (p values >0.5), 
in the M1, hippocampus or striatum.  For this reason, these factors were not included 
as covariates in any further analyses.  
5.3.6. Cerebrovascular Reactivity
CBF measurements displayed low SNR, such that an obvious increase in CBF 
following onset of the CO2 challenge was not apparent. Out of 31 subjects 9 subjects 
showed a decrease in CBF in the motor cortex, 17 in the striatum and 13 in the 
hippocampus. Where CO2 is a potent physiological stimulus, CBF is expected to 
increase CBF regardless of genotype and thus the present results were unexpected.
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There was no interaction between HD status or running condition in any of the three 
regions (Genotype x Running, p>0.05), however within the striatum there appeared 
to be a genotype difference, whereby HD mice showed a positive elevation in CVR 
where WT animals showed a decrease (Genotype, F (1,27) =3.13, p=0.09, n.s., 
partial 2=0.10).  There was no main effect of genotype or running in any other 
regions (p>0.05).   CVR levels were greater within the motor cortex than in subcortical 
regions (F (2,40) = 6.20, p = 0.01, Greenhouse-Geisser corrected for violation of 
sphericity).
5.3.7. Vascular density
5.3.7.1. Sub-regional Analysis
Striatum. Visual inspection revealed that vascular density was higher in wild type 
animals than controls, however no obvious difference was apparent between running 
and non-running animals.  This trend can be seen in figure 5.12, however statistical 
inference found no main effect Genotype (F (1,26) = 0.76, p=0.39, n.s., partial η2= 
0.03), nor an interaction with running (Running x Genotype; F (1,16) =0.012, p=0.91,
n.s., partial η2< 0.01) as hypothesised. There was also no overall effect of running 
(Running; (F (1.26) = 0.45, p=0.52, n.s., partial η2= 0.20).  There was however, a 
significant main effect of Sub region (F (2,52) = 5.1, p=0.01, n.s., partial η2= 0.16), 
whereby paired t-tests revealed that on average the dorsal sub-ventricular zone 
(DSVZ) had a higher vascular density than the caudate putamen (CP; t (29) = 2.8, 
Figure 5.11 Genotype differences in CBF CVR between running and non-running 
mice. Cerebrovascular reactivity was quantified as percentage change in CBF to a 
5% CO2 elevation in inhaled CO2. Response to hypercapnia was not consistent 
across animals. Variation across the group and across regions was high.  Mean ± 
S.E.M.
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p=0.007) and the ventral sub ventricular zone (VSVZ; t (29) = 2.3, p=0.03), with an 
average increase of ~7%. 
Hippocampus. Within the hippocampus, vessel density was greater in the CA1 
region of the hippocampus than the dentate gyrus (Sub region; F (1,25) = 11, p= 
0.003, partial η 2 = 0.3), a difference which was not observed in Chapter 3.  Vessel 
density did not differ within the DG, however HD animals had a greater vessel density 
in the CA1 than WT controls (Sub region x Genotype; F (1,25) = 5.4, p=0.03, n.s., 
partial η 2 = 0.18) irrespective of running. There were no differences between HD and 
control animals (Genotype; F (1,25) = 0.44, p=0.51, n.s., partial η 2 = 0.02).  Running 
related differences were evident in WT mice compared to HD mice, whereby runners 
seemed to have a reduced vessel density compared to non-runners across both DG 
and CA1, whereas HD animals showed no difference in vessel density because of 
running (figure 5.12).  This did not however, reach statistical significance (Running X 
Genotype; F (1,25) = 2.60, p= 0.12, n.s., partial η 2 = 0.09).  
Motor cortex. Only one ROI was imaged within the motor cortex.  As can be seen in 
figure 5.12, there was no interaction present to reflect a genotype moderating effect 
of running on vessel density (Genotype x Running; F (1,24) = 0.94, p=0.76, n.s., 
partial η 2= 0.04; figure 5.12). Furthermore, there was no clear difference in vessel 
density between running and non-running animals (Running; F (1,24) = 0.0, p=0.99, 
n.s., partial η 2<0.001) or between HD mice compared to controls (Genotype; F (1,24) 
=0.01, p = 0.99, n.s., partial η 2 < 0.001) (figure 5.12).  
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5.3.7.2. Between-region Analysis
As no sub-regional differences were found, vessel density measurements were 
collapsed across each  gross brain region and compared bilaterally for the striatum, 
hippocampus and motor cortex, with Running (running x non-running) as the 
between-subject variable to address whether exercise influenced vascular density 
differently between ROIs (Figure 5.13). 
A main effect of ROI was observed whereby greater vessel density was observed in 
the motor cortex than the striatum or hippocampus (ROI; F (2,26) = 22.7, p<0.001, 
partial η 2= 0.50). Each region differed significantly from the others (t-test; p values 
<0.01) where the motor cortex had the greatest vessel density, followed by the 
hippocampus then striatum.   ROI differences in vessel density did not vary 
significantly with either running (ROI x Running; F (2,46) = 0.031, p = 0.97, n.s., 
partial η 2= 0.01) or genotype (ROI x Genotype; F (2, 46) = 1.01, p = 0.37, n.s., partial 
Figure 5.12 Genotype differences in sub regional vessel density in runners vs non-
runners. Vessel density was quantified within the striatum, hippocampus and motor 
cortex by calculating the percentage area within each ROI that contained vessels 
stained by Tomato Lectin (Lycopersicon esculentum) using ImageJ. CP, Caudate 
Putamen; CA1, Cornu Ammonis of the hippocampus; DSVZ, Dorsal Sub-ventricular 
Zone; DG, Dentate Gyrus; M1, Primary motor cortex; VSVZ, Ventral Sub-ventricular 
Zone.
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η 2= 0.04) or as a result of both running and genotype (ROI x Genotype X Running; 
F (2, 46) = 1.4, p = 0.26, n.s., partial η2= 0.06).  
5.3.7.3. The effects of a dose response of wheel running on blood vessel density
Pearson’s correlations were carried out on regions independently, to assess whether 
total number of rotations could predict blood vessel density in running HD and WT 
mice. As can be seen in figure 5.10, there was a generally positive dose-response 
relationship between running and vessel density in WT mice, across all regions 
(striatum (r (10) =0.39, p=0.26, n.s.); hippocampus (r (10) = 0.38, p=0.27); M1; (r (10) 
=0.27, p=0.46, n.s.).  In HD mice, this relationship was not so clear.  Whilst there was 
a weak positive relationship between running and vessel density in the motor cortex 
(r (7) =0.45, p=0.32, n.s.), running was negatively associated with vessel density in 
the striatum HD (r (7) = -0.54, p=0.27, n.s.), and absent within the hippocampus HD 
(r (7) =-0.21, p=0.65, n.s.).  
5.3.7.4. Relationship between vascular density and CBF
Pearson’s correlation was used to assess whether the two vascular measurements, 
vascular density and CBF were related to one another.  A negative trend was present 
in the hippocampus (r (29) = -0.3, p=0.06) that was not seen in the striatum (r (30) = 
0.02, p=0.46) or motor cortex (r (28) = -0.01, p=0.48), such that increased vessel 
density was associated with a decline in level of CBF measured (figure 5.14).
Figure 5.13 Regional genotype differences in vessel density in runners compared 
to non-runners. Gross ROI’s were collapsed across sub-regions by averaging.  
Motor cortex had a greater vessel density than the striatum or hippocampus, with 
significantly lower vessel density within the striatum.  This did not differ a result of 
running or genotype.  Mean ± S.E.M.
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5.3.8. mHTT inclusions
S830 was used to visualise cells expressing mHTT protein.  Representative light 
microscope images of the progression of S830 immunoreactivity within the Q175/+ 
mouse striatum can be seen in Figure 5.15. All staining was negative in wild type 
animals. 
S830 positive cells were marked throughout the striatum.  Whilst nuclear inclusion 
bodies (IB’s) were present in most diffusely stained cells, a proportion of positive 
cells showed diffuse staining throughout the cytoplasm without the presence of IBs 
(figure 5.15a).  The total number of diffusely stained cells affected by mHTT within 
the striatum appeared greater in non-runners compared to runners but this was not 
significant (Running; F (1,10) = 1.4, p=0.26, n.s., partial η2= 0.12; figure 5.15c), nor 
was there a significant interaction between Running X Cell Type; F (1,10) = 0.2, 
p=0.71, n.s., partial η2= 0.02), such that there were generally more S830 positive 
cells in non-runners, for both IB positive and IB negative cell types. 
S830 positive aggregates were also present in the neuropil (figure 5.15b) which did 
not appear to be located within the cell body, however number (F (1,10) = 0.16, 
p=0.70, n.s., partial η2= 0.02) or inclusion size (F (1,10) = 0.44, p= 0.52, partial η2= 
0.04) did not differ significantly between running and non-running mice (figure 5.15d).
Figure 5.14. Relationship between rCBF signal and vessel density. A negative, but 
non-significant, relationship was observed within the hippocampus but no 
association was observed in the striatum or motor cortex (n.s).
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Figure 5.15 S830 staining for mHTT expression. Representative images from a single 
subject at a) x40 and b) x100 magnification. Diffuse staining was evident in all visible 
cells, with the majority also showing the presence of nuclear inclusion bodies (IBs). 
Total number of S830+ cells within the striatum (c) reveal a greater number of mHtt+ 
cells in the non-running mice compared to running mice for cells with IBs and cells 
without IBs, but this was not significant (p=0.26). Number of extracellular aggregates 
were also counted (d), but these did not differ significantly between groups.  Mean ± 
S.E.M. mHtt (mutant huntingtin).
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5.4. Discussion
Key Findings
• Q175 mice displayed a hyperactive phenotype at 11 weeks. Running wheel 
activity and balance time-to-climb the balance beam was noticeably greater 
in Q175 mice but only the latter was significant.
• Genotype differences in CBF at baseline were not observed in Q175 mice at 
this early stage in the disease, although a non-significant trend suggests that 
CBF may be slightly higher in the striatum and motor cortex in HD mice.
• CBF did not differ significantly between groups following a 6-week voluntary 
running intervention.
• Blood vessel density did not increase significantly in the running group 
compared to the non-running group, although a trend for a dose response 
relationship between running and vessel density was observed.
• S830 diffuse staining for mHTT appeared lower in runners compared to non-
runners, but runners had a greater number of extracellular aggregates, 
although this wasn’t statistically significant.
In recent years, MRI has been used to characterise changes that occur within the 
HD brain, including changes in macro- and micro-structure.  Whilst some effort has 
been made to assess the cerebrovascular changes that occur in patients, there has 
been little consensus in findings across studies, nor how cerebral blood flow (CBF) 
changes map onto the mechanisms occurring at a microscopic level.  In the present 
study, we asked whether early changes in CBF can be detected at a ‘pre-
symptomatic’ stage of the disease in a Q175 mouse model of HD, where MRI and 
histological techniques can be adopted.  We asked whether alterations in CBF are 
related to vascular density, and whether 6-weeks of voluntary running, would 
influence outcome measures including resting CBF, vascular reactivity, vascular 
density, balance beam performance and expression of mHTT.  
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Results revealed no clear differences in cerebral blood flow in the Q175 mice at 11 
weeks of age, prior to wheel exposure, although a hyperactive phenotype was 
evident.  We did not observe any running related alterations in CBF following 6 weeks 
of wheel exposure, nor any clear differences between vascular density or balance 
beam performance, however a decrease in the number of diffuse mHTT expression 
in running mice, suggests that exercise may have been having a subtle effect on 
neuronal health that could not be detected in the cerebrovasculature at this early 
stage in the disease. 
5.4.1. Behavioural Findings
Whilst it has been previously shown that exercise can improve some aspects of 
motor (Pang et al., 2006) and cognitive function (Harrison et al., 2013) in HD mouse 
models such as the R6/1 transgenic strain, the present study is the first to address 
the early effects of an exercise intervention in a less severe HD mouse model, the 
Q175 knock-in strain. 
We initially set out to confirm that our HD cohort was not symptomatic at the 
commencement of testing. Although a thorough behavioural assessment was not 
feasible in the present study, voluntary wheel running and testing on the balance 
beam was administered, since this quick test has been found previously to be the 
most sensitive test of motor and cognitive function at ~3months of age in Q175 mice 
(Brooks et al, personal communication).   
HD mice demonstrated a more hyperactive phenotype at 11 weeks than wild type 
control subjects, whereby they did more voluntary wheel running over the 6 weeks.  
Voluntary wheel running is not a typical assessment of hyperactivity, where other 
studies in Q175 mice have relied upon open field and climbing activity.   Whereas
other HD mouse models show hyperactivity in the early stage of the disease (Slow 
et al., 2003), this has not before been reported in the Q175 mouse model, where 
open field testing revealed no difference even at 2 months (Heikkinen et al., 2012). 
A genotype difference in the time taken to climb the balance beam was observed, 
whereby HD mice climbed the beam faster than WT controls at baseline, but not after 
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6 weeks of wheel exposure.  This too is likely to reflect a hyperactive phenotype in 
these animals that disappeared by 18 weeks of age. Previous research in the lab has 
reported a beneficial effect of exercise on the time taken for mice to turn at the end 
of the beam, which can be interpreted as an improvement in motor coordination 
(Harrison et al., 2013).   The absence of any differences between HD and control 
animals in the time-to-turn parameter in the present experiment suggest that motor 
initiation and coordination was not impaired at 12 or 18 weeks in HD or WT in these 
Q175 mice.  The absence of any differences on this task between runners and non-
runners after 6 weeks of wheel exposure, therefore suggests that running did not 
modify cognitive or motor performance on this task at this early stage in the disease. 
5.4.2. MRI Findings
Preclinical MRI is an under-utilised technique for assessing quantitative changes 
over time.  The present study scanned asymptomatic subjects before and after 6-
weeks of voluntary wheel running, using PASL MRI to noninvasively quantify 
baseline blood flow and vessel reactivity to a vasodilatory stimulus (5% CO2.).  This 
is the first time MRI has been used to assess blood flow in the Q175 model and in 
combination with their early age, such that this study was exploratory.
Previous MRI studies have observed elevations in blood volume in HD mouse 
models in the absence of motor dysfunction (Lin et al., 2013).  However, differences 
in baseline cerebral blood flow have not been addressed.  In this study, Q175 mice 
had a slightly higher baseline CBF at baseline (age 11 weeks) in the striatum and 
motor cortex compared to WT animals but this difference was not statistically 
significant however, even after considering differences in physiological noise due to 
depth of anaesthesia.  It was not known whether genotype related differences would 
be observed at this early time point in the disease, especially since behavioural 
differences are not robust at this age. However, an fMRI-CBV study in transgenic 
R6/2 mice has shown elevated CBV compared to WT controls preceding any overt 
behavioural phenotypes (Cepeda-Prado et al., 2012) in addition to findings from 
human studies of pre-symptomatic patients in which cerebrovascular function is 
altered (Wolf et al., 2011).
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Follow up scans after 6 weeks of exercise showed a decrease in CBF over time that
was present in both runners and non-runners.  Whilst it is possible that this is due to 
environmental enrichment, it seems more likely to be due to a decline in CBF with 
age or because of extraneous variables such as scanner drift and physiological 
instability that differed over time, rather than due to the exercise intervention itself.  
CBF is known to decline with age (Lu et al., 2011), although 6-weeks is unlikely to 
yield such a vast decrease. 
Dose response relationships were also explored whereby total running wheel activity 
was correlated with regional CBF values. It appears a generally positive relationship 
was present between running and CBF, except for an apparent decoupling in HD 
animals within the hippocampus, such that rCBF decreased in those that ran further.  
Whilst CBF is generally thought to increase with fitness, directionality of results here 
would support the relationship reported in Chapter 2, where CBF was negatively 
correlated with fitness.  A dose response relationship between number of rotations 
and vessel density was seen within the striatum, which may suggest a beneficial 
effect of exercise in the striatum, where running may act to reduce the apparent 
elevation in vessel density that has previously been reported in HD mice (Drouin-
Ouellet et al., 2015; Hsiao et al., 2015; Lin et al., 2013).  Although we did not observe 
group differences it may be that amount of running is a more sensitive independent 
measure, although in our case our small sample size means that interpretation of 
correlational analyses should be treated with caution.
Results from the cerebrovascular reactivity measure are somewhat inconclusive.  
Cerebrovascular reactivity is thought to be a sensitive marker of neuronal health 
which is thought to precede changes in structure or even baseline blood flow (Glodzik 
et al., 2011).  The present study utilised a 5% CO2 challenge which is robustly used 
to induce a quantitative CBF change of up to 30% (Wells et al., 2014).  A previous 
study in R6/2 mice, aged 7 weeks, showed an impaired vascular reactivity to a similar 
challenge which got worse with disease progression (Hsiao et al., 2015), with no 
difference between HD and WT animals at a comparably early disease stage.  We 
did not see a consistent elevation in CBF under hypercapnic conditions, where 
several animals showed a decrease in blood flow following gas switching to CO2. 
Reactivity was highest in the motor cortex, with increases in CBF reaching 
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approximately 10%, however much lower values of <5% in the striatum and 
hippocampus suggest that the signal was not being adequately detected.  A single 
TI of 1500ms was used in the present study as this was determined through piloting 
to yield the highest tissue perfusion signal and is in line with what has been used 
previously in mouse models of neurodegeneration (Wells et al., 2014).  A caveat of 
single TI imaging is that SNR is lower, where T1 must be assumed and may 
underestimate the tissue perfusion signal, yielding lower CBF estimates.  
Nonetheless, we would still expect to see an increase in CBF during each of the 
challenges. With the experimental apparatus available, we were unable to measure 
the end-tidal gases being exhaled by our subjects, such that it was not clear how 
much gas was being breathed-in.  Simultaneous pulse oximetry would have allowed 
us to measure blood gases, however this was not possible in the present study and 
we, like others, had to assume that mice were breathing in the air mixture as and 
when it was switched. Alterations in physiological parameters including respiration 
and heart rate following CO2 switching, however, mean that we could assume that 
they were breathing the desired concentrations.  Beyond piloting, this is the first time 
that this single TI method has been used within the University and as such results 
should be treated with caution.  Further technical optimisation is required before this 
can be interpreted as a biomarker of cerebrovascular health as others have done.  
Few MRI studies measure CBF in the diseased mouse brain, partly due to the low 
signal to noise ratio and the scarcity of preclinical scanners.  Those that do, tend to 
rely on the use of dynamic contrast enhanced (DCE) MRI to exogenously increase 
contrast in the tissue as blood flows through the brain. DCE-MRI can also be used 
to estimate CBV, which is an interesting measure which has been related to vessel 
density (Drouin-Ouellet et al., 2015; Lin et al., 2013).  ASL makes use of an 
endogenous signal through magnetically labelling blood, and is related to local tissue 
perfusion, rather than global blood volume. ASL therefore provides information about 
the metabolic and neuronal changes that are taking place at the level of the 
capillaries.  Were this technique optimised more fully, it would be preferable to DCE 
imaging since it is non-invasive, repeatable, allows for longer scan times and does 
not interact with pharmacological or behavioural interventions that may be assessed. 
Further still, reliance on a contrast agent for measuring signal, assumed that blood 
brain barrier permeability is equal among subjects (Sourbron et al., 2009), however 
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evidence suggests that the blood-brain barrier is impaired in HD and this technique 
should therefore be used carefully  (Drouin-Ouellet et al., 2015).
5.4.3. Vessel Density
Increased vessel density within the striatum and cortex has been reported in a 
number of HD mouse models at advanced stages of disease progression (Cisbani et 
al., 2013; Cisbani and Cicchetti, 2012; Franciosi et al., 2012; Lin et al., 2013).  We 
carried out histology after 6 weeks of wheel running such that animals were aged 17-
18 weeks at the time of fixation, when animals were still considered to be in the 
‘asymptomatic’ phase.  This experiment is the first to assess vessel density in an HD 
mouse model following an exercise intervention.
Density values were like that reported regionally in Chapter 3, with greatest density 
within the motor cortex.  We first asked whether there was a cross-sectional 
difference in vessel density between HD and WT mice at this age.  Following from 
our findings in Chapter 3 we expected to see a positive effect of running on vascular 
density in wild type animals.   However, there was no evidence of a genotype effect 
within the striatum or the motor cortex, and this relationship was consistent 
regardless of whether animals were in the running or non-running condition.  In the 
non-running group, WT mice seemed to have a slightly greater vessel density in the 
striatum although this was not significant.  Interestingly, within the hippocampus, a 
region particularly known for running induced angiogenesis (van Praag et al., 1999b), 
running HD mice had increased vessel density compared to running WT controls.  
The difference between genotype may be explained by the increased levels of 
running by HD animals compared to WT because of their hyperactive phenotype. 
Alternatively, deficits in adult hippocampal neurogenesis have been reported in the 
R6/1 HD mouse model (Ransome and Hannan, 2013), such that angiogenesis in this 
region may be an early compensatory response by which to preserve neuronal health 
in that region prior to cognitive dysfunction.  This would be consistent with human 
studies in which an increase in hippocampal blood flow has been observed in the 
hippocampus in pre-symptomatic HD patients (Wolf et al., 2011).
The present study was interested in the long-term effects of exercise on 
cerebrovasculature, with the hope of investigating its therapeutic value.  In this study, 
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animals were culled after 5 days of exercise cessation.  It is possible that vascular 
effects had returned to baseline by the time of fixation, which would suggest that the 
effects are not long-term.   Indeed, evidence has shown previously that vessel 
density in the hippocampus can return to normal after just 24h of running cessation 
(Van der Borght et al., 2009).  While our results from Chapter 3 suggest that 
differences in vascular density are observable even 5 days after running, it is possible 
that additional scanning and behavioural testing in this experiment introduced stress 
or enrichment that interfered with the vascular effects being measured.
In the present study we report vascular density, but due to time constraints were 
unable to measure other morphological measures, that have previously been shown 
to be altered in HD mouse models, including lumen diameter, vessel wall thickness 
and branching (Franciosi et al., 2012; Lin et al., 2013).  Given that changes in vessel 
density were not clear in the present study, we hypothesised that it may be too early 
to detect changes in these parameters.  Time constraints meant that we were unable 
to carry out investigations into the subtypes of vessel being measured.  Tomato 
Lectin stains endothelial cells indiscriminately, and therefore stains all vessels.  
Evidence from Lin et al. (2013) observed a dichotomy between the type of blood 
vessels that are affected in HD, namely capillaries versus arteries by co-staining 
tissue with an antibody that binds to the smooth muscle actin in the vessel walls of 
arteries.  They found that whilst microvascular density was increased in R6/2 HD 
mice, whilst the number of arteries were decreased, from an early disease stage, 
prior to behavioural impairment.   Where vessel density is deemed to be both a 
positive hallmark of exercise, but a pathogenic feature of HD, it is important to 
understand the type of vessel being assessed. I hypothesis that it may be that the 
type of angiogenesis being measured because of exercise that is important.  Whilst 
exercise may lead to increased arteriogenesis (the growth and widening of arteries), 
growth of immature capillaries in the case of HD would have the same net effect on 
measures of vascular density, both of which fall under the term ‘angiogenesis’.  It is 
known that CBF is primarily influenced by increases in capillary density and vessels 
that lack smooth muscle. CBF should then be influenced more heavily by small 
vessels, whereas measures more typical measures reporting CBV, reflects a global 
difference in blood volume, regardless of vessel subtype.  
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A negative association was observed between hippocampal CBF and vessel density, 
suggestive of a decline in CBF with increased density.  We can speculate that this 
may reflect an efficiency of cerebral perfusion, such that an increased capillary 
density could increase the rate of oxygen extraction in the tissue bed, leading to an 
apparent reduction in the CBF signal.  Why this relationship was only observable in 
the hippocampus and not the cortex or striatum however, remains unclear.
5.4.4. Intracellular inclusions
S830 was used to visualise cells expressing mHTT in the striatum using well 
established methods within the lab (Bayram-Weston et al., 2016). Compared to 
runners, non-runners had a greater number of diffusely stained cells with and without 
IBs than runners, whilst runners demonstrated a greater number of extracellular 
aggregates, although neither of these results reached statistical significance.  
Neuronal inclusions are typically deemed problematic for the cells in which they are 
located, causing significant changes in cell structure, trapping and interfering with 
the normal production of other proteins such as the CREB-binding protein (CRB), 
and eventually becoming toxic to the nerve cell.  An array of evidence has shown 
that aggregates located in the nuclei (inclusion bodies; IBs) can block transcription, 
and other cellular processes such as neuronal axonal transport and impair major 
protein degradation pathways including the ubiquitin-proteasome system (UPS) and 
autophagy which under normal circumstances would acts to destroy affected cells 
(Kirkin et al., 2009).  Albeit non-significant, running mice in this chapter had a 
reduction in the number of IBs compared to non-running mice, suggestive that 
exercise may ameliorate one or more of these processes, thereby reducing mHTT 
build up in the cell.  
Whether IBs are a cause or a result of HD pathology is still not clear, and there is a 
large amount of evidence to suggest that IB formation may be protective (Arrasate 
and Finkbeiner, 2012). There is a mounting array of evidence to support the idea that 
aggregates do not cause HD, but reflect an attempt by cells to isolate toxic cell 
fragments, to prevent these fragments from causing too much harm .  Slow et al. 
(2005) found that HD mice with frequent, widespread aggregates did not display any 
evidence of behavioural abnormality, neuronal dysfunction or degeneration, 
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indicating that HTT aggregation may not be sufficient to cause neurodegeneration.  
Further evidence has proposed that IB formation may be neuroprotective since it 
reduces the amount of toxic diffuse mHTT throughout the cytoplasm, acting as a 
cellular ‘coping mechanism’ to temporarily cluster toxic fragments before they are 
degraded by the proteasome (Arrasate and Finkbeiner, 2012).  Diffuse forms of 
polyQ-expanded HTT could in fact be the principal toxic species, and that their levels, 
rather than inclusion bodies themselves, govern neuronal survival (Arrasate et al., 
2004).  In their study, Cox proportional hazard analysis was used, and found that 
levels of diffuse HTT staining in neurons on the first day after transfection were 
correlated significantly and negatively with neuronal lifespan whereas IB load did not 
predict neuronal death.  
In this chapter, diffuse cells were counted and grouped according to those with or 
without IBs, and it appeared that the largest difference between runners and non-
runners, was in the number of diffuse cells without IBs.  This could suggest that 
exercise acts by decreasing the amount of toxic mHTT in the cytoplasm.  It was also 
found that runners displayed an elevated (but non-significant) number of protein 
aggregates that appeared to occur outside the cytoplasm, within the extracellular 
space.  It is possible to speculate that exercise may protect against the damaging 
effects of mHTT through better cell clearance mechanisms(e.g. lysosomal clearance 
and autophagy), and could be a neuroprotective hallmark of  voluntary running on 
mHTT expression. 
Together these visual, but non-significant, trends hint towards an alteration in mHTT 
aggregation even after 6 weeks of running, whereby exercise may act 1) by reducing 
the number of mHTT affected cells by modulating Htt levels, and 2) increasing the 
level of protein aggregation (IBs) as a ‘coping mechanism’ by modulating the 
propensity to mis-fold and 3) improving mechanisms underlying clearance of toxic 
fragments leading to an elevation in extracellular protein aggregates.  Whilst these 
are interesting speculations, interpreting these preliminary findings is premature and 
further work is needed to elucidate the cellular mechanisms underlying neuronal 
protein aggregation, in particular whether IBs are toxic, incidental, or part of an 
important coping response, and how exercise might work to mediate these processes.
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A caveat of the present study, is that we were unable to co-localise the type of cells 
which were expressing mHTT.   Recent evidence has shownt hat mHTT is expressed 
in all apsects of the neurovascular unit, including the basal membrane sheaths of 
small and large caliber vessels as well as the nuclei of cells imbedded within the 
basal membrane including endothelial cells, smooth muscle cells and perivascualar 
macrophages (Drouin-Ouellet et al., 2015) in R6/2 mice. Mutant HTT can impair 
mitochondrial integrity and/or trafficking (Chang et al., 2006) and induce oxidative 
stress, which may affect the physiology of cells forming the cerebral vasculature and 
influence small vessel growth. Exercise is known to reduce oxidative stress (Durrant 
et al., 2009), and may therefore protect vulnerable cells from mHTT accumulation.  
Further work would consider using fluorescence microscopy to co-localise mHTT 
markers with neurovascular markers such that the benefit of exercise on mHTT within 
specific cells known can be explored.
5.4.5. General Limitations
Small sample sizes in this study mean that results should be treated with caution and 
used as a stepping stone from which to probe these questions further.  Whereas 
group and genotype differences were not significant, low power may have masked 
some interesting effects.   The present study was limited by the number of individual 
running wheels, such that greater numbers were not feasible.  Previous studies have 
used alternative designs such as group housing with a single wheel or by limiting the 
amount of daily running (Harrison et al., 2013), however we wished to measure 
individual running activity and limit fighting such that this was not an option. 
This is the first time many of these questions have been asked of a Q175 mouse 
model and thus it was unknown what age we would expect to see changes in 
vascular function.  We chose young adulthood so that our cohort could be compared 
to that used in Chapter 3 and because we wanted to investigate differences within 
an early time-window, prior to obvious cognitive and motor impairment, such that 
results could be analogous to those measured in our pre/early-symptomatic HD 
patients in Chapter 4.  Whilst we had initially planned to repeat the same experiment 
in a cohort of Q175 littermates at 1 year of age, time-restrictions meant that this was 
not feasible.  At 1 year, we would expect obvious cognitive and motor impairment in 
this mouse model (Heikkinen et al., 2012) and perhaps more exacerbated differences 
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in cerebrovascular function.  This work is taking place, but cannot be presented within 
the scope of this thesis.
5.4.6. Conclusion
At 11-weeks of age, prior to voluntary wheel exposure, Q175 mice did not show 
elevations in cerebral blood flow or vessel density compared to wild-type mice as 
hypothesised.  We conclude that this is likely due to the early stage of disease in 
which they were tested.  A six-week running intervention did not yield clear 
differences in vessel density as expected according to our previous experiment in 
Chapter 3.  A decline in CBF over time was seen in all animals, but was not influenced 
by genotype or running. Technical development of the cerebrovascular reactivity MRI 
pipeline is necessary before conclusions can be made regarding vascular function.  
Future work will repeat this study in an older Q175 cohort to confirm that vascular 
function is jeopardised in these animals and larger sample sizes will be adopted for 
statistical power.
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Chapter 6
General Discussion
Cerebrovascular health is essential for efficient neuronal function.  Identifying 
mediators of cerebrovascular health may provide us with therapeutic targets by which 
to delay cognitive and neuronal deterioration in healthy aging and disease.  The aim 
of this thesis was to investigate the link between cardiorespiratory fitness and 
cerebrovascular health in young adulthood and in Huntington’s disease, both in 
humans and in mice.  The purpose of addressing this question in two species was to 
allow for bi-directional translation, in which insight into the human brain was 
motivation for translational research in mouse models whilst increased biological 
specificity gained from animal work could inform interpretation of current research 
and motivation for future research in humans.
6.1. Summary of findings
In Chapter 2, PASL was used to measure resting cerebral blood flow, arterial 
compliance and cerebrovascular reactivity in a sample of highly fit male adults, which 
are known markers of cerebrovascular health.  The key finding from this study, was 
that cardiorespiratory fitness ( O2MAX) was positively associated with arterial 
compliance.  This is the first time the relationship between fitness and arterial 
compliance has been addressed using MRI measures, and is suggestive of improved 
cerebrovascular health even in young adulthood. The finding that O2MAX negatively 
predicted resting CBF was counter-intuitive, where higher CBF is typically associated 
with improved cerebrovascular health.  In line with this, a negative trend was also 
observed between O2MAX and CVR, but this was not significant.  Despite fitness-
related differences in cerebrovascular parameters, there was no association 
between O2MAX and performance on cognitive tasks that have been previously 
associated with fitness in aged participants.  
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In Chapter 3, healthy young adult mice underwent a six-week running wheel 
intervention to replicate previous findings of exercise-induced angiogenesis, that 
might help explain the cerebrovascular differences observed in Chapter 2.  Increased 
vessel density was observed in running mice, within all regions studied 5 days after 
running cessation.  The greatest changes were seen in the striatum, a region that is 
rarely examined, but is largely involved in executive cognitive performance, and the 
hippocampus, known to decline in ageing. These findings corroborate and extend 
the existing literature whereby vascular changes appeared more stable than 
previously thought, lasting up to 5 days after exercise cessation.
In Chapter 4, I aimed to address whether exercise may be a clinically useful 
intervention in patients with Huntington’s Disease. This is the first time an MRI study 
has addressed the relationship between cardiorespiratory fitness and the HD brain. 
It was found that resting CBF and CVR were generally lower in HD patients than 
controls, even when correcting for partial volume effects that are likely to be important 
in the atrophying HD brain. However, unlike previous studies, these differences were 
not significant.  Disease burden and symptom severity was associated with a 
decrease in whole-brain CBF. However, elevated CBF in functionally relevant 
regions including the frontal cortex and thalamus was associated with worse disease 
outcomes.  Fundamental to our aims was whether HD patients differed from controls 
in their response to higher cardiorespiratory fitness.  O2PEAK was not associated with 
cognitive performance in controls or HD patients.  O2PEAK did not appear to predict 
CBF or CVR across subjects, although negative trends were observed in a whole 
brain ROI, as in Chapter 2.  An interaction in the left caudate was found in which 
O2PEAK predicted higher CBF in controls, but lower CBF in HD patients.  Overall, 
these results do not provide clear support for the benefits of fitness in HD.  The 
interaction observed in the caudate may suggest fitness is able to jeopardise 
cerebrovascular function, or even perhaps the existence of a compensatory 
response in a key region known to be particularly affected in HD.
In Chapter 5, the study performed in Chapter 3 was replicated in a transgenic Q175 
HD mouse- line prior to onset of typical disease-related cognitive and behavioural 
impairments. This age was chosen to be analogous to pre-/early-symptomatic 
patients examined in Chapter 4. Behavioural, histological and PASL outcome 
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measures were used.  No differences in CBF or CBF CVR were observed at baseline 
or after 6 weeks of wheel running between HD mice and controls. Vessel density was 
not elevated in running mice as was reported in Chapter 3, nor were there any clear 
genotype differences. The most intriguing effect was the observation that diffuse 
mHTT expression in the striatum was greater in non-running HD mice than controls, 
although this was not statistically significant.  This is the first study to assess the 
benefits of exercise in an HD mouse model using MRI. However, it may be too early 
into the disease to detect cerebrovascular deficits, such that the benefits of exercise 
could not be observed.
6.2. Is physical activity related to improved cerebrovascular health in 
healthy young humans and mice?
It is suggested that aerobic fitness is predictive of better cerebrovascular health and 
reduced risk of cognitive decline. However, there has been little evidence to suggest 
whether these changes occur as early as young adulthood. Chapters 2 and 3 aimed 
to address this question in humans and mice respectively, providing promising 
evidence that improvements in cerebrovascular function can be detected early in the 
lifespan.  Chapter 2 addressed this in humans, using a cross-sectional measure of 
aerobic fitness ( O2MAX) as a surrogate measure, where causality following an 
exercise intervention was not assessed.  Chapter 3 addressed this in mice, by 
investigating vessel density in mice who had undergone 6 weeks of voluntary wheel 
running.
A clear benefit to cerebrovascular health was observed in Chapter 2, whereby fitter 
individuals appeared to have better arterial compliance. The importance of arteries 
in protecting the capillary bed by buffering pulsatile blood arising from the heart, has 
been proposed previously (Poels et al., 2012), and systemic arterial compliance has 
been linked to cognitive function (Davenport et al., 2012). Here we demonstrate this 
link for the first time in cerebral arteries.  Evidence for early cerebrovascular changes 
in aerobically fit adults, provides a promising mechanism by which physical activity 
can mediate cerebral health and preserve cognition later in life. Physical training is 
thought to drive adaptation and arterial remodelling of the endothelial and smooth 
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muscle cells via changes in hemodynamic and shear stress patterns (Newcomer et 
al., 2011). In the absence of time, it was not possible to probe this mechanism further 
in the healthy young mice in Chapter 3.  Planned work to extend these results will 
examine expression of smooth muscle actin in the major cerebral arteries in the 
mouse brain, to validate the link between arterial remodelling of smooth muscle cells 
because of exercise.  This would help to shed light on the mechanisms underpinning 
elevated arterial compliance observed in Chapter 2.
It was also found that vessel density was increased in young adult mice. This can 
also be taken as evidence that exercise can improve cerebrovascular health.  This 
finding corroborates previous studies and supports literature in humans that have 
identified an increase in CBF with fitness and following an exercise intervention.  
Vessel density is thought to reflect angiogenesis which, when new vessels function 
properly, provides greater surface area from which oxygen and nutrients can perfuse 
into the tissue.   How this corresponds to the findings in Chapter 2, that CBF was 
lower in fitter subjects is not clear.    
In Chapter 2, the findings that CBF was reduced in fitter subjects was unexpected.  
Where CBF (MCAv) and CVR are typically thought to increase with fitness (Bailey et 
al., 2013), reductions in these measures are usually thought to be a pathological 
biomarker.  In the present context, it is unlikely that this is a pathological process and 
the possibility that this may in fact be an adaptive process is discussed.  This study 
utilised a cohort with an unusually high range of cardiorespiratory fitness, such that 
altered vascular response, may be protective to those that engage in physical activity 
regularly.  Possible adaptive mechanisms discussed, include increased efficiency of 
oxygen extraction in these highly-trained subjects.  Work within the lab provides 
preliminary evidence for a link between fitness and enhanced oxygen extraction and 
planned work will extend this investigation in a wider cohort.
Whether the findings of reduced CBF in Chapter 2 can be reconciled with the 
increased angiogenesis reported in Chapter 3 is unknown.  Typically, angiogenesis 
has been associated with a concomitant elevation in cerebral blood volume in 
preclinical studies (Swain et al., 2003), although it has been observed that the 
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relationship between angiogenesis and cerebral blood flow are not always tightly 
coupled (Vogel et al., 2004).
6.3. Is physical activity related to improved cerebrovascular health in 
pre-/early-symptomatic HD patients and in transgenic HD mice?
Chapter 4 is the first PASL study to address the benefits of fitness on cerebrovascular 
health in the HD brain, whilst Chapter 5 is the first study to address the benefits of 
exercise on cerebrovascular health in an HD mouse model.  However, no convincing 
evidence was observed by which to claim any beneficial effects of exercise on 
cerebrovascular health in the preHD stages examined.
6.3.1. Fitness might alter CBF in the caudate nucleus differently for patients and
controls.
In Chapter 4, interesting differences were found between HD patients and controls 
in aspects of cognition, mood and differences in perfusion, however, the primary 
interest was in the moderating effect of cardiorespiratory fitness.  The most 
interesting observation was in the left caudate nucleus. Firstly, it was observed that 
this region showed a reduction in resting CBF relative to controls, although this only 
approached statistical significance.  Secondly, a group interaction with fitness in the 
same region unveiled an interesting pattern of results, whereby O2MAX predicated a 
higher CBF in the controls, but a lower CBF in HD patients. Of course, this is a cross-
sectional study, such that CBF differences cannot reflect ‘change’ as a result of HD, 
however this relationship was deemed worthy of further exploration. 
Unlike the highly fit subjects studied in Chapter 2, an observed elevation in CBF with 
fitness is in line with what has been reported previously in the general population 
(Ainslie et al., 2008). Conversely, what causes hypoperfusion in the caudate in HD 
because of exercise is less clear and motivated further investigation in Chapter 5.  
Vessel density in an HD mouse model was measured to assess whether this CBF 
interaction in the patient brain could be explained by a reduction in vessel density.  
Although caudate vessel density appeared lower in HD mice than controls, this was 
not significant at baseline and did not appear to interact with running.
Chapter 6
201
Metabolic function has been shown to be reduced in Huntington’s disease, where 
mitochondrial dysfunction and glucose metabolism have been observed in the 
caudate (Browne et al., 1997).  It is possible that people with HD do not benefit from 
exercise in the same way as controls, where metabolic function is already under 
stress from the disease, leading to hypoperfusion in fitter subjects. This is in line with 
previous reports of the negative effects of exercise in HD mice (Potter et al., 2010).  
These results are only speculative and it is acknowledged that this relationship is not 
causal and may mask the same underlying factor which is that HD severity is 
associated with lower fitness levels and reduced CBF. 
6.3.2. Running wheel activity does not influence cerebrovascular health in early-
stage HD mice or wild-type controls.
Contrary to the findings in Chapter 4, running Q175 mice in Chapter 5 did not show 
any differences in CBF, CVR or angiogenesis compared to runners following 6 weeks 
of wheel exposure. It was hypothesised that diseased mice would have higher vessel 
density than wild-type controls, which would be reflected in a higher level of resting 
CBF, although this difference was not significant in this study.  Because this is the 
first time such a study has been performed, we were unsure whether exercise would 
increase or decrease vessel density or CBF.   No differences were seen between 
runners and non-runners on any of the measures assessed, and this did not interact 
with group.  It is possible that our measures were at ceiling levels and thus the 
running intervention did not yield an effect on the observed cerebrovascular 
measures in this cohort.  Whilst the benefits of exercise were not detected in this 
study, neither were there any negative effects of exercise on cerebrovascular health.  
Homozygous Q175 mice were adopted as the model of interest.  This transgenic 
model is known to have a relatively long disease progression, which was of interest 
in this study where a longitudinal aspect was initially planned. Assessment at later 
time-points was not feasible and it is possible, therefore, that mice were too far from 
disease onset such that differences in CBF, CVR or angiogenesis did not differ from 
wild-type controls.  Planned work will repeat this experiment in subjects from the 
same litter at >1 year of age, where behavioural symptoms are evident, to address 
the benefits of exercise in these animals.  It is unknown whether hypoperfusion is 
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evident in HD mice prior to symptom onset although reports have shown that 
heterozygous Q175 mice display significant atrophy in the striatum and cortex by 4 
months (Heikkinen et al., 2012) and behavioural differences by 12 weeks (Brooks et 
al; unpublished).  Future work would consider repeating the first scan closer to 
symptom onset where the efficacy of exercise may be observed in the behavioural 
and cerebrovascular outcome measures by the second time-point.  BrdU analysis 
will also be carried out to investigate differences in endothelial growth that can be 
directly attributed to the running intervention.
6.4. Can PASL measures be considered reliable cerebrovascular 
biomarkers in humans and in mice?
Advances in arterial spin labelling have come on greatly over the last 20 years and 
there are a variety of labelling sequences and acquisition strategies that offer 
different benefits. A number of well validated, but also novel measurements were 
adopted to measure cerebrovascular health in the present thesis.  A biomarker can 
be defined as a characteristic by which a particular pathological or physiological 
process/disease can be identified.  In this respect, a reliable MRI biomarker is one 
that has been well validated and taps into a particular process characteristic of 
cerebrovascular health.  The measurements used in this thesis will be discussed in 
turn with regard to the above definition.
6.4.1. Arterial Compliance
Measurement of arterial compliance in Chapter 2 employed short inversion time 
PASL to map arterial blood volume at different phases of the cardiac cycle.  This is 
a recently developed technique such that, at time of scanning, this was the second 
study to apply it for measuring cerebrovascular health. This technique has since been 
validated by a number of studies (Warnert et al., 2015a, 2015b) and ongoing work is 
validating this measure in the Huntington’s Disease cohort studied here, where time 
did not permit its inclusion in this thesis. 
Regarding the specificity of the measurement, the direction of the results observed 
using this measure so far, correspond to physiologically meaningful changes that 
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would be hypothesised in the groups tested.  Compliance is thought to increase in 
systemic arteries with physical activity (Tanaka et al., 1998), to play an important role 
in increasing cerebrovascular resistance (Warnert et al., 2015a), and to mediate 
arterial remodelling in response to altered patterns of shear stress (Newcomer et al., 
2011). These mechanisms work to prevent capillary damage by increasing the 
capability to buffer pulsatile flow arising from the heart.  Further validation is needed 
in aged and diseased patients; however, this measure can be considered a promising 
cerebrovascular biomarker.
6.4.2. Resting CBF
CBF can be influenced by a number of underlying factors and as such, does not 
provide definitive information about a particular pathological process. CBF appears 
to be lower in young healthy athletes and also in Huntington’s Disease.  Whether a 
reduction in CBF is pathological or adaptive is not clear, and may depend upon 
disease/fitness status in a complex way.  As such, resting CBF may not be a good 
biomarker of disease, but rather a surrogate marker of vascular function.
Resting CBF in humans was acquired and analysed using well established methods 
within the lab, using a multi-inversion time spiral readout gradient echo sequence 
and FSL BASIL for CBF quantification (Chappell et al., 2009). The same methods 
were used in both human chapters, however, the number and spacing of inversion 
times in Chapter 4 was chosen to minimise scan time for patients.  As a result, it is 
possible that SNR may be slightly lower in Chapter 4 than Chapter 2, where fewer 
repetitions meant averaging of the signal may have been noisier.  Nonetheless, all 
perfusion values were within the range reported elsewhere. Inflated PVC corrected 
values were also in the expected range (Chappell et al., 2011) such that resting CBF 
values were considered reliable in the human studies.
Preclinical imaging of resting CBF was acquired using a FAIR EPI sequence (Kim, 
1995).  This is the default sequence in Bruker’s ParaVision 5 software and has been 
validated in mice (Leithner et al., 2010).  This sequence used a total of 13 TIs to 
model T1 relaxation, which is more robust than the 5 TIs used in the FAIR-EPI 
sequence used to assess CBF in the R6/2 mice (Hsiao et al., 2015).  A repeatability 
study conducted prior to scanning, tested repeatability of CBF estimates on separate 
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days (data not reported).   This pilot study also explored whether CBF estimates were 
affected by the number of TIs used to model T1 relaxation.  Analysis was performed 
on 24 (recommended by Bruker), 12, or 9 inversion times.  Coefficients of variability 
for between-subject scans were 0.2-21.8%, which is higher than the variability 
estimates expected between scans in humans (~3.5%; Tancredi et al., 2015).  
However, between subject differences were found to vary greatly with depth of 
anaesthesia. It was also found that a CBF model with 12 TIs did not differ from CBF 
estimates modelled with 24TIs. In reaction to these findings, scan time was reduced 
in Chapter 5 by measuring 13 TI’s with an emphasis on controlling variability in 
anaesthesia between scans to maximise within-subject reliability.   Nonetheless, 
where anaesthesia is a vasodilator, reliability of ASL in preclinical scanning is an 
inherent challenge and it is not known whether the HD mouse model would respond 
differently to wild-type animals. Further validation of this sequence is needed is 
healthy and diseased mice.
6.4.3. Cerebrovascular reactivity
CVR is thought to be a more sensitive marker of cerebrovascular health than resting 
CBF. Regulation of CBF in response to vasoactive stimuli, reflects efficiency of the 
vasculature, and implicates a number of well-established mechanisms.  Where CVR 
is jeopardised, quantifying CVR with MRI may be useful for tracking disease 
progression and targeting treatments and further research.  Nonetheless, the 
biological specificity of this method remains limited.
In Chapters’ 2 and 4, cerebrovascular reactivity was measured in response to a 
breath-hold task.  Whilst the breath-hold is not the most robust challenge for 
manipulating arterial CO2 (Tancredi and Hoge, 2013), we deemed it worthy of 
investigation in patients due to its ease of use by patients.  Chapter 2 measured 
reactivity of the BOLD response in addition to the CBF response which has 
notoriously low SNR, but contains more specific information regarding the origin of 
the signal. Established methods were used (Bright and Murphy, 2013) and it was 
found that the BOLD and CBF CVR responses were closely related, despite 
increased noise in the CBF time-series.  Because CVR measurements aligned with 
the findings of previous studies, it was deemed a reliable measure for use in HD 
patients in Chapter 4.  In this study, absolute CBF CVR but not BOLD CVR was 
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reported.  Data from this study was not what was expected, whereby several subjects 
showed a negative CBF response, particularly in the HD group.  These findings are 
discussed in more depth in Chapter 4, however it does a raise questions as to the 
reliability of the data.  Whilst it would be expected that HD patients have lower CBF 
than controls (Hsiao et al., 2015), ongoing work is being carried out to establish 
whether CBF CVR in response to a breath-hold challenge is a reliable biomarker of 
cerebrovascular health.
In Chapter 5, relative CBF change was measured in response to a hypercapnic 
challenge (5% CO2).  FAIR-EPI parameters adopted were similar to those used 
previously (Wells et al., 2014), however this is the first time this sequence or a gas 
challenge has been used within Cardiff University and, as such, has not been 
previously validated.  A negative CVR was also observed in many animal subjects 
and overall CVR appeared elevated in HD mice and reduced in wild-type animals. 
This is contrary to the findings observed in HD patients in Chapter 4 or previous 
scientific reports (Hsiao et al., 2015). Due to time limitations, further exploration of 
the data was not performed, such that CVR results in Chapter 5 should be treated 
as preliminary. 
6.5. Can exercise be reliably recommended as a prophylactic to 
deterioration of cognitive function? 
The present studies provide little evidence to support the link between exercise and 
improved cognitive function.  This is not to say that exercise does not yield benefits 
in mood and cognition, but that this could not be detected in the present studies.   
Evidence in rodent models have reported improvements on tasks including Pattern 
Separation (Creer et al., 2010a), Morris Water Maze (van Praag et al., 1999; spatial 
working memory), T-maze (Harrison et al., 2013; procedural and reversal learning); 
Forced Swim Test (Duman et al., 2009; depressive symtoms), Wisconsin General 
Testing Apparatus (Rhyu et al., 2010; rule learning), Radial Arm Maze (Anderson et 
al., 2000; spatial memory) and Passive Avoidance (Radák et al., 2001; Long-term 
memory).   Cognitive function was not measured in the rodent studies within this 
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thesis, in part due to the long-period of training necessary for complex behavioural 
assessment on operant tasks.  
As described in Chapter 2, there is little available evidence in the literature to support 
a link between fitness and/or exercise and cognition in young adults, possibly 
because cognitive performance is at ceiling level.  The largest effect sizes are in 
elderly participants, where lifelong exercise is associated with better cognitive 
performance on tasks of executive functioning (Colcombe and Kramer, 2003).  
Whether exercise is beneficial earlier in the lifespan is still a relevant question, where 
detection of cognitive deficits later in life may be too late to begin exercising.  It is 
likely that many of the cognitive tests, including those in Chapter 2, are not sensitive 
enough to detect the small effect sizes expected as a result of exercise.  Visual trends 
were observed between VO2PEAK and cognitive performance in HD patients, on a 
number of the cognitive tasks, and these relationships appeared stronger than in 
controls.  It could be that because cognitive performance is not at ceiling levels in 
patients, the influence of mediators such as fitness become more apparent.  Although 
interactions between group and fitness were not significant in these patients, it is 
possible that this relationship would become stronger as the disease progresses. 
Research has proposed that maximal gains come from a combination of exercise 
and brain ‘training’ in order to gain the cognitive benefits from exercise (Lauenroth et 
al., 2016). Future exercise interventions within the Cardiff HD Centre will consider
incorporate brain training exercises to maximise the functional benefits. 
Development of more sensitive measures of cognitive function are needed before 
exercise can be reliably recommended as a prophylactic to deterioration of cognitive 
function. 
6.6. Practical considerations for exercise prescription in people with 
Huntington’s Disease
The view that exercise is good for the body and the mind is by no means novel.  
Despite the vast amount of research demonstrating the importance of physical 
activity, 20million UK adults are classified as physically inactive according to the 2017 
report by the British Heart Foundation. Even healthy gene negative individuals 
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struggle to meet the recommended goal of 150 minutes of moderate intensity 
exercise per week, so it is important to consider how best to encourage uptake of 
physical activity in HD patients where barriers may be even more severe.  
6.6.1. Exercise in HD
Just a few of the specific challenges that should be considered when recommending 
exercise to people with HD include, low mood, apathy, self-confidence, degree of 
mobility, difficulty with balance, level of supervision and risk of falls.  It is also worth 
noting that it is unknown whether vigorous exercise is beneficial in people, where 
metabolic and immune function may already be compromised by the disease.  For 
example, in the RCT conducted by Quinn et al (2016a), HD participants who a 
supported multi-modal exercise programme had substantial weight loss when 
assessed at 13 weeks, which is not ideal in this population where there is a 
propensity for weight loss as the disease progresses.  With these challenges in mind 
it is unlikely that a ‘one size fits all’ approach would work, and that recommended 
activity should be tailored according to the clinical presentation of the individual. 
Findings from the RCT from Quinn et al (2016a) demonstrated that people with HD 
could exercise safely in an aerobic zone and conduct progressive strengthening 
exercises, even in the presence of advanced motor impairments.  In their study, 
retention was attributed to the support structure in which a trainer was available to 
monitor that the program was being conducted, to provide support and 
encouragement and to facilitate adherence. 
A number of referral schemes are available, which run active groups for people 
suffering (or have suffered) from a wide range of conditions.  Whilst such schemes 
are a fantastic idea, symptomatic HD patients may be prevented from tapping into 
these resources without the assistance of a carer or trained physiotherapist.  A recent 
study at Cardiff assessed the feasibility and uptake of a fortnightly HD walking group.  
Patient feedback from this study revealed that patients felt uncomfortable taking part 
in organised activities that might draw attention to their disease, and that they had 
trouble committing to a time and a place (personal communication with Una Jones 
from Active HD).  Continued efforts are needed to 1) normalise public attitudes 
towards patients with neurological conditions such as HD, so that they are not 
deterred from attending group exercise sessions and 2) provide specific training to 
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exercise instructors such that exercises may be tailored to suit individual needs 
based upon an understanding of disease features. 
Recommending physical activity early in life is preferential, regardless of gene status, 
as the life-long effects are likely to be cumulative.  In the case of HD, introducing 
exercise into their daily routine early in the disease process may have several 
additional advantages.  For example, where perseverative symptoms are typical as 
the disease progresses, introducing physical activity into a patient’s routine later in 
the disease may be particularly challenging, and require more motivation from the 
carer.  Introducing physical activity earlier in life, before symptoms manifest, may 
have better uptake, provide additional benefits and have greater longevity in terms 
of persevering with the exercise as the disease progresses.  There remains a lack of 
clear-cut research in humans that demonstrates the benefits of exercise, although 
evidence from this study found that self-reported quality of life was higher in fitter 
subjects.  Feedback from patients studied in Chapter 4 suggested that they were 
reluctant to introduce additional complexity into their lives as they did not believe it 
would have much direct benefit on their physical prognosis.  Longitudinal studies in 
pre-symptomatic patients are warranted to explore the lasting benefits of exercising 
and combined with sensitive outcome measures so that the benefits can be captured 
and conveyed to patients in a convincing way.
6.6.2. Exercise Mimetics
Where exercise prescription in HD is inherently challenging, pharmacological 
compounds that mimic systemic and central effects of exercise, ‘exercise mimetics’ 
is appealing. In vivo and in vitro research has identified metabolic networks of 
transcriptional activators and interconnected enzymes known to be implicated in 
muscle metabolism such as the AMPK-SIRT1-PGC-1 pathway in response to 
exercise (Guerrieri et al., 2017). The most well-known of these compounds are 
metformin, GW501516 and AICAR (5-Aminoimidazole-4-carboxa-mide 
ribonucleotide). AICAR is the analog of AMP and intermediate metabolite of the 
purine synthesis pathway and has been found to affect many organs and regulate a 
range of metabolic processes by replicating some of the effects of exercise e.g. 
increasing glucose transporter type-4 (GLUT-4), hexokinase activity, resting 
glycogen content and muscle mitochondria numbers (Lauritzen et al., 2013; Sánchez 
Chapter 6
209
et al., 2013).  AICAR has also reported to increase angiogenesis and vascularization 
by inducing VEGFa expression in muscle, in a similar way to exercise (Ouchi et al., 
2005). It is currently unclear however, to what extent this compound can cross the 
blood brain barrier. Short-term but not long-term treatment has been found to 
increase BDNF levels, neuronal proliferation and spatial memory in the dentate gyrus 
(Kobilo et al., 2011), but this effect was not stable after 14 days where AICAR 
appears to upregulate expression of apoptotic genes and inflammatory cytokine 
interleukin-1β (Guerrieri and van Praag, 2015). Dietary supplements such as 
resveratrol and (-) epicatechin (van Praag et al., 2007) have found similar benefits to 
exercise in mice with evidence demonstrating improved spatial memory, increased 
dentate granule cell spine density, neurogenesis, hippocampal vascularization, 
neuroprotection following ischemia and expression of genes implicated in synaptic 
plasticity (Guerrieri et al., 2017).
A mounting array of evidence has shown the benefits of resveratrol in in vitro and in 
vivo models of Huntington’s Disease, in which function of the principal metabolic 
regulator, peroxisome proliferator-activated receptor gamma coactivator-1α (PGC-
1α), is significantly impaired. Resveratrol has been shown to rescue mutant 
polyglutamine–specific cell death in cultured striatal neuronal cells derived from Hdh 
Q111 knock-in mice via Sir2 activation (Parker et al., 2005). Furthermore, treatment 
with Resveratrol for 45 days (5days/week) in N171-82Q HD transgenic HD mice, 
yielded a significant elevation of PGC-1α and NRF-1 mRNA expression was reported 
in the cortex, but not striatum, nor was it related to striatal atrophy or motor function 
(Ho et al., 2010).  Together, an increasing understanding of the functioning of 
metabolic pathways implicated in both Huntington’s disease and physical exercise, 
appear to be converging on similar pharmacological targets.  Drugs that mimic 
systemic and central effects of exercise are promising as they remove multiple 
challenges associated with exercising, however care should be taken, since the 
cacophony of benefits associated by exercise may not be recreated by a pill alone. 
The effects of exercise-mimetics on central versus peripheral systems is currently 
limiting the viability of these pharmacological alternatives (Guerrieri et al., 2017) and 
the effects of such compounds on cerebrovascular function is needed.
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6.7. Theoretical and practical considerations.
6.7.1. Sample size
Neuroimaging studies are costly, time-consuming and strict criteria exist for 
participant inclusion. It is acknowledged that the sample sizes adopted in all the 
studies presented in this thesis are small.  Where correlational analysis and 
multifactorial designs are used, it is possible that some of the results in this study 
may be hampered by this low statistical power. Nonetheless, these practical 
challenges were unavoidable given the timescale and budget. Participants in 
Chapter 2 were recruited from an existing cohort at the University of South Wales, of 
which only 11 participants were eligible to take part in the follow up MRI study at 
Cardiff University and it was not possible to extend the study.  Recruitment of 
participants in Chapter 4, was impressive given the number of exclusion criteria 
present in this study and the time commitment required of these patients, however 
further recruitment was prevented due to closure of the MRI scanner.  Animal studies 
were also limited in power due to limited number of running wheels, housing costs 
and longitudinal MRI costs.
6.7.2. Assessment of cardiorespiratory fitness
O2MAX is currently considered to be the ‘gold-standard’ measure of cardiorespiratory 
fitness, however a few practical issues were raised in the present study.  Future work 
should consider using a semi-recumbent cycle ergometer to maximise safety in those 
who have balance issues. As mentioned in Chapter 4, participants struggled to push 
through the steep load transitions, where it appeared that muscle fatigue and/or 
motivation caused them to terminate exercise before they reached their aerobic 
threshold.  Previous studies have used predictive O2MAX tests where symptomatic 
patients were unable to complete a full protocol (Quinn et al., 2016b).  The present 
study included all subjects, regardless of whether they completed a valid test, 
reporting the peak O2 at the point of subjective exhaustion since exclusion of 
patients who did not complete a valid test would have resulted in even lower power.   
It is possible that the reliability of this measure may have influenced the results of 
this study, however in the absence of a strong alternative, O2PEAK was the most 
informative available measure of cardiorespiratory fitness.  
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6.7.3. Correction of partial volume effects
Atrophy was visible in many HD patients such that a corrective step was included in 
our analysis to minimise partial volume effects.  Other ASL studies in HD have used 
corrective measures, by spatial erosion of subcortical masks or by including cortical 
thickness as a co-variate (Chen et al., 2012), however this is not a robust way to 
remove intra-voxel partial-volume effects. The current measure used a Bayesian 
approach which employs a probabilistic kinetic curve analysis, using adaptive spatial 
priors and has therefore been found to preserve spatial detail better than the more 
standard linear regression approach (Chappell et al., 2011).   Inflation of CBF 
estimates in HD subjects than controls was found, suggesting that PVC should be 
recommended as a critical step in all ASL analysis, especially in those where atrophy 
is hypothesised.  Cortical thickness and volumetric differences were not reported in 
this thesis, however planned analysis is underway to assess atrophy and will also 
cross-reference these volumetric differences with the degree of partial volume 
correction observed.  
6.7.4. Cross-species translation
Translation between the human and rodent findings in this thesis is a challenge and 
it is acknowledged that very different designs were used to probe the question of 
physical activity.  It is possible to measure  O2MAX in rodents , using calorimetry in 
metabolic treadmill chambers (Schefer and Talan, 1996), and studies have yielded 
similar age-related alterations in O2MAX as human studies.   This requires a complex 
setup and is considered extremely stressful for the animal, which in this study would 
likely interfere with our outcome measurements, particularly in HD mice.  
Alternatively, an interventional design could have been used in the human study to 
assess the effects of a long-term exercise intervention.  Such interventions are time 
consuming and costly, such that it was deemed sensible to assess the relationship 
with fitness in a cross-sectional design as a proof of principle study prior to 
developing an intervention.  It is also unknown how long an intervention would need 
to be in order to detect cerebral benefits, and study retention over long periods could 
be extremely challenging in HD patients.  Plans are currently ongoing to include a 
neuroimaging arm into an exercise randomised controlled trial in HD patients. 
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In planning these experiments, age of the rodent cohorts was chosen to be as 
analogous as possible to the human cohorts.  A young-adult age (8 weeks) was 
chosen in Chapter 3 and Chapter 5, albeit slightly older in Chapter 5 (10 weeks). 
Time of onset in the HD condition is dependent upon several factors, particularly 
CAG repeat length, which can influence the age of disease onset. Pre-symptomatic 
patients varied in age, whereas all mice were the same age and expected to have a 
similar age of disease onset. Because the human condition is so heterogeneous, 
translating disease stage across species is a practical challenge and should be 
considered carefully in future studies. 
6.8. Concluding Remarks
The research undertaken in this thesis explored the benefits of physical activity on 
markers of cerebrovascular health in both humans and mice.  Clinical application of 
exercise as a therapeutic was explored by addressing this question in Huntington’s 
Disease, both in HD patients and in a transgenic HD mouse model.   It is not known 
at exactly what stage cerebrovascular function becomes jeopardised in Huntington’s 
disease. However, evidence in young healthy adult subjects suggests that the 
benefits of exercise on cerebrovascular health can begin early in life.  Whether these 
benefits of exercise translate to improved cerebrovascular health in HD, however, 
remains unknown. Future work should aim to incorporate ASL imaging into 
longitudinal exercise studies in HD patients, such that its efficacy for identifying the 
progression of cerebrovascular decline can be explored in the same subjects.   
Where thorough fitness tests may not be feasible in HD, it is also recommended that 
a self-reported measure of physical activity, or activity monitoring, be assessed in all
neuroimaging studies such that the importance of physical activity as a covariate can 
be explored.  The findings in the present thesis attempt to bridge the gap between 
preclinical and clinical understanding of the importance of exercise in healthy 
subjects and in those with HD.  Addressing the complex mechanisms in preclinical 
models is essential in unpacking the relevance of changes seen in humans and the 
emphasis on collaboration between preclinical and clinical imaging centres should 
be promoted.
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